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SUMMARY
UV fi lters are widely and increasingly used in sunscreens for direct protection of the skin, in 
a variety of cosmetic products and other materials. Organic UV fi lters have environmental 
relevance, because of their demonstrated occurrence in aquatic ecosystems and their estrogenicity, 
antiestrogenic and antiandrogenic activity in mammalian systems. However, it remains unclear 
whether environmental concentrations of UV fi lters negatively affect the hormone system of 
aquatic organisms, and the ecotoxicological risk is unknown.
This dissertation was aimed at fi lling some of these signifi cant gaps by investigating the hormonal 
activity of UV fi lters towards aquatic organisms by the use of a series of ecotoxicological in vitro 
and in vivo assays. The overall goal was to evaluate the estrogenic, aniestrogenic, androgenic 
and antiandrogenic activity in vitro of a series of single UV fi lters and estrogenic mixtures 
activities thereof. In addition the estrogenic and thyroid activity in vivo was evaluated in order 
to understand the hormonal activity and ecokinetics in important aquatic organisms, such as 
fi sh and frogs.
All 19 compounds analysed in vitro showed hormonal activities, surprisingly most of them 
multiple activities. Ten UV fi lters possessed estrogenic, 14 antiestrogenic, 6 androgenic and 
17 antiandrogenic activities in recombinant yeast. Similar estrogenic activities were found in 
the two yeast systems, carrying either a hERα but also toward rtERα. To our surprise most UV 
fi lter mixtures are synergistic, especially when mixed at their NOEC.
Our experiments in vivo in juvenile fathead minnows showed that three UV fi lters were estrogenic 
in vivo and that the in vitro systems have a predictive value. The strongest of these UV fi lters, 
3BC, adversely affected reproduction in fi sh. On the other hand the UV fi lters 4MBC and 
3BC did not negatively affect metamorphosis and sex development of frogs at concentrations 
expected to be found in the environment. 
Our study reveals a novel and more detailed picture of the hormonal activity of UV fi lters, 
as single compounds and in mixtures, in vitro and in vivo. It discloses unexpected multiple 
hormonal activities and synergistic properties of these compounds in vitro and an unexpected 
negative effect on fi sh reproduction by the UV fi lter 3BC at nearly environmentally relevant 
concentrations in vivo. Hence, diverse hormonal activities of UV fi lters found in this study are 
of signifi cant scientifi c and practical interest.
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ZUSAMMENFASSUNG
UV-Filter fi nden zum Schutze der Haut eine breite und zunehmende Anwendung in 
Sonnenschutzmitteln, unterschiedlichsten kosmetischen Produkten und anderen Materialien. 
Organische UV-Filter gewannen an Umweltrelevanz wegen  nachgewiesener Rückstände 
im aquatischen Ökosystem und ihrer östrogenen, antiöstrogenen, und antiandrogenen 
Aktivitäten in Säuger-Systemen. Trotzdem ist es bisher weitgehend unklar ob sich diese 
Umweltkonzentrationen negativ auf das Hormonsystem aquatischer Organismen auswirken 
und auch das ökotoxikologische Risiko das von diesen Substanzen ausgeht ist unbekannt.
Das Ziel dieser Dissertation war es, einige dieser relevanten Lücken zu füllen indem eine Serie 
von ökotoxikologische In vitro- und In vivo-Untersuchungen durchgeführt wurden. In vitro 
wurde die östrogene, antiöstrogene, androgene and antiandrogene Aktivität von einer Serie 
von UV-Filtern, sowie auch Mischungskombinationen davon, untersucht. Die östrogene und 
thyroide Aktivitäten dieser Substanzen wurde ausserdem in vivo untersucht um die hormonelle 
Aktivität  und Ökokinetik in relevanten aquatischen Organismen, wie Fischen und Fröschen, 
zu verstehen.
Alle 19 untersuchten Substanzen besassen in vitro hormonelle Aktivitäten, überraschenderweise 
die meisten davon multiple. Zehn UV-Filter zeigten in der rekombinanten Hefe östrogene 
Aktivität, 14 antiöstrogene, 6 androgene und 17 antiandrogene Aktivität. Ähnliche östrogene 
Aktivitäten könnten in den beiden Hefesystemen nachgewiesen werden, ob sie nun einen a hERα 
oder einen rtERα trugen. Zu unserer Überraschung zeigtne die meisten UV-Filter Mischungen 
synergistische Aktivität, vor allem wenn sie bei NOEC Konzentrationen gemischt wurden.
Unsere in vivo Experimente mit juvenilen Dickkopfelritzen zeigten, dass 3 UV-Filter auch in 
vivo östrogene Aktivität besitzen und dass die benutzten In vitro-Systeme  prädikativen Wert 
haben. Der stärkste dieser UV-Filter, 3BC, beeinträchtigte negativ das Fortpfl anzungsverhalten in 
Fischen. Andererseits hatten die UV-Filter  4MBC und 3BC, in Konzentrationen die in der Umwelt 
zu erwarte wären, keine Auswirkungen auf die Metamorphose und Geschlechtsentwicklung 
beim afrikanischen Krallenfrosch
Die Resultate unserer Studie zeichnen ein neues, detaillierteres Bild der hormonellen Aktivität 
von UV-Filtern, bezüglich Einzelsubstanzen wie auch Mischungen, in vitro wie in vivo. In vitro 
sie zeigt die unerwarteten multiplen hormonellen Aktivitäten dieser Substanzen wie auch deren 
synergistische Eigenschaften in Mischungen. In vivo der UV-Filter 3BC führte zu unerwarteten 
negativen Fortpfl anzungs-Effekten bei Fischen bei schon beinahe umweltrelevanten 
Konzentrationen. Die diversen hormonellen Aktivitäten von UV-Filtersubstanzen, die in dieser 
Arbeit aufgedeckt wurden, zeigen, dass diese Substanzen von wissenschaftlichem wie auch 
praktischem Interesse sind.
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Short introduction on endocrine disrupting chemicals
Chemicals present in the environment that possess the ability to disrupt the endocrine system 
of humans and animals, are of high ecotoxicological importance. Potentially the can affect the 
survival of populations and even the species. The identifi cation of endocrine disrupting chemicals 
(EDC) has increased our knowledge about potential hazards and effects on reproduction as 
well as their mechanism of action. Organisms exposed to EDC can suffer from several effects. 
The development and quality of sperms and eggs can be negatively affected, as well as sex 
development and determination. Reproductive behaviour can be altered, fertility reduced and 
the biological sex reversed. Up to now at least 150 chemicals were identifi ed, which interact 
with the endocrine system and may negatively affect reproduction (Damstra et al., 2002).
Thus far, endocrine disruption has been mostly concerned with estrogenic compounds because 
of the discovery that certain chemicals  and sewage effl uents were estrogenic and fi eld studies 
showed that estrogenic effects occur in wild fi sh (Tyler et al., 1998). Only in the last few years, 
antiandrogenic compounds (Kelce et al., 1995; Vinggaard et al., 2005), and androgenic activities 
in the aquatic environment (Thomas et al., 2002) were identifi ed, originating for example from 
kraft mill effl uents . In fi sh polycyclic musks have found to be antiestrogenic (Schreurs et al., 
2004), but better known are antiandrogenic activities of compounds like p,p’-DDE, vinclozolin 
and  fenarimol (Vinggaard et al., 2005). Relatively few environmental contaminants have been 
shown to exhibit antagonistic besides agonist activity to steroid hormone receptors. For instance, 
alkylphenols elicited estrogenic and antiandrogenic activity in vitro (Sohoni and Sumpter, 1998), 
similarly to bisphenol A (Lee et al., 2003) and methoxychlor , to name a few chemicals. In the 
fi elds of endocrinology and pharmacology, on the other hand, multiple hormonal activities were 
investigated extensively, especially on the receptor level.  For instance drugs targeted to the 
estrogen receptor (ER) were found to be selective receptor modulators (SRM’s, for a detailed 
review see (Smith and O'Malley, 2004)) with partial agonistic activities towards the receptor, 
like the weakly estrogenic tamoxifen which acts antiestrogenic in the presence of estradiol (E2) 
(Jordan et al., 1987). Few studies have investigated multiple endocrine disrupting mechanisms 
of environmental contaminants. The pyrethroid insecticide fenvalerate was found to possess 
estrogenic as well as anti-progesteronic activity in vitro (Garey and Wolff, 1998). Pesticides 
have been shown to have agonist and/or antagonists activities with one or more receptors 
(Andersen et al., 2002; Kojima et al., 2004). Despite this knowledge, most chemicals found 
in the environment have not been analysed systematically either for agonist and antagonist 
activities, or different steroid receptors. Therefore, it remains elusive to what extent multiple 
hormonal activities are a common feature of hormonally active compounds.
Chapter 1
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UV fi lters – Application, use and environmental concentrations
This dissertation focuses on organic ultraviolet absorbing chemicals (UV fi lters), a group 
of chemicals which is currently of concern because of the demonstrated hormonal activity. 
UV fi lters are widely used in sunscreens for direct protection of the skin against erythema 
and cancer, in a variety of cosmetic products and in the UV protection of plastic products. 
They are added to sunscreens and cosmetics including lipsticks, skin lotions, hair sprays, hair 
dyes, shampoos, and numerous other products like moldings, jet ink, tyres and fabrics contain 
increasing amounts of UV fi lters protecting from ultraviolet (UV) radiation. Either organic UV 
fi lters, or inorganic micropigments (ZnO, TiO2), or combination of both are applied in order 
to absorb, scatter and refl ect UV light. Increased sunlight protection factors are being used for 
preventing negative effects on the human skin, which generally requires higher percentages of 
UV fi lters in the products. 
Commonly, combinations of several different UV fi lters are added to sunscreens, cosmetics and 
other materials, depending on the desired protection factor and range. By using sunscreens and 
personal care products different UV fi lters are applied on human skin, thus it is no surprise that 
humans can be exposed to UV fi lters via dermal absorption or food.  Residues of benzophenone-
3 (BP3) and octyl methoxycinnamate (OMC) were found in human breast milk samples up to 
445 ng/g lipid (Hany and Nagel, 1995).  In human urine, BP3 and its metabolite benzophenone-
1 (BP1) have been detected 4 h after application of commercially available sunscreen products 
to the skin (Felix et al., 1998).
However, the high consumption volumes combined with critical physico-chemical properties 
such as environmental persistence and high lipophilicity (log Kow 3-7), make UV fi lters also 
of potential environmental concern. Consequently it is not surprising that residues of UV fi lters 
have been detected in the environment, particularly in the aquatic environment. They enter 
the aquatic system either directly into surface water via recreational activities (bathing) or 
indirectly via wastewater.  Hence residues of several UV fi lters have been detected in lake 
and river water in the range of 2-80 ng/L (Poiger et al., 2004) and in treated wastewater up to 
2300 ng/L (Balmer et al., 2005). In southern California two UV fi lters (benzophenone, octyl 
methoxycinnamate (OMC)) were found in the range of 0.26 to 5.61 µg/L in raw and treated 
drinking water (Loraine and Pettigrove, 2006) . 
As UV fi lters are most likely relatively stable in the aquatic environment (Poiger et al., 2004; 
Balmer et al., 2005) they are critical for bioaccumulation. Indeed, residues of several UV fi lters 
have been detected at concentrations of 21-3100 ng/g lipid in fi sh (Balmer et al., 2005). In lake 
fi sh four different UV fi lters were identifi ed in a recent monitoring study In recent monitoring 
studies in lake fi sh 4-methylbenzylidene camphor (4MBC), benzophenone-3 (BP3), OMC, and 
octocrylen (OC) were found up to concentrations of  2’400 ng/g (Balmer et al., 2005; Buser et 
al., 2006).
General Introduction
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UV fi lters as endocrine disrupting chemicals
Besides being present in the environment, UV fi lters recently gained importance because 
of their reported estrogenic activity in vitro and in vivo. Some UV fi lters were found to be 
estrogenic in vitro in MCF-7 cells , recombinant cell lines (Schreurs et al., 2002; Mueller et al., 
2003) and recombinant yeast systems carrying the human ERα (Routledge and Sumpter, 1997; 
Schultz et al., 2000; Kunz and Fent, submitted). Estrogenic activity has also been observed 
in vivo in rats (Durrer et al. 2005; Schlumpf et al. 2001; Seidlová-Wuttke et al. 2004) and 
fi sh. In rats 3BC, 4MBC, OMC, benzophenones-2 (BP2), bezophenone-3 (BP3) and 4,4-
dihydroxybenzophenone (4DHB) elicited estrogenic effects (Schlecht et al., 2004). In rainbow 
trout 3BC led to vitellogenin induction (Holbech et al., 2002), whereas 4MBC and OMC were 
found to be estrogenic in male medaka (Inui et al., 2003). Besides being estrogenic, some UV 
fi lters such 4MBC, homosalate (HMS) and BP3 showed antiestrogenic activity (Schreurs et al., 
2002; Mueller et al., 2003), and BP3 and HMS had antiandrogenic activity in vitro (Ma et al., 
2003; Schlumpf et al., 2004). However, it is not known whether multiple hormonal activities 
are a common feature of these compounds. 
 
Despite the increasing amount of literature on environmental residues and endocrine disruption 
properties of UV fi lters it remains unclear whether environmental concentrations of UV 
fi lters negatively affect the hormone system of aquatic organisms. Due to the lack of data on 
the ecotoxicological and hormonal activity of UV fi lters, currently an ecotoxicological risk 
assessment for aquatic organisms is unthinkable unless suffi cient data are generated in the near 
future.
Objectives
This dissertation is aimed at fi lling these signifi cant gaps by the use of a series of ecotoxicological 
in vitro and in vivo assays. The overall goal is to evaluate the estrogenic, antiestrogenic, 
androgenic and antiandrogenic activity of a series of single UV fi lters. Furthermore estrogenic 
mixtures activities in vitro will be evaluated. In addition, the estrogenic and thyroid activity in 
vivo will be assessed in order to understand the hormonal activity and ecokinetics in important 
aquatic organisms such as fi sh and frog.
In order to shed some light on other possible endocrine properties of UV fi lters, especially as 
these compounds are found in surface waters and fi sh (Balmer et al., 2005; Buser et al., 2006), 
we screened 19 compounds for their hormonal activity in vitro. We used a reporter gene assay 
with recombinant yeast carrying either a human estrogen (hERα) or androgen (hAR) receptor 
in order to investigate the estrogenic, antiestrogenic, androgenic and antiandrogenic activity of 
these UV fi lters. We compared the estrogenic activities of UV fi lters found in the hERα with 
Chapter 1
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their estrogenic activities in a recombinant yeast system carrying a rainbow trout ER (rtERα). 
We also evaluated their predictive value when compared with results of in vivo experiments in 
fi sh.
With the UV fi lters found to be estrogenic towards the hERα we furthermore conducted mixture 
experiments where UV fi lters were combined at low and no observed effect concentrations in 
order to fi nd out whether and how the estrogenic and/or antiestrogenic activity of single UV 
fi lters contribute to mixture effects.
We further examined the estrogenic activity of 9 major UV fi lters in fi sh in vivo, which are 
important representatives of aquatic organisms, and evaluated whether the estrogenic activity 
in vitro translates to in vivo. We fi rst performed a short-term experiment with juvenile fathead 
minnows (Pimephale promelas), in order to investigate whether these nine UV fi lters lead to 
vitellogenin (VTG) induction as a biomarker for estrogenic activity. Second we investigated 
whether the most potent UV fi lter of the short-term experiment, 3BC, adversely affects 
reproduction in fathead minnows.
In addition we investigated in frogs, Xenopus laevis, as another important representative for 
aquatic organisms, whether two UV fi lters, 4MBC and 3BC, interfere with the thyroid and sex 
hormone system during frog metamorphosis. 
In order to estimate actual effect concentrations in ecotoxicological experiments with fi sh and 
frog we modifi ed an existing GC/MS method, (Poiger et al., 2004; Balmer et al., 2005) for the 
analysis of the UV fi lters 4MBC and 3BC. We subsequently extended it for the analysis of 9 
different UV fi lters used in the fi sh experiments by developing a method based on solid phase 
extraction followed by analysis with HPLC-DAD.
Ultimately the aim of the thesis was to gain a better knowledge on the hormonal activities of 
UV fi lters by using in vitro and in vivo systems. These data should help to better understand the 
potential hazards and risks associated with these compounds in aquatic ecosystems.
The thesis is presented in 8 chapters, examining hormonal activity of UV fi lters toward the 
aquatic ecosystem as follows:
CHAPTER 1 gives a general introduction to the topic and the study
CHAPTER 2 addresses the hormonal activity of 19 commonly used UV fi lters in vitro 
by employing a recombinant yeast system carrying either a human estrogen (hERα) or 
androgen (hAR) receptor. In a systematic manner the UV fi lters are screened for estrogenic, 
antiestrogenic, androgenic and antiandrogenic activity. Furthermore one estrogenic UV fi lter, 
General Introduction
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ethyl 4-aminobenzoate (Et-PABA), was evaluated for its estrogenicity in a recombinant yeast 
assay carrying a rainbow trout ER (rtERα) and for vitellogenin induction in vivo in juvenile 
fi sh (Pimephales promelas). This approach enables to evaluate whether results in the hERα are 
transferable to the rtERα in vitro, and to what extend this may translate to activity in fi sh in 
vivo.
CHAPTER 3  addresses the hormonal activity of UV fi lter mixtures. For the mixture components 
commonly used UV fi lters were selected, which were demonstrated to be pure hERα agonists 
(BP1, BP2, 4DHB and Et-PABA) or partial hERα agonists (BP3, BS, PS and 3BC) in vitro in 
Chapter 1. The mixture activities of 2, 4 and 8 UV fi lters, with and without E2, are investigated 
at different effect levels and at the no observed effect level concentration (NOEC). This question 
is important as commonly combinations of several different UV fi lters are added to sunscreens 
and cosmetics and are applied on human skin. As they enter the aquatic ecosystem as mixtures; 
increasing attention should be paid on the mixture effects.
CHAPTER 4 addresses the modifi cation of an existing GC/MS method (Poiger et al., 2004; 
Balmer et al., 2005) and its extension for the analysis of 9 different UV fi lters in experimental 
waters by a method based on solid phase extraction followed by analysis with HPLC-DAD. 
Accurate detection of UV fi lters in water of ecotoxicological experiments with fi sh and frogs is 
crucial for the determination of exposure and effect concentrations. 
CHAPTER 5 addresses the estrogenic activity of commonly used UV fi lters in fi sh and 
elucidates whether estrogenic activity of chemicals is best assessed by the use of a tiered 
approach using a combination of in vitro and in vivo assays of the same phyla. Therefore 
estrogenicity of 8 UV fi lters is assessed in juvenile fathead minnows (Pimephales promelas), 
by means of vitellogenin induction. The estrogenic activity in fi sh is then compare with in vitro 
activities of these UV fi lters in two in vitro systems carrying either a fi sh or the human ERα. 
CHAPTER 6 evaluates whether a common UV fi lter, 3BC, adversely affects reproduction 
in fathead minnows. In this thesis, 3BC was previously found to be estrogenic in vitro and in 
vivo (Chapter 1 and 4). Adult fathead minnows were exposed for 21 days to fi ve increasing 
concentrations of 3BC and parameters for endocrine disruption, such as fecundity, vitellogenin 
induction, secondary sex characteristics and gonad histology were investigated. 
CHAPTER 7 elucidates possible activities of the two UV screens, 4-methylbenzylidene 
camphor (4MBC) and 3-benzylidene camphor (3BC), towards the thyroid and sex hormone 
system of frogs Xenopus laevis. It investigates whether these UV fi lters negatively affect 
metamorphosis, which is regulated by the thyroid system, and sex development of frogs at 
concentrations expected to be found in the environment. 
Chapter 1
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CHAPTER 8 gives a general conclusion and outlook 
Our fi ndings reveal a novel picture of the hormonal activities of UV fi lters and address the 
question of their modes of action. All 19 compounds analysed in vitro showed hormonal 
activities, surprisingly most of them multiple activities. Ten UV fi lters possessed estrogenic, 
14 antiestrogenic, 6 androgenic and 17 antiandrogenic activities in recombinant yeast. Similar 
estrogenic activities were found in the two yeast systems, carrying either a hERα but also 
toward rtERα. To our surprise most UV fi lter mixtures are synergistic, especially when mixed 
at their NOEC.
Our experiments in vivo in juvenile fathead minnows showed that in vitro systems had a 
predictive value. It did not predict false negatives and three UV fi lters were estrogenic in vivo 
leading to signifi cant vitellogenin induction. The strongest of these UV fi lters, 3BC, adversely 
affected reproduction in fi sh in a dose-dependent manner. On the other hand the UV fi lters 
4MBC and 3BC did not negatively affect metamorphosis and sex development of frogs at 
concentrations expected to be found in the environment. 
Our in vitro and in vivo fi ndings on hormonal activity of UV fi lters indicate the need for a 
tiered approach combining in vitro and in vivo assessments for ecological risk assessment. 
They raise the question whether UV fi lter residues found in the environment are potentially 
able to adversely affect aquatic organisms with their multiple hormonal activities. In particular 
the substantial mixture effects even though each UV fi lter was present below its NOEC level, 
and the ability of 3BC to negatively affect fi sh reproduction at rather low concentrations 
demonstrate potential ecotoxicological hazard and risks and the environmental importance of 
these compounds.
References
Andersen, H. R., Vinggaard, A. M., Rasmussen, T. H., Gjermandsen, I. M., Bonefeld-Jorgensen, E. C., 2002. 
Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in 
vito. Toxicol. Appl. Pharmacol. 179, 1-12.
Balmer, M., Buser, H. R., Müller, M. D., Poiger, T., 2005. Occurrence of some organic UV fi lters in wastewater, in 
surface waters, and in fi sh from Swiss lakes. Environ. Sci. Technol. 39, 953-962.
Buser, H. R., Balmer, M. E., Schmid, P., Kohler, M., 2006. Occurence of UV fi lters 4-methylbenzylidene camphor 
and octocrylene in fi sh from various swiss rivers with inputs from wastewater treatment plants. Environ. 
Sci. Technol. 40, 1427-1431.
Damstra, T., Barlow, S., Bergmann, A., Kavlock, R., Van Der Kraak, G., 2002. Global assessment of the state-of-
the science of endocrine disruptors. Geneva, Word Health Organisation, International Health Programme 
on Chemical Safety.
Felix, T., Hall, B. J., Brodbelt, J. S., 1998. Determination of benzophenone-3 and metabolites in water and human 
urine by solid-phase microextraction and quadrupole ion trap GC-MS. Anal. Chim. Acta 371, 195-203.
Garey, J., Wolff, M. S., 1998. Estrogenic and antiprogestagenic activities of pyrethroid insecticides. Biochem. 
Biophys. Res. Com. 251, 855-859.
General Introduction
- 16 -
Hany, J., Nagel, R., 1995. Nachweis von UV-Filtersubstanzen in Muttermilch. Deut. Lebensm.-Rundsch. 91(11), 
341-345.
Holbech, H., Norum, U., Korsgaard, B., Bjerregaard, P., 2002. The chemical UV-fi lter 3-benzylidene camphor 
causes an oestrogenic effect in an in vivo fi sh assay. Pharmacol. Toxicol. 91, 204-208.
Inui, M., Adachi, T., Takenaka, S., Inui, H., Nakazawa, M., Ueda, M., Watanabe, H., Mori, C., Iguchi, T., Miyatake, 
K., 2003. Effect of UV-screens and preservatives on vitellogenin and choriogenin production in male 
medaka (Oryzias latipes). Toxicology 194, 43-50.
Jordan, V. C., Phelps, E., Lindergreen, J. U., 1987. Effects of anti-estrogens on bone in castrated and intact female 
rats. Breast Cancer Res. Treat. 10, 31-35.
Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., Wilson, E. M., 1995. Persistent DDT 
metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 375, 581-585.
Kojima, H., Katsura, E., Takeuchi, S., Niiyama, K., Kobayashi, K., 2004. Screening for estrogen and androgen 
receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese Hamster ovary cells. 
Environ. Health Perspect. 112(5), 524-531.
Kunz, P. Y., Fent, K., submitted. Multiple hormonal activities of UV fi lters in vitro.
Lee, H. J., Chattopadhyay, S., Gong, E. Y., Ahn, R. S., Lee, K., 2003. Antiandrogenic effects of bisphenol A and 
nonylphenol on the function of androgen receptor. Toxicol. Sci. 75, 40-46.
Loraine, G. A., Pettigrove, M. E., 2006. Seasonal variations in concentrations of pharmaceuticals and personal 
care products in drinking water and reclaimed wastewater in southern california. Environ. Sci. Technol. 
40, 687-695.
Ma, R., Cotton, B., Lichtensteiger, W., Schlumpf, M., 2003. UV fi lters with antagonistic action at androgen 
receptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol. Sci. 74, 43-50.
Mueller, S. O., Kling, M., Firzani, P. A., Mecky, A., Duranti, E., Shields-Botella, J., Delansorne, R., Borschard, 
T., Kramer, P. J., 2003. Activation of estrogen receptor α and ERβ by 4-methylbenzylidene-camphor in 
human an rat cells: comparison with phyto- and xenoestrogens. Toxicol. Lett. 142, 89-101.
Poiger, T., Buser, H. R., Balmer, M., Bergqvist, P. A., Müller, M. D., 2004. Occurrence of UV fi lter compounds 
from sunscreens in surface waters: regional mass balance in two Swiss lakes. Chemosphere 55, 951-
963.
Routledge, E. J., Sumpter, J. P., 1997. Structural features of alkylphenolic chemicals associated with estrogenic 
activity. J. Biol. Chem. 272(6), 3280-3288.
Schlecht, C., Klammer, H., Jarry, H., Wuttke, W., 2004. Effects of estradiol, benzophenone-2 and benzophenone-
3 on the expression pattern of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related 
receptor 1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats. Toxicology 205, 
123-130.
Schlumpf, M., Schmid, P., Durrer, S., Conscience, M., Maerkel, K., Henseler, M., Gruetter, M., Herzog, I., Reolon, 
S., Ceccatelli, R., Faass, O., Stutz, E., Jarry, H., Wuttke, W., Lichtensteiger, W., 2004. Endocrine acitivity 
and developmental toxicity of cosmetic UV fi lters - an update. Toxicology 205, 113-122.
Schreurs, R. H., Lanser, P., Seinen, W., Van der Burg, B., 2002. Estrogenic activity of UV fi lters determined by an 
in vitro reporter gene assay and in vivo transgenic zebrafi sh assay. Arch. Toxicol. 76, 257-261.
Schreurs, R. H., Legler, J., Artola-Garicano, E., Sinnige, T. L., Lanser, P. H., Seinen, W., Van der Burg, B., 2004. 
In vitro and in vivo antiestrogenic effects of polycyclic musks in zebrafi sh. Environ. Sci. Technol. 38(4), 
997-1002.
Schultz, T. W., Seward, J. R., Sinks, G. D., 2000. Estrogenicity of benzophenones evaluated with a recombinant 
yeast assay: Comparison of experimental and rules-based predicted activity. Environ. Toxicol. Chem. 19, 
301-304.
Smith, C. L., O'Malley, B. W., 2004. Coregulator function: A key to understanding tissue specifi city of selective 
receptor modulators. Endocr. Rev. 25(1), 45-71.
Sohoni, P., Sumpter, J. P., 1998. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158(3), 
327-339.
Thomas, K. V., Hurst, M. D., Matthiessen, P., McHugh, M., Smith, A., Waldock, M. J., 2002. An assessment of in 
vitro androgenic activity and the identifi cation of the environmental androgens in the United Kingdom 
estuaries. Environ. Toxicol. Chem. 21, 1456-1461.
Tyler, C. R., Jobling, S., Sumpter, J. P., 1998. Endocrine disruption in wildlife: a critical review of the evidence. 
Crit. Rev. Toxicol. 28(4), 319-61.
Vinggaard, A. M., Jacobsoen, H., Metzdorff, S. B., Andersen, H. R., Nellemann, C., 2005. Antiandrogenic effects 
in short-term in vivo studies of the fungicide fenarimol. Toxicology 207(1), 21-34.
Chapter 1
- 17 -
Acknowledgments
First of all, I want to express my gratitude to my supervisor Karl Fent who gave me the opportunity 
to do this thesis. He introduced me to the fascinating world of ecotoxicology and guided me through 
a very interesting topic. His trust in me, his fl exibility and open mindedness made the last four years 
to a time in my life, that I enjoyed very much. His moral and practical support helped me in times, 
when things did not go so smoothly, and also in times when I was too optimistic. I appreciated 
our inspiring scientifi c discussions about the study-design, amendments, future perspectives, and 
how to write a good discussion, and I also appreciated our non-scientifi c discussions very much. 
Especially, I highly appreciate the time and effort he put into critically reading and reviewing of all 
my writings, in particularly at the end of my thesis, so that I was able to fi nish “in time”. I could not 
have wished for a better supervisor. 
I also want to express my gratitude to Prof. Friedrich Jüttner and Prof. Jakob Pernthaler, who gave 
me the feeling to belong to the Limnological Station, although I did my thesis in Basel. I highly 
appreciated their interest in my thesis and their repeated invitations to give a talk and keep them 
up to date. Jakob Pernthaler I furthmore would lik to thank for his efforts at the end of my thesis. I 
appreciate that very much!
I am also very grateful to the Insitute of Environmental Technology  and the Department of Chemistiy 
and for giving me lab and work facilities and supported me. Especially I am very grateful to Markus 
Wolf, Thomas Heim, Ernst Hungerbühler, Hansrudolf Schmutz and Daniel Gygax who always gave 
me the feeling, that I was one of them. 
A great thank you goes to Hanruedi Schmutz and his analytics group for introducing me to SPE, 
HPLC and GC/MS and for valuable and great support in developing and testing several analytical 
methods in order to analyse my water and fi sh samples. Especially I would like to thank Beny 
Gygax, who helped me a lot with his critical and constructive suggestions and his dry humor.
Another great thank you goes to the people of bioanalytics lab for supporting me in every way. 
Especially Peter Spies, without whom I would be still unaware of how to use a pipette and who was 
the best room mate one could wish for! 
I would also like to thank the ecotoxicology group members Karl, Daniel, Anna, Christin, Claudia 
and Armin for your support and encouragement when needed. Anna, Daniel, Christin and Claudia, 
you are probably the best “fi sh test determination group” in the world. Daniel, thanks for making 
very serious jokes and being “Bündner”, Anna thanks for being also a little paranoid, Christine 
thanks for being my best “fi sh test partner” and “never tired egg counter”, and Claudia thanks for 
helping in fi sh matters and making me “sporty”. 
I would also like to sincerely thank Héctor Galicia and the Springborn Smithers Laboratories for 
providing an excellent laboratory to conduct all the in vivo experiments. Especially I would like to 
thank Thomas Gries for his support and advice during my “fi eldwork” at Springborn. Furthermore 
my thanks go also to Tony, Ceo, Lea, Karin, Alessandra, Daniela and all other Springborn people, 
who helped whenever I got lost and always had time to answer one of my questions, and for giving 
my some social life in Horn.
And more thanks go to all the other chemistry and IfU people who contributed to this thesis by just 
being as nice as they are: Illu, René, Eric, Viviane, Roger, Antje and Astha.
Furthermore I want to say thank you to all people who contributed to this thesis in their own 
wonderful way by being part of my life. Especially Rosine queen of frog dissections and other things, 
Vre, Sabine, Gabrie, Chandra, Nîck, Claudi, and all the others, whose names are too numerous to 
be listed here, they are and will be remembered. Deep thanks go to my parents and my brother, who 
let me grow and supported me.
And a very special thank goes to Lukas, who is the true home of my life.
General Introduction
- 18 -
Chapter 2
- 19 -
Chapter 2
Activity of UV fi lters towards the estrogen and androgen 
receptor and comparison of in vitro and in vivo activity of ethyl 4-
aminobenzoate in fi sh
Petra Y. Kunz and Karl Fent
accepted in Aquatic Toxicology
Hormonal activity of single UV fi lters
- 20 -
Abstract
UV fi lters have been detected in surface water, wastewater and fi sh, and some of them are 
estrogenic in fi sh. At present, little is known about their additional hormonal activities in different 
hormonal receptor systems despite their increasing use and environmental persistence. Besides 
estrogenic activity, UV fi lters may have additional activities, both agonistic and antagonistic 
in aquatic organisms. In our study, we investigate a series of UV fi lters for multiple hormonal 
activities in vitro in human receptor systems and evaluate the predictive value of these fi ndings 
for the activity in fi sh in vitro and in vivo. First we systematically analysed the estrogenic, 
antiestrogenic, androgenic, and antiandrogenic activity of 18 UV fi lters and one metabolite in 
vitro at non-cytotoxic concentrations with recombinant yeast systems carrying either a human 
estrogen (hERα  or androgen receptor (hAR). All 19 compounds elicited hormonal activities, 
surprisingly most of them multiple activities. We found 10 UV-fi lters having agonistic effects 
towards the hERα. Surprisingly, we identifi ed for the fi rst time 6 UV fi lters with androgenic 
activities and many of them having pronounced antiestrogenic and antiandrogenic activities. 
As much as 17 compounds inhibited 4,5-dihydrotestosterone activity in the hAR assay, while 
14 compounds inhibited estradiol activity in the hERα assay, indicating antiandrogenic and 
antiestrogenic activity, respectively. In particular, the antiandrogenic activities of phenyl- and 
benzyl salicylate, benzophenone-1 and -2, and of 4-hydroxybenzophenone were higher than 
that of fl utamide, a known hAR antagonist. 
In a second series of experiments, we investigated the predictive power of the hERα assay for 
aquatic organisms by further investigating the estrogenic UV fi lter ethyl 4-aminobenzoate (Et-
PABA) in vitro and in vivo in fi sh. Et-PABA showed estrogenic activity in a recombinant yeast 
system carrying the rainbow trout estrogen receptor (rtERα with higher activity than in the hERα  
assay. In addition, Et-PABA induced vitellogenin after 14 d of exposure in juvenile fathead 
minnows at 4’394 µg/L.Our study shows estrogenic activity of this UV fi lter in fi sh both in vitro 
and in vivo. In conjunction with in vitro human receptor-based systems our results give a more 
detailed picture about distinct hormonal activities of UV fi lters occurring in aquatic systems. 
We conclude that receptor-based assays are important for in vitro assessment of UV-fi lters prior 
to or concurrently with in vivo assays, which ultimately provide data for the environmental risk 
assessment of these important personal care products. 
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Introduction
Thus far, endocrine disruption has been mostly concerned with estrogenic compounds because 
of the discovery that certain chemicals (Soto et al., 1991) and sewage effl uents were estrogenic 
and fi eld studies showed that estrogenic effects occur in wild fi sh (Tyler et al., 1998). Only 
in the last few years, antiandrogenic compounds (Kelce et al., 1995; Vinggaard et al., 2005), 
and androgenic activities in the aquatic environment (Thomas et al., 2002) were identifi ed, 
originating for example from kraft mill effl uents (Parks et al., 2001). In fi sh polycyclic musks 
have found to be antiestrogenic (Schreurs et al., 2004), but better known are antiandrogenic 
activities of compounds like p,p’-DDE, vinclozolin (Kelce and Wilson, 1997) and  fenarimol 
(Vinggaard et al., 2005). Thus far, relatively few environmental contaminants have been shown 
to exhibit antagonistic besides agonist activity at steroid hormone receptors. For instance, 
alkylphenols elicited estrogenic and antiandrogenic activity in vitro (Sohoni and Sumpter, 
1998), similarly to bisphenol A (Lee et al., 2003) and methoxychlor (Maness et al., 1998), to 
name a few chemicals. In the fi elds of endocrinology and pharmacology, on the other hand, 
multiple hormonal activities were investigated extensively, especially on the receptor level.  For 
instance drugs targeted to the ER were found to be selective receptor modulators (SRM’s, for 
a detailed review see Smith and O’Malley (2004)) with partial agonistic activities towards the 
receptor, like the weakly estrogenic tamoxifen which acts antiestrogenic in the presence of E2 
(Jordan et al., 1987). Few studies have investigated multiple endocrine disrupting mechanisms 
of environmental contaminants. The pyrethroid insecticide fenvalerate was found to possess 
estrogenic as well as anti-progesteronic activity in vitro (Garey and Wolff, 1998). Pesticides 
have been shown to have agonist and/or antagonists activities with one or more receptors 
(Andersen et al., 2002; Kojima et al., 2004). Despite this knowledge, most chemicals found 
in the environment have not been analysed systematically either for agonist and antagonist 
activities, or different steroid receptors. Therefore, it remains elusive to what extent multiple 
hormonal activities are a common feature of hormonally active compounds.
Organic ultraviolet absorbing chemicals (UV fi lters) are currently of concern because of the 
demonstrated estrogenicity of some of these compounds (Miller et al., 2001; Schlumpf et al., 
2001). UV fi lters are widely used in sunscreens for direct protection of the skin against erythema 
and cancer, in a variety of cosmetic products and in the UV protection of plastic products. 
Thus it is no surprise that humans can be exposed to UV fi lters via dermal absorption or food. 
Residues of BP3 and OMC were found in human breast milk samples (Hany and Nagel, 1995). 
In human urine, BP3 and its metabolite benzophenone-1 (BP1) have been detected 4 h after 
application of commercially available sunscreen products to the skin (Felix et al., 1998). But 
the high consumption volumes combined with critical physico-chemical properties such as 
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environmental persistence and high lipophilicity, make UV fi lters also of potential environmental 
concern. Recently, residues of UV fi lters have been found in lake and river water in the range 
of 2-80 ng/L (Poiger et al., 2004) and in treated wastewater up to 2300 ng/L (Balmer et al., 
2005). In lake fi sh four different UV fi lters were identifi ed in a recent monitoring study at 
concentrations up to 166 ng/g (lipid) 4-methylbenzylidene camphor, 123 ng/g benzophenone-3 
(BP3) and 64 ng/g octyl methoxycinnamate (OMC)(Balmer et al., 2005; Buser et al., 2006).
Besides being present in the environment, UV fi lters recently gained importance because of 
their reported estrogenic activity in vitro (Miller et al., 2001; Schlumpf et al., 2001; Schreurs 
et al., 2002; Mueller et al., 2003). In juvenile fathead minnows 3BC, BP1 and BP2 led to 
vitellogenin induction (Kunz et al., 2006) and 3BC did as well in rainbow trout (Holbech et 
al., 2002), whereas 4MBC and OMC were found to be estrogenic in male medaka (Inui et 
al., 2003). An indication for VTG expression in rainbow trout was found after the exposure 
to benzophenone-3 (BP3) (Daniel Schlenk, personal communication). BP3 was also present 
in wastewater from New York City and the exposure of male medaka to wastewater fractions 
lead to VTG induction (Sapozhnikova et al., 2005). BP3 also occurred in marine sediment 
and exposure of male California halibut to this sediment led to VTG induction (Schlenk et 
al., 2005). In rats 3BC, 4MBC, OMC, BP2, BP3 and 4,4-dihydroxybenzophenone (4DHB) 
elicited estrogenic effects (Schlumpf et al., 2001; Yamasaki et al., 2003; Schlecht et al., 2004). 
Besides being estrogenic, some UV fi lters such 4MBC, homosalate (HMS) and BP3 showed 
antiestrogenic activity (Schreurs et al., 2002; Mueller et al., 2003), and BP3 and HMS had 
antiandrogenic activity in vitro (Ma et al., 2003; Schlumpf et al., 2004). However, it is not 
known whether multiple hormonal activities are a common feature of these compounds. 
In order to shed some light on other possible endocrine properties of UV fi lters, especially 
as these compounds are found in surface waters and fi sh (Balmer et al., 2005; Buser et al., 
2006), we screened 19 compounds for additional agonistic and antagonistic activities besides 
estrogenicity. Therefore we employed a recombinant yeast system in order to investigate, in a 
systematic manner, the estrogenicity, antiestrogenicity, androgenicity and antiandrogenicity of 
commonly used UV fi lters. We used this approach, because earlier results on estrogenicity of 
UV fi lters demonstrated that the yeast assay is particularly useful for screening this group of 
compounds. First results indicate that it identifi es possible estrogenic compounds and separates 
them from compounds with no estrogenic activity, averting false negative results (Kunz et al., 
2006). Therefore we furthermore investigated one UV fi lter, ethyl 4-aminobenzoate (Et-PABA), 
that was found to be estrogenic in the hERα assay, for its estrogenicity in a recombinant yeast 
assay carrying a rainbow trout ER (rtERα). Et-PABA is also used as an anaesthetic in veterinary 
medicine. In addition, we analysed this compound in juvenile fathead minnows for vitellogenin 
induction. With this approach we were able to validate whether our fi ndings for the hER are 
transferable to the rtER in vitro, and fi sh in vivo. 
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Our results reveal a novel picture of the hormonal activities of these environmentally relevant 
chemicals and address the question of their modes of action. All 19 compounds analysed showed 
hormonal activities, surprisingly most of them multiple activities. Moreover, antiestrogenicity 
and antiandrogenicity of UV fi lters are possibly even more environmentally relevant than 
estrogenicity. Et-PABA displayed its estrogenic activity not only towards the hERα but also 
toward rtERα and in vivo in fi sh. These fi ndings raise the question whether UV fi lter residues 
found in the environment are potentially able to adversely affect aquatic organisms with their 
multiple hormonal activities. Forthcoming studies on their effects on fi sh reproduction will 
show whether multiple hormonal activities will be of importance in vivo. 
Material and Methods 
Chemicals
17β-Estradiol (E2), 4,5-dihydrotestosterone (DHT), 4-hydroxytamoxifen (4HT) and 
fl utamide (FT) were purchased from Fluka AG (Buchs, Switzerland). UV fi lters (Tab. 
1) were obtained as follows. Benzophenone-1 (BP1, 2,4-dihydroxybenzophenone), 
benzophenone-2 (BP2, 2,2’,4,4’-tetrahydroxybenzophenone), benzophenone-3 (BP3, 2-
hydroxy-4-methoxybenzophenone), benzophenone-4 (BP4, 2-benzoyl-5-methoxy-1-phenol-
4-sulfonic acid), 4,4’-dihydroxybenzophenone (4DHB), 4-hydroxybenzophenone (4HB), 4-
aminobenzoic acid (PABA), ethyl 4-aminobenzoate (Et-PABA), benzyl salicylate (BS, benzyl 
2-hydroxybenzoate), phenyl salicylate (PS, phenyl 2-hydroxybenzoate), octyl salicylate (OS, 
2-ethylhexyl salicylate), octocrylene (OC, 2-cyano-3,3-diphenyl acrylic acid, 2-ethyl hexyl 
ester) and octyl dimethyl PABA (OD-PABA, 2-ethylhexyl 4-(dimethylamino)benzoate) 
were obtained from Fluka AG (Buchs, Switzerland). Octyl-methoxycinnamate (OMC, 
2-ethylhexyl p-methoxycinnamate), 3-(4`-methylbenzylidene-camphor) (4MBC, 3-(4-
methylbenzylidene)bornan-2-one), 3-benzylidene-camphor (3BC, 3-benzylidenebornan-2-
one) and homosalate (HMS, 3,3,5-trimethylcyclohexyl salicylate) were purchased from Merck 
(Glattburgg, Switzerland). Ethoxylated ethyl-4-aminobenzoate (PEG25-PABA) was purchased 
from Induchem AG (Volketswil, Switzerland), and isopentyl-4-methoxycinnamate (IMC) was 
from Haarmann & Reimer (Holzminden, Germany). All purchased compounds used were >99% 
pure. Stock solutions were made in ethanol and stored in the dark at 4°C. Analytical grade 
ethanol (free of UV fi lter) was purchased from T.J. Baker (Stehelin AG, Basel, Switzerland). 
Bidestilled water was produced using a Jencons Autostill double D-ionstill (Renggli AG, 
Rotkreuz, Switzerland).
Hormonal activity of single UV fi lters
- 24 -
Table 1. Chemical structures, molecular weight and CAS numbers of compounds analysed. 
Compound Chemical Molecular CAS 
 structure Weight (g/kg) 
4-Methylbenzylidene camphor (4MBC)   254.37  36861-47-9 
3-Benzylidene camphor (3BC)   240.34 15087-24-8 
O
O
Benzophenone-1 (BP1)   214.22 131-56-6 
O
OH
OH
Benzophenone-2 (BP2)    246.22 131-55-5  
O
OHOH
OHOH
4-Hydroxy benzophenone (4HB)  198.22 1137-42-4 
O
OH
4,4’-Dihydroxybenzophenone (4DHB)  214.22 611-99-4 
Benzophenone-3 (BP3) 228.25 131-57-7 
OOH
O
O
OHOH
Benzophenone-4 (BP4) 308.31 4065-45-6
O
HO3S
OHO
Isopentyl-4-methoxycinnamate (IMC)   248.32  71671-10-2 
Octyl-methoxycinnamate (OMC)  290.40 5466-77-3 
O
O
O
Octocrylene (OC)  361.48 6197-30-4 
Benzyl salicylate (BS) 228.25 118-58-1 
Phenyl salicylate (PS) 214.22 118-55-8 
Homosalate (HMS) 262.35 118-56-9 
O
O
O
O
OH
O
N
O
O
O
OH
O
O
OH
O
Octyl salicylate (OS) 250.33 118-60-5 
Para amino-benzoic acid (PABA)  137.10 150-13-0 
O
OH
O
NH2
O
OH
Ethyl-4-aminobenzoate (Et-PABA)  165.19  94-09-7 
Octyl dimethyl para amino 277.41 21245-02-3 
N
O
O
NH2
O
O
benzoate (OD-PABA) 
Ethoxylated ethyl 4-amino 165.2 113010-52-9 N
O
O
O
z
OH
OH
y
x
benzoate (PEG25-PABA) 
Abbreviations: CAS, Chemical Abstracts Service 
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Yeast hERα and hAR assays
Yeast estrogen assay expressing human estrogen receptor alpha (hERα assay). The estrogen-
inducible expression system used is described in detail by Routledge and Sumpter (1996). In 
brief, the yeast (Saccharomyces cerevisiae) genome carries a stably integrated DNA sequence 
of the human estrogen receptor (hERα). Yeast cells also contain expression plasmids carrying 
estrogen responsive elements, regulating the expression of the reporter gene lacZ (encoding 
the enzyme β-galactosidase). Thus, when an active ligand (i.e. E2 or an estrogenic UV fi lter) 
binds to the receptor, β-galactosidase is synthesised and secreted into the medium, leading to a 
colour change of chromogenic substrate chlorophenol red ß-D-galactopyranoside (CPRG) from 
yellow to red.
Yeast androgen assay expressing the human androgen receptor (hAR assay). The main 
principles of the hAR assay are basically the same as those of the hERα assay, if not stated 
otherwise (for details see Sohoni and Sumpter (1998). The yeast cells contain a constitutively 
expressed gene for the human androgen receptor (hAR). In the presence of a ligand such as DHT 
or an androgenic UV fi lter, the androgen receptor binds to an androgen responsive element on a 
plasmid, thereby initiating transcription of the reporter gene lacZ and β-galactosidase activity.
Preparation of assay media. Preparation of medium compounds was done as previously described 
(Routledge and Sumpter, 1996). All components except Fe2(SO4)3, inotisol, copper (II) sulphate 
(Fluka, Buchs, Switzerland) and CPRG (Roche, Basel, Switzerland), were purchased from 
Sigma (Glattbrugg, Switzerland). Ten-times concentrated stock cultures of both recombinant 
yeast strains were stored at -20°C in 0.5 mL aliquots. Every four months (shelf life), both 
yeast strains were replaced with new -20°C stock cultures. Prior to the experiments the growth 
medium was inoculated with 125 µL ten times concentrated yeast stock, and incubated at 28°C 
for 24 h on an orbital shaker. The fi nal assay medium was prepared by seeding 50 mL fresh 
growth medium with 4x107 yeast cells, then 0.5 mL CPRG was added. 
Estrogenic and androgenic assay procedure. Yeast assays were carried out within a type II 
laminar fl ow. Stock solutions of chemicals were serially diluted in ethanol. Aliquots of 10 µL 
were then transferred 96-well optically fl at-bottomed microtitre plates (Greiner Bio-One, Huber 
AG, Basel, Switzerland) and ethanol was allowed to evaporate to dryness. The same stock 
solutions were tested in both hERα and hAR assays for reliable comparison of the results. In 
all assays each plate contained a positive control with either E2 or DHT, in triplicates. The 
tested compounds were analysed in quadruplicates. A blank row with ethanol was added in 
order to control for a possible CPRG conversion due to the medium components or materials 
alone. After adding aliquots of 200 µL of the fi nal assay medium (hERα or hAR yeast) to 
the plates, they were sealed with plate sealers (Micronic, Vitaris AG, Baar, Switzerland) and 
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shaken vigorously for 2 min on a titre plate shaker before incubation at 32 °C. The hAR plates 
were removed after 24 h, incubated overnight at 28°C and then at room temperature, in order 
to optimise the reaction without risking a signifi cant increase in background expression of β-
galactosidase. The hERα plates were removed after 72 h of incubation. This was done because 
the colour change (yellow to red) occurs faster in the hAR than in the hERα assay (Sohoni and 
Sumpter, 1998). 
After the appropriate incubation time, plates were shaken vigorously for 2 min and left for 1 h 
to allow yeasts to settle. The plates were than read at absorbance of 540 nm (CPRG, hormonal 
activity) and 620 nm (turbidity as a measure of yeast growth and as a control for cytotoxicity), 
using a Tecan GENios plate reader (Tecan AG, Männedorf, Switzerland). 
Antiestrogenic and antiandrogenic assay procedure. Assessment of antagonistic activities 
was similar to agonistic activities, with the following adaptations as described previously by 
Sohoni and Sumpter (1998). E2 or DHT was added to the medium of the appropriate assay at a 
concentration that produced 65% of the maximal response (EC65), followed by the addition of 
the UV fi lter and the antagonistic standards (4HT or FT). It was measured to what extend the 
UV fi lter inhibited the colour change induced by the natural ligand.
Yeast rtERα assay
Recombinant yeast assay expressing the rainbow trout estrogen receptor alpha (rtERα assay). 
We investigated estrogenic activity of one selected UV fi lter (Et-PABA) in vitro by applying a 
quantitative β-galactosidase assay in liquid culture of recombinant yeast expressing the estrogen 
receptor of rainbow trout (rtERα) that was kindly provided by F. Pakdel, University of Rennes. 
We used a slightly modifi ed assay procedure of the previously described assay (Petit et al., 
1995; Le Guével and Pakdel, 2001). The estrogen-inducible expression system and procedure 
used is described in detail in (Kunz et al, 2006). Similar to the hERα, the assay is based on 
transactivation of rtERα and induction of β-galactosidase leading to a color change. 
Preparation of rtERα assay media and yeast growth. The assay media were prepared as 
previously published (Kunz et al. 2006). Prior to the assay yeast cell growth was conducted as 
described (Petit et al., 1995), but with the modifi cation that yeast colonies from CM medium 
were inoculated in Erlenmeyer fl asks containing 15 mL of YPD growth medium instead of CM 
medium, which lead to increasing growth rates and better assay performance.
rtERα  assay procedure. The whole assay was performed in clear polystyrene 96-well 
microplates (Greiner Bio-One, Huber AG, Basel, Switzerland) as described in detail previously 
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(Kunz et al., 2006). In order to assess and correct for yeast growth and as a control for 
cytotoxicity, yeast turbidity (A620) was measured. Cytotoxicity was manifested by signifi cantly 
reduced yeast growth or even cell lysis. High concentrations of some UV fi lters that lead to 
cytotoxicity were omitted from curve fi tting and calculations. For screening of Et-PABA a 96-
well V-bottomed microtitre plate was fi lled with 100 µL/well S. cerevisiae cells in YPD culture. 
Three rows contained serially diluted positive control E2, one row the ethanol-blank, and four 
rows the analysed UV fi lter in quadruplicates with increasing concentrations resulting in dose 
response curves. After cell lyses the lysed suspension was transferred to a new fl at-bottom 
96-well plate (Greiner Bio-One, Huber AG, Basel, Switzerland), ONPG was added and the 
estrogenic activity measured at absorbance of 405 nm as previously described  (Petit et al., 
1995; Le Guével and Pakdel, 2001; Schultis and Metzger, 2004). 
Experiments in vivo in fi sh
Fish. The 14-day fi sh experiment was conducted using juvenile, sexually undifferentiated 
fathead minnows (Pimephales promelas), between 2-3 months of age and with a total body length 
between 19-27 mm. This fi sh species has been chosen because of its frequent used in the fi eld of 
endocrine disrupters and established techniques including vitellogenin (VTG) antibodies.  The 
experimental procedure and duration was similar to that of Panter et al. (2002), who showed 
that estrogens are detectable after 14 days of exposure by virtue of the VTG response. Mixed 
sex juvenile fathead minnows were received from the cultivator (Aquatic Research Organisms, 
Hampton NH, USA) and adapted for a minimum of 14 d in our laboratory in aquaria prior to 
the experiment. Fish were fed with Tetramin pellets (Tetra GmbH, Melle, Germany) twice a day 
with a quantity of 1% of body weight prior to the onset of experiments. During the experiments, 
fi sh were fed with brimeshrimp (Artemia salina, Argent Chemical Labs, Redmond WA, USA) 
at a feeding rate of 1% of body weight twice a day.
Exposure. Fish were held in well-aerated reconstituted tab water medium (total hardness 160 
mg/L as CaCO3, total alkalinity 30 mg/L as CaCO3, conductivity 500 µs/cm) and a 16 h/8 h 
light/dark cycle at 25±1°C.  The studies were conducted using a 24 h static-renewal procedure 
with daily renewal of total aquaria water. For exposure, 10 randomly selected fi sh each were 
placed in stainless steel tanks (10 L) and exposed to Et-PABA at nominal concentrations of 10, 
100, 500, 1000 and 5000 μg/L for 14 d. A control, solvent control (SC, 1 mL ethanol in 10 L 
water) and positive control for estrogenic activity (100 ng/L E2) was included. Stock solutions 
of Et-PABA were prepared freshly in ethanol prior to the start of the experiment and added 
daily to the experimental water by mixing.
Physico-chemical measurements and biological observations. Physico-chemical parameters 
were determined daily. pH and oxygen saturation ranged between 7.2–7.9 and 6.5–8.3 mg/
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L, respectively, throughout the whole exposure period. Mortalities and abnormal behavior 
were recorded daily and dead fi sh were removed from the tanks. On day 14 all fi sh were 
anaesthesized with buffered tricaine methan sulfonate (MS-222, 100 mg/L with 200 mg 
NaHCO3/L). Subsequently individual fi sh were measured, weighted, transferred into labelled 
Eppendorf® tubes, frozen and stored at -20 °C for homogenisation and VTG analysis.
Vitellogenin analysis. Fish were defrosted at 4°C and individually homogenized in ice-cold 
assay buffer (Biosense, Bergen, Norway) in a 1:2 ratio wet weight:buffer volume, using a Ultra 
Turax homogenizer (IKA, Huber + Co. AG, Reinach, Switzerland). The homogenates were 
centrifuged at 10’000 g for 3 min at room temperature using a microcentrifuge (Eppendorf 
centrifuge 5415 D, Vaudaux-Eppendorf AG, Schönenbuch, Switzerland). The supernatant 
was withdrawn and immediately used for VTG analysis or frozen at –80 °C until required for 
VTG analysis. Whole-body homogenates of individual fi sh were assayed for VTG using a 
commercially available quantitative carp vitellogenin ELISA kit, which is based on a sandwich 
ELISA format (Biosense, Bergen, Norway) and shown to cross-react with fathead minnow 
VTG. 
Analytical chemistry. For the duration of the experiment four aliquots of 250 mL exposure 
waters were taken from the two highest and the two lowest concentrations of Et-PABA and 
controls at the beginning (0 h) and prior to water renewal (24 h). The aliquots of the same 
concentration and time point were pooled in brown glass fl asks, acidifi ed with HCl to pH 2-3 
and stored at 4°C until analysis. Chemical analyses of UV fi lter concentrations were carried out 
by high performance liquid chromatography and UV detection according to Kunz et al. (2006). 
Briefl y, 25 or 250 mL of water samples, depending on sample concentration, were extracted 
and concentrated by solid phase extraction (SPE). The 2’500-times concentrated eluent was 
then analyzed by HPLC-DAD.
Data processing and statistical analysis
Recombinant yeast assays. The absorbance-measurement at 540 nm (CPRG, hERα and hAR), 
at 405nm (ONPG, rtERα) and 620 nm (yeast growth) allowed for subsequent correction for 
variations in yeast growth (turbidity), as follows:
[ ]nm 620nm 540
nm 620nm 540
 absorbanceblank  -  absorbanceblank  -
 absorbance chemical-  absorbance chemical  absorbance Corrected =
Concentrations of test compounds that lead to cytotoxicity, which was manifested by signifi cantly 
reduced yeast growth or even cell lysis and determined by absorbance at 620 nm, were omitted 
from further data analysis.
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For curve fi tting, EC50 and IC50 calculations, the corrected absorbance values versus the 
logarithm of concentration were plotted, whereby the best fi t from a number of non-linear 
regression models was selected for fi nal data analysis. In this study, we used the four-parameter 
logistic equation (Hill equation) as a non-linear regression model to fi t full dose-response curves 
according to 
                                                ,
where X is the logarithm of concentration and Y is the response showing a sigmoid shape. 
LogEC50 is the concentration of the test compound yielding half maximal effects and HillSlope 
is the slope parameter, which describes the steepness of the curve. A standard sigmoid dose-
response curve has  a Hill Slope of 1. A hill slope smaller or greater than 1, indicates a shallower 
or steeper curve respectively. Coeffi cient of determination (R2), residuals and 95% confi dence 
intervals were calculated so as to verify that the fi tted curve represents the data correctly. The 
runs test was carried out in order to ensure that the model chosen to fi t the curve does not 
signifi cantly deviate from the data. Submaximal dose-response curves, which are defi ned as 
dose-response curves that reached only < 80% of the height of the corresponding standard, were 
fi tted using the best fi t from a number of non-linear regression models. Curve fi tting was carried 
out using GraphPad Prism software (GraphPad Software Inc., San Diego, USA). Agonistic 
activities were calculated for compounds displaying full dose-response curves, which reached 
the same height (≥ 80% of maximal height) as the corresponding standards (maximal height = 
100%). Thereby the EC50 of a compound was divided by the EC50 of E2 or DHT, respectively. 
For submaximal dose- response curves of lesser height than the standards (< 80%), EC50 values 
were calculated and used as an estimate for their agonistic activities, despite differences in curve-
steepness and -height when compared to the standards. Thereby a good approximation for the 
E2- and DHT-equivalents for the agonistic activities of submaximal UV fi lters was achieved. In 
order to get a suffi cient accurate assessment of antagonistic activities, we proceeded in the same 
manner as with the agonistic activities. We divided IC50 of an antiestrogenic or –androgenic 
compound by the IC50 of the corresponding standard (4HT or FT), and used this in the case 
of submaximal antagonists as approximations, because of the differences in height, shape and 
steepness of the dose-response curves. Effi cacy, or curve height as percentage of the respective 
standard, was calculated as follows for all compounds: 
                                                                                                    ,
where the  curve height (Top UV fi lter - Bottom UV fi lter) of the compound was compared with the 
curve height of the corresponding standard (Top Standard - Bottom Standard, set at 100 %).
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Fish experiment. After testing the data distribution for normality by using the Kolmogorov-
Smirnov test, means of wet weight and total length of individual fi sh were calculated and data 
analysed by analysis of variance (ANOVA) followed by a Dunnett’s Multiple Comparison test 
to compare the treatment means with respective controls.  Means of VTG concentrations of 
individual fi sh were calculated and data analysed with the non-parametric Kruskal-Wallis test 
followed by a Dunn’s Multiple Comparison test to compare the treatment means with respective 
controls. Statistical comparisons with the control were made using the SC as the overall control. 
The results are given as mean ± standard error of mean (SEM). Differences were considered 
signifi cant at p ≤ 0.05. All computations were performed with PRISM 4.0 (GraphPad Software 
Inc., San Diego, USA).
Results
We have systematically analysed 18 commercially available and commonly used UV fi lters 
for estrogenic, antiestrogenic, androgenic and antiandrogenic activities in vitro. 4HB was also 
assessed for these activities, a compound 
which is not used as an UV fi lter itself, but 
represents an estrogenic metabolite. The 
recombinant yeast assays, carrying either 
hERα or hAR, were used for assessing 
either estrogenic and antiestrogenic, or 
androgenic and antiandrogenic activities, 
respectively (Routledge and Sumpter, 
1996; Routledge and Sumpter, 1997; 
Sohoni and Sumpter, 1998). The hERα 
assay showed a high degree of specifi city 
for estrogens, whereas the hAR assay 
was not similarly specifi c for androgens. 
E2 was able to stimulate β-galactosidase 
activity in the hAR assay, but was 20-
times less potent than DHT (data not 
shown), as demonstrated previously for 
the hAR assay (Routledge and Sumpter, 
1996; Gaido et al., 1997; Routledge and 
Sumpter, 1997; Sohoni and Sumpter, 
1998). In every assay we checked for 
potential cytotoxicity caused by the test 
compounds, by routinely measuring yeast 
Table 2.  Cytotoxicity of investigated UV filters in hER?  and  
 hAR transactivation assays.  
Compound hER? assay hAR assay  
  Cytotoxicity (M) Cytotoxicity (M)  
4MBC -- --   
3BC  -- >3.3x10-4
BP1 -- >2.0x10-5
BP2 >2.5x10-3 >3.1x10-4
4HB >5.0x10-4 >4.2x10-5
4DHB -- --  
BP3 -- --  
BP4 -- --  
IMC -- --  
OMC -- --  
OC -- --  
BS -- --  
PS -- --  
HMS -- --  
OS -- --  
PABA -- --  
Et-PABA >2.5x10-3 >2.5x10-3
OD-PABA >2.5x10-3 --   
PEG25-PABA  -- --  
Abbreviations of compounds see Table 1. --, no cytotoxicity; Cytotoxic 
concentrations derive from 3 experiments with four replicates each. 
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growth (620 nm) besides β-galactosidase activity (540 nm). Hence test compound concentrations, 
which lead to signifi cant reduced yeast cell growth or complete growth inhibition, were omitted 
from data analysis for hormonal activities. As shown in Table 2, cytotoxicity was found for 
3BC, BP1, BP2, 4HB and OD-PABA at high concentrations. As an example cytotoxicity and 
normal variations in yeast growth are shown for the antiandrogenic compounds in Figure 1. 
Hormonal activity was therefore assessed at non-cytotoxic concentrations only.
Estrogenic activity of UV fi lters in fi sh in vitro
Estrogenic activity.  Nine of 18 analysed UV fi lters, and the 4HB metabolite exhibited estrogenic 
activity in the hERα assay. BP1, BP2, 4DHB, 4HB and Et-PABA were full hERα agonists 
exhibiting full dose-response curves (Fig. 2A). The most potent UV fi lter tested was BP1, which 
was found to be about 5’000 times less potent than E2.  4HB, BP2, 4DHB and Et-PABA showed 
lower estrogenicity being approximately 16’000-, 21’000-, 170’000 and 3'500’000-times less 
potent than E2, respectively (Tab. 3). Submaximal dose-response curves were observed for 
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Figure 1. Yeast growth and cytotoxicity of antiandrogenic compounds in the hAR assay, shown in six 
panels (A to F) for clarity. Data represent. 3 experiments with 4 replicate each and are shown in means 
± S.E.M.
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Figure 2. Estrogenic compounds in the hERα  assay, 
shown in panel A, B and C for clarity. Data shown are 
means ± S.E.M. (3 experiments with 4 replicates each).
Figure 3. Antiestrogenic compounds in the hERα assay, shown in four panels (A, B, C and D) for clarity. Data 
shown are means and 95% confi dence intervals (3 experiments with 4 replicates each).
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Table 3.  E
ffects of 18 U
V
 filters and E
2 on the estrogenic response in the yeast hE
R? trans- 
activation assay.
C
om
pound 
Efficacy
a 
Estrogenic 
A
sym
m
etric hill function param
eters 
 
 
 
activity
b
 
 
 
 
H
ill Slope 
M
ax
c 
EC
50 (M
) 
E2 
 
100%
 
1 
1.632 ± 0.38 
1.536 ± 0.16 
2.59E
-10 ± 1.19E
-10 
4H
T 
 
nd 
- 
- 
- 
nd
4M
B
C
 
nd 
- 
- 
- 
nd 
3B
C
   
21%
 
1/1'300'000 
1.000 
0.326 
3.10E
-04 
B
P1 
 
96%
 
1/5'000 
1.300 
1.604 
1.15E
-06 
B
P2 
 
91%
 
1/21'000 
2.107 
1.336 
1.09E
-05 
4H
B
 
 
108%
 
1/16'000 
1.794 
1.717 
1.82E
-06 
4D
H
B
  
91%
 
1/170'000 
1.902 
1.256 
7.34E
-05 
B
P3 
 
18%
 
1/45'000 
2.322 
0.324 
1.86E
-05 
B
P4 
 
6%
 
1/380'000 
1.000 
0.097 
9.48E
-05 
IM
C
 
nd 
- 
- 
- 
nd 
O
M
C
 
nd 
- 
- 
- 
nd 
O
C
 
nd 
- 
- 
- 
nd 
B
S 
 
12%
 
1/860'000 
1.000 
0.157 
1.66E
-04 
PS 
 
32%
 
1/480'000 
1.699 
0.529 
1.10E
-04 
H
M
S
 
nd 
- 
- 
- 
nd 
O
S
 
nd 
- 
- 
- 
nd 
PA
B
A
 
nd 
- 
- 
- 
nd 
Et-PA
B
A
 
87%
3'515’963
2.395 
1.490 
8.69x10
-4
O
D
-PA
B
A
 
nd 
- 
- 
- 
nd 
PEG
25-PA
B
A
nd 
- 
- 
- 
nd 
A
bbreviations: 
For 
abbreviations 
of 
listed 
com
pounds 
see 
Table 
1, 
except 
E
2, 
17?-estradiol; 
4H
T, 
4-
hydroxytam
oxifen; nd, not detected; -, not calculated; E
C
50, the concentration of the com
pound exhibiting 50%
 of 
its total effect; a effect (curve height) of a com
pound given as percentage of the effect of E
2; b ratio of the E
C
50 of 
a com
pound divided by the E
C
50 of the corresponding assay standard, num
bers in italics are approxim
ations for 
com
pounds w
ith subm
axim
al activity; c curve-height = top – bottom
; V
alues for E
2-standard are given in m
ean 
S
.E
.M
. (n= 9). V
alue of com
pounds from
 3 experim
ents w
ith four replicates each. 
Table 4.  E
ffects of 18 U
V
 filters and 4H
T on the antiestrogenic response in the yeast hE
R?
transactivation assay.
C
om
pound 
Efficacy
a 
A
ntiestrogenic 
A
sym
m
etric hill function param
eters 
 
 
activity
b
 
 
 
H
ill Slope 
M
ax
c 
IC
50 (M
) 
 
 
 
 
 
 
4H
T 
100%
 
1.000 
-1.199 ±
0.28 
0.913 ± 0.11 
4.92E
-07 ± 2.14E
-07 
4M
B
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181%
 
1 /190 
-0.300 
1.596 
8.73E
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3B
C
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P1 
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98%
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PEG
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37%
 
1/75'500 
-0.910 
0.362 
3.71E
-02 
A
bbreviations: For abbreviations of listed com
pounds see Table 1; nd, not detected; -, not calculated;IC
50, 
concentration of com
pound exhibiting 50%
 of its total possible inhibition; a effect (curve height) of a com
pound 
given as percentage of the effect of 4H
T; 
b ratio of the IC
50 of a com
pound divided by the IC
50 of the 
corresponding assay standard, num
bers in italics are approxim
ations for com
pounds w
ith subm
axim
al activity; c
curve-height = top – bottom
; V
alues for 4H
T-standard are given in m
ean S
.E
.M
. (n= 14). V
alue of com
pounds 
from
 3 experim
ents w
ith four replicates each. 
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BP3, BP4, BS, PS and 3BC indicating partial agonism to hERα (Fig. 2B-C). These UV fi lters 
displayed estrogenicity between 45’000- and 1.3 million-times lower than E2 and exhibited 
effi cacies between 6-32 % (Tab. 3). The remaining 9 UV fi lters were not estrogenic up to 10-2 
M (data not shown).
Antiestrogenic activity. A surprisingly high number of 14 UV fi lters inhibited the activity of E2 
(EC65) in the hERα assay (Fig. 3), thus demonstrating antiestrogenicity. Noteworthy, the 13 
UV fi lters 4MBC, 3BC, BP3, BP4, IMC, OMC, HMS, OC, BS, PS, OS, PABA and OD-PABA 
completely inhibited the activity of E2 at the highest concentrations tested and produced full 
dose-response curves. This indicates a much higher frequency of antiestrogenic than estrogenic 
activity. PEG25-PABA leads to submaximal inhibition at highest concentrations only. The 
most potent antiestrogenic UV fi lter tested was BP3 being about 45-times less potent than the 
known antiestrogen 4HT. 4MBC, BS and IMC were 190- to 540-times less potent and the other 
antagonistic UV fi lters were between 1’000- and 25’000-times less potent than 4HT (Tab. 4). 
PEG25-PABA, the only UV fi lter with submaximal dose-response curve and an effi cacy of 
37%, showed a 75’000-times lower antiestrogenic activity (Tab. 4). 
Androgenic activity. Six UV fi lters were found to possess androgenic activity in the hAR assay 
(Fig. 4). BP2 and HMS produced full dose-response curves, while OMC, OS, OC and IMC 
displayed a partly agonistic behaviour indicated by submaximal dose-response curves. BP2 was 
the most active androgenic UV fi lter being about 30’000-times less potent than DHT.  HMS 
was approximately 110’000-times less potent (Tab. 5). UV fi lters with submaximal activities 
reached effi cacies between 21-61%.  OS was found to be 45’000-times, IMC 260’000-times, 
OC 290’000-times and OMC 4’100’000-times less potent than DHT (Tab.5). 
Antiandrogenic activity. A surprisingly high number of UV fi lters inhibited androgenic 
activity, demonstrating antiandrogenicity. Of the 19 compounds analysed, 16 UV fi lters and the 
metabolite 4HB displayed full dose-response curves with complete inhibition of DHT activity 
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Figure 4. Androgenic compounds in the hAR assay, shown in panel A and B for clarity. Data are 
shown as means ± S.E.M. (3 experiments with 4 replicates each).
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(Fig. 5). This was found with 4MBC, 3BC, BP1, BP2, BP3, BP4, 4DHB, IMC, OMC, HMS, 
OC, BS, PS, OS, PABA and 4HB. Four UV fi lters produced non-monotonic dose-response 
curves. PS displayed antagonistic activity at low concentrations, followed by an agonistic 
interaction with DHT at medium concentrations and again antagonism at high concentrations. 
BP2 followed the same pattern as PS, except of cytotoxicity at high concentrations (>3.7x10-4 
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Figure 5. Antiandrogenic compounds in the hAR assay, shown in six panels (A to F) for clarity. Data are 
shown in means and 95% confi dence intervals, except for non-monotonic curves (mean ± S.E.M.). Data 
are representative of 3 experiments with 4 replicates each.
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high concentrations. BP1 was the most potent antiandrogenic UV fi lter tested and even found 
to be about 4-fold more potent than the known antiandrogen FT.  4HB was approximately 
2.5- fold more potent than FT, whereas PS, BP2, BS, OS, and BP3 were about equally potent 
(Tab. 6). OD-PABA, 4MBC, 3BC and IMC were 2- to 3-times weaker than FT and the other 
antiandrogenic compounds showed between 11- and 40-times lower antiandrogenic activities 
(Tab. 6). Et-PABA was the only antiandrogenic UV fi lter, which only partially inhibited DHT 
and it was cytotoxic at high concentrations (>2.5x10-3 M).
Multiple hormonal activities of UV fi lters. To our surprise all investigated UV fi lters possessed 
hormonal activities in vitro, as demonstrated by the relative potencies of the chemicals in 
the different assays (Tab. 7). Moreover, most of the UV fi lters showed multiple hormonal 
activities. 
Table 7. Semiquantitative assessment of the agonist and antagonist activities of the 
compounds in the hER? and hAR assay.  
Compound Estrogenic 
activity 
Anti- 
estrogenic
activity 
Androgenic  
activity 
Anti- 
androgenic 
activity 
4-Methylbenzylidene camphor (4MBC) -- +++ -- +++
3-Benzylidene camphor (3BC) + +++ -- +++
Benzophenone-1 (BP1) +++ -- -- +++
Benzophenone-2 (BP2) +++ -- +++ +++
4-Hydroxy benzophenone (4HB) +++ -- -- +++
4,4’-Dihydroxybenzophenone (4DHB) +++ -- -- +++
Benzophenone-3 (BP3) + +++ -- +++
Benzophenone-4 (BP4) + +++ -- +++
Isopentyl-4-methoxycinnamate (IMC) -- +++ ++ +++
Octyl methoxycinnamate (OMC) -- +++ ++ +++
Octocrylene (OC) -- +++ + +++
Benzyl salicylate (BS) + +++ -- +++
Phenly salicylate (PS) ++ +++ -- +++
Homosalate (HMS) -- +++ +++ +++
Octyl salicylate (OS) -- +++ ++ +++
Para amino-benzoic acid (PABA) -- +++ -- --
Ethyl-4 amino benzoate (Et-PABA) +++ -- -- ++  
Octyl dimethyl para amino benzoate 
(OD-PABA) -- +++ -- +++
Ethoxylated ethyl 4-amino benzoate 
(Peg25-PABA)  -- + -- --
Abbreviations: Signs indicate efficacy of each compound in different assays: +++, maximal dose-response curves with ? 80% 
efficacy; ++, submaximal dose-response curves with ? 30% efficacy; +, submaximal dose-response curves with < 30% 
efficacy. Bold, most potent hormonal activity found for each compound; --, not detected.
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Surprisingly, 11 compounds displayed as much as three distinct hormonal activities each. All 
compounds were full hAR antagonists, except Et-PABA with partial antiandrogenic activity, and 
PABA and PEG25-PABA with no antagonistic activity. Hence antiandrogenicity and estrogenicity 
were either found along with androgenic activity (BP2) or with antiestrogenic (3BC, BP3, BP4, 
BS and PS). Moreover antiandrogenicity was found to be coupled with antiestrogenic and 
androgenic activities (IMC, OMC, HMS, OC and OS). Five compounds exhibited two distinct 
hormonal activities each, while antiandrogenicity was either coupled with antiestrogenicity or 
estrogenicity, which holds for 4MBC, BP1, 4HB, 4DHB, Et-PABA  and OD-PABA. Interestingly, 
full hERα agonists did not possess any antiestrogenic activity, whereas partial hERα agonists 
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Figure 6. (A) Comparison of estrogenic activity 
of Et-PABA between the rtERα (bold lines) and 
the hERα (dashed lines) assay. Data shown are 
means and 95% confi dence intervals (3 expe-
riments with 4 replicates each). Effect (%) re-
presents percentage of β-galactosidase induc-
tion of UV fi lters versus solvent (0%) and E2 
(100%) controls. Compound abbreviations see 
Table 1. (B) Vitellogenin concentration in juveni-
le fathead minnows exposed to eight UV fi lters. 
Values are means ± SEM (n=10). Asterics de-
note a signifi cant difference from solvent control 
at p ≤ 0.05. Concentrations given as actual me-
dian measured, except 100 and 500 µg/L. nd, 
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to the solvent control. For compound abbrevia-
tions see Table 1.
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and compounds with no estrogenic activity were fully antiestrogenic (except PEG25-PABA, 
displaying submaximal antiestrogenicity). For androgenic and antiandrogenic compounds no 
such pattern was observed (PABA and PEG25-PABA displayed antiestrogenicity only).
Comparison with rtERα. Et-PABA that was found estrogenic in the yeast hERα assay (Fig. 
2) was investigated for its estrogenicity in a recombinant yeast system expressing the rainbow 
trout estrogen receptor alpha (rtERα). The estrogenic activity of Et-PABA was relatively higher 
with rtERα than hERα, but with a lower effi cacy in the rtERα assay, where Et-PABA produced 
a submaximal dose response curve only (Fig. 6 A). Et-PABA displayed an estrogenic activity of 
38’547-times less than that of E2 with rtERα and 3’515’963-times less with hERα. In contrast 
to the relatively higher activity of Et-PABA in the rtERα assay, E2 was about 62-times more 
active in the hERα assay.
Estrogenic activity of UV fi lters in fi sh in vivo 
Measured exposure concentrations. Concentrations of Et-PABA in aquaria waters was 
measured at the beginning of exposures (0 h) and 24 h later prior to water renewal at the lowest 
and the two highest exposure concentrations in order to determine actual effect concentrations 
and to get an estimate of concentration decrease. At 0 h actual concentrations determined 
by HPLC analysis were close to nominal; they were 9.2 μg/L (nominal 10 μg/L), 921 μg/L 
(nominal 1000 μg/L), and 4’939 μg/L (nominal 5000 μg/L), respectively. After 24 h before 
water renewal, concentrations decreased to 45-77% of initial values and were 4.5 μg/L (45%, 
nominal 10 μg/L), 595 μg/L (60%, nominal 1000 μg/L), and 3’848 μg/L (77%, nominal 5000 
μg/L), respectively. 
Estrogenicity of Et-PABA. No mortality was observed in controls, solvent controls (SC) and 
positive controls (E2) exposed fi sh. Et-PABA did not affect survival during exposure. No 
difference occurred in wet weight and mean length in the SC and E2, and no decreases in body 
weight gain and body length were observed for Et-PABA at all exposure concentrations.
Et-PABA, which exhibited estrogenic activity in vitro was also estrogenic in vivo at high 
concentrations (Fig. 6). VTG induction was signifi cant at the highest exposure concentration of 
4’919 µg/L Et-PABA (96’281 ng VTG/mL, p < 0.05). Signifi cant VTG induction also occurred 
in fi sh exposed to the 100 ng/L E2 (positive control). Mean whole-body VTG content was 
2’600’000 ng/mL and highly induced (p < 0.001), compared to the water and solvent control 
having a residual level of 300 ng/mL. 
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Discussion 
Our study reveals a more detailed picture of the hormonal activity of UV fi lters in vitro and 
in vivo and discloses an unexpected complexity of their multiple hormonal properties. Until 
recently estrogenicity was regarded as the most important endocrine activity of UV fi lters in 
vitro (Miller et al., 2001) and in vivo in rats and fi sh (Schlumpf et al., 2001; Schlumpf et al., 
2004; Kunz et al., 2006). To our surprise all investigated compounds were found to possess 
hormonal activity either in the hERα or hAR assay, or both. For one UV fi lter, we compared 
the activity in the hERα assay with that in the rtERα assay and found that Et-PABA was 
equally estrogenic in both assays despite the lower activity of E2 in the rtERα assay. In fi sh 
we observed that this UV fi ler was estrogenic in vivo as well. This clearly demonstrates that 
Et-PABA leads to transactivation of both the hERα and rtERα in recombinant yeasts. Both in 
vitro systems are indicative for estrogenicity in vivo, but the rtERα had a more predictive power 
for in vivo activity in fi sh. Hence estrogenic activity of chemicals is best assessed by the use 
of a tiered approach with a combination of in vitro and in vivo assays incorporating related or 
even identical species. Our fi ndings may be of considerable practical importance due to the 
occurrence of UV fi lters residues in aquatic ecosystems and in fi sh (Balmer et al., 2005; Buser 
et al., 2006), caused by frequent use of these compounds in sunscreens, skin care products, 
cosmetics and a variety of different materials.
hERα agonistic and antagonistic UV fi lters.  According to their estrogenic and antiestrogenic 
activities observed in the hERα assay, UV fi lters can be classifi ed into three groups. First, 
compounds such as the benzophenones, BP1, BP2, 4HB and 4DHB and the para amino 
benzoate Et-PABA, with pure estrogenic activity showing full dose-response curves. Second, 
compounds including BP3, BP4, BS, PS, and 3BC with submaximal estrogenic activity and full 
antiestrogenic activity. Third, pure antiestrogenic compounds lacking any estrogenic activity 
including 4MBC, IMC, OMC, OC, HMS, OS, PABA, OD-PABA, and PEG25-PABA.
Nine UV fi lters and the metabolite 4HB exhibited estrogenic activity in the hERα assay, either 
as full or partial hERα agonists. Even though all benzophenones were estrogenic, partly because 
they were carrying at least one ring substituted hydroxyl group, full estrogenic activity was 
only exhibited when the OH-group was situated in para- or, ortho- and para-position (BP1, 
4HB, BP2, 4DHB). Of these full agonists the highly symmetric benzophenones (4DHB and 
BP2) possessed weaker estrogenic activity than their asymmetric counterparts (4HB and BP1). 
Et-PABA, the weakest of the pure agonists, has only one benzene ring, a polar amino-group 
it attached to it, which might be the reason for its maximal estrogenic activity (Routledge and 
Sumpter, 1997; Schultz et al., 2000). 
These structural features required for optimal estrogenic activity, were already described for 
alkylphenols (Routledge and Sumpter, 1997; Sohoni and Sumpter, 1998; Schultz et al., 2000) 
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and match with previous results for benzophenones (Schultz et al., 2000). Furthermore, these 
UV fi lters lack any antiestrogenic activity and even enhanced E2 activity; hence they act as pure 
hERα agonist. 
In contrast, a second group of UV fi lters displayed only submaximal estrogenic activity and 
completely inhibited the activity of E2 in the hERα assay. This partial hERα agonism such as 
of BP3 and BP4 may be caused by additional substituents like hydroxyl-, methoxy- or sulfonic 
acid groups. This was reported for benzophenones (Miller et al., 2001), but also found in our 
study for the salicylates BS and PS, and the camphor derivate 3BC. 
Partial agonism of a compound is characterized by its reduced effi cacy, eliciting only submaximal 
dose-response curves and its ability to block the effect of full agonist when co-exposed with 
this compound. If a partial agonist is exposed alone or in the presence of low concentrations of 
a full agonist, the resulting effect is submaximal agonistic or additive, respectively (for details 
see Stephenson (1997) and Kenakin (2004)). We hypothesize that partial agonistic UV fi lters 
of the second group preferably bind to the hormone-binding site of hERα and display a similar 
behavior as proposed for type I antiestrogens, which are characterized by partial agonistic 
activity at low concentrations and antagonistic activity at high concentrations (Jensen and Khan, 
2004). Exposed alone these UV fi lters display submaximal estrogenic activity only, whereas co-
exposure with high concentrations of the full hER-agonist E2 results in antiestrogenic activity. A 
possible mode of action that accounts for partial agonism of UV fi lters is that they only induce a 
suboptimal conformational change of the hERα, which needs a agonist induced conformational 
change to be activated. Thus partial agonists can lead to steric or ionic interferences, which then 
result in reduced effi cacy (Pike et al., 1999; Bowers et al., 2000; Gangloff et al., 2001). Another 
possible mode of action is the two site model, that showed that type I antiestrogens have a 
higher affi nity for the hormone (E2-specifi c) than for a secondary (antagonist-specifi c) binding 
site (Dudley et al., 2000; Jensen and Khan, 2004). Studies with 4HT or tamoxifen indicate that 
the hERα may indeed have more than one binding site, whereby these type I antiestrogens were 
shown to act primarily through the hormone-binding site of the hERα but are also able to bind 
to a secondary binding site (Dudley et al., 2000).
On the other hand, a third arbitrary group of compounds lacked estrogenic activity and had, 
with very few exceptions, only one non-hydroxylated ring that possessed other substituents 
such as ethoxy, alkyl-, amino-, cyano- or methoxy-groups, which were shown to signifi cantly 
decrease the chemical’s affi nity for the estrogen receptor (Blair et al., 2000). 4MBC, IMC, 
OMC, OC, HMS, OS, PABA, and OD-PABA acted as pure hERα antagonists inhibiting E2 
dose-dependently, like type II antiestrogens such as ICI 182780 (Dudley et al., 2000). Possibly, 
antiestrogenic UV fi lters bind to and block the primary E2 binding site of the hERα, and it is 
assumed that they are able to bind with comparable affi nities to a secondary binding site of the 
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Table 8. Agonist and antagonist activities of UV filters found in other in vitro and in vivo 
assays.  
Hormonal activities 
Estrogenic Antiestrogenic Androgenic Antiandrogenic  
4MBC In vitro, Schlumpf et. al (2004)
In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002)
In vivo, Inui et al. (2003) 
In vitro, Müller et al. (2003) -- In vitro, Ma et al. (2003)
3BC In vitro, Yamasaki 2003  
In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002)
In vivo, Holbech et al. (2002)
In vivo, Kunz et al. (2006) 
-- -- In vitro, Ma et al. (2003)
BP1 In vitro, Yamasaki 2003
In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002)
In vivo, Kunz et al. (2006) 
-- -- --
BP2 In vitro, Yamasaki 2003
In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002)
In vivo, Kunz et al. (2006) 
-- -- --
4DHB In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002)
-- -- --
BP3 In vitro, Yamasaki 2003
In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002)
In vivo, Müller et al. (2003) -- In vitro, Ma et al. (2003)
BP4 -- -- -- In vitro, Ma et al. (2003)
OMC In vivo, Schlumpf et al. (2004)
In vivo, Müller et al. (2003) 
In vivo, Tinwell et al. (2002) 
In vivo, Inui et al. (2003) 
-- -- --
HMS -- In vitro, Müller et al. (2003) -- --
OD-PABA -- -- -- In vitro, Ma et al. (2003)
Abbreviations: For abbreviations of compounds see Table 1. For full references of the cited literature see 
the referenc list.  --, no data available. 
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receptor (Collins et al., 1997; Jensen and Khan, 2004). They cause a conformational change 
(Hedden et al., 1995), interfere with hERα dimerisation and result in antagonism. PEG25-PABA 
displayed submaximal antiestrogenicity only, probably because of the ethoxylated side-chains, 
resulting in a large molecule that might only partly be able to sterically hinder E2 binding.
Estrogenicity of UV fi lters - comparison with other in vitro and in vivo systems.  Our results 
are consistent with other in vitro studies using the same system (Miller et al., 2001) or one 
expressing a rainbow trout estrogen receptor (Schlumpf et al., 2004; Kunz et al., 2006) (for 
details see Tab. 8).  BP1, BP2, BP3 and 3BC were estrogenic in MCF-7 cells (Schlumpf et al., 
2001; Schlumpf et al., 2004) and reporter hERα /HeLa cells (Yamasaki et al., 2003). 4MBC 
lacked estrogenicity in the hERα assay (our data and Tinwell et al. (2002), but induced MCF-
7 cell proliferation  (Schlumpf et al., 2004). In vivo BP1, BP2, 4DHB, BP3, 3BC, 4MBC and 
OMC were shown to have estrogenic activity in rats (Tinwell et al., 2002; Mueller et al., 2003; 
Schlumpf et al., 2004) and in fi sh. 4MBC and OMC were estrogenic in juvenile rainbow trout 
(Inui et al., 2003) and 3BC in medaka (Holbech et al., 2002) and BP3 in rainbow trout (Daniel 
Schlenk, personal communication), whereas no estrogenicity was observed for OMC, OD-
PABA, HMS, BP3 and 4MBC in zebrafi sh (Schreurs et al., 2002). In fathead minnows we found 
that 3BC, BP1 and BP2 lead to vitellogenin induction (Kunz et al., 2006). At environmental 
concentrations, however, neither 4MBC, nor 3BC showed estrogenic or androgenic activity 
such as skewed sex-ratios in tadpoles of frogs (Kunz et al., 2004). However, environmental 
samples of marine sediment and New York City wastewater, which also contained the UV fi lter 
BP3 were found to be estrogenic in rainbow trout and male medaka (Sapozhnikova et al., 2005; 
Schlenk et al., 2005).
Our identifi cation of 13 antiestrogenic UV fi lters in the hERα assay is consistent with the 
recently reported in vitro antiestrogenicity of 4MBC, HMS and BP3 (Mueller et al., 2003). In 
human Ishikawa cells, 4MBC inhibited E2 binding at the ERα and ERβ (Mueller et al., 2003), 
whereas in the HEK 293 reporter gene system, neither 4MBC nor OMC, BP3 and B-MDM 
showed clear and dose-dependent antiestrogenic activities at the ERα or to ERβ (Schreurs et 
al., 2002). 
For the few differences between our results obtained in the hERα assay and other in vitro and 
in vivo assays, various reasons might be responsible. On one hand, UV fi lters may be active 
towards the ERβ, but not the ERα, or may display different activities to both receptors, similar 
to the methoxychlor metabolite HPTE, which showed selective agonist activity through ERα 
and antagonistic activity through ERβ (Gaido et al., 1999; Waters et al., 2001). This holds 
for 4MBC, which binds preferably to the ERβ (Schlumpf et al., 2004). Furthermore, yeasts 
have only a low capability for metabolism, hence estrogenic UV fi lter metabolites formed in 
vivo or in metabolically active in vitro systems are not identifi ed in the hERα assay. Besides, 
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estrogenicity may occur via indirect action not governed by the estrogen receptor, and therefore 
be detectable in vivo but not in vitro. Differences in species susceptibility may also partly be 
responsible for distinct estrogenic activities of a compound. Nevertheless the hERα assay can 
be applied to estimate estrogenicity of UV fi lters in fathead minnows (Kunz et al., 2006).
hAR agonistic and antagonistic UV fi lters. Agonistic and antagonistic UV fi lters were also 
found in the hAR assay. To our surprise 6 UV fi lters (BP2, HMS, IMC, OMC, OC, OS) exhibited 
submaximal to full androgenic activity, and full antiandrogenic activity in addition. On the 
other hand, 4MBC, 3BC, BP1, 4HB, 4DHB, BP3, BP4, BS, PS, PABA, and OD-PABA acted 
like pure antiandrogens lacking any androgenic activity. 
Our study shows for the fi rst time that at least 6 UV fi lters exhibit androgenic activity, and an 
unexpectedly high number of 16 UV fi lters showed full antiandrogenic activity via binding to 
the hAR, while Et-PABA was the only UV fi lter with partial antiandrogenic activity. Our results 
are consistent with fi ndings on BP3, BP4, OD-PABA, 3BC, and 4MBC in the human breast 
carcinoma MDA-kb2 reporter gene assay (Ma et al., 2003) (Tab 8). However, HMS and OMC 
were not active in MDA-kb2 cells, probably due to the low endogenous occurrence of hAR in 
this cell line. Only one study investigated androgenicity of UV fi lters in fi sh, but neither 4MBC 
nor OMC possessed androgenic activity towards the AR in male medaka (Inui et al., 2003). 
This may be related to higher metabolic activity in vivo, rather than differences between human 
and fi sh AR. As androgenic or antiandrogenic activities of UV fi lters in fi sh have not yet been 
evaluated, potential in vivo consequences for aquatic organisms remain elusive. Similar to the 
estrogen receptor, the androgen receptor lacks high substrate specifi city, and some estrogenic 
compounds also activate the androgen receptor (Gaido et al., 1997; Sohoni and Sumpter, 1998). 
In our study, we only found this to be the case for BP2, which showed strong estrogenic and 
androgenic activity.
Interestingly, we did not fi nd pure hAR agonists; all 6 androgenic UV fi lters possessed 
antiandrogenic activity in addition by inhibiting DHT activity. Wong et al (1995) noted that 
metabolites of hydroxyfl utamide caused AR activation in the absence of the androgen. However 
in the presence of DHT, these compounds had antagonistic activity. It was suggested that 
mixed ligand hAR dimers, i.e. agonist (natural androgens) and antagonist, bound in the same 
dimer, are required for antagonism, whereas the same ligand dimers of suffi ciently high affi nity 
promote receptor activation (Wong et al., 1995). This mode of action was for example found 
for p,p’-DDE (Schrader and Cooke, 2000). The UV fi lters BP2, HMS, OMC, OS, OC, and IMC 
possibly followed the same mode of action, showing both partial to full hAR-agonist activity in 
the absence of DHT, and full hAR antagonism in the presence of DHT.
Another mode of action is proposed for the 11 antiandrogenic UV fi lters (camphor derivates, 
benzophenones, salicylates, Et-PABA and OD-PABA) that lacked any androgenic activity. AR 
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antagonists prevent or reduce the binding of AR to the androgen response elements (ARE), 
either by preventing - via diverse conformational changes – the formation of the AR dimer, 
or by preventing the DNA-binding of the dimer (Kelce et al., 1995; Kelce and Wilson, 1997). 
AR antagonists fail to induce a transcriptionally competent conformation in the AR ligand 
binding domain in vitro, but reverse the agonist-elicited conformational change in the ligand 
binding domain (Kallio et al., 1994; Kuil and Mulder, 1995). We hypothesize that the purely 
antagonistic UV fi lters bind to the hAR, either to the hormone binding site - or similar to the 
ER - to a second non-hormone binding site of the hAR. Hence, transactivation may have failed, 
because of conformational changes preventing dimer formation or ARE binding similar to FT 
and vinclozolin act in vitro and in vivo  (Kelce and Wilson, 1997),and p,p’-DDE (Kelce et al., 
1995).
The antiandrogenic UV fi lters showed unexpectedly high activities coupled with potencies that 
were between up to 4-fold higher and only 40-fold lower than that of the known antiandrogen 
fl utamide (FT), used in prostate cancer treatment. BP1 was the most potent UV fi lter, followed 
by 4HB, PS, BP2, BS, OS, BP3, OD-PABA, 4MBC, 3BC, IMC, 4DHB, OC, HMS, OMC, 
BP4 and Et-PABA. The UV fi lters PS, BP2, and 4DHB produced non-monotonic dose 
response curves, which may result from superimposition of monotonic dose response curves 
of component biological reactions (Maness et al., 1998; Conolly and Lutz, 2004). The high 
antiandrogenic activity of UV fi lters in vitro, with EC50 values similar or considerably lower 
than that of FT may have consequences in vivo (Vinggaard et al., 2005). Flutamide, for example, 
leads to signifi cant reduction of androgen-dependent play behavior in neonatal male rats at 
50 mg/kg/day (Hotchkiss et al., 2004). Consequently, antiandrogenic UV fi lter may result in 
overall estrogenic effects in vivo, which will be assessed for aquatic organisms in forthcoming 
studies in our laboratory.
Multiple hormonal activities of UV fi lters. This is the fi rst report on multiple hormonal activities 
for as many as 18 UV fi lters (Tab. 7). Surprisingly, all UV fi lters but PABA and PEG25-PABA 
exhibited multiple hormonal activities in vitro.  An unexpectedly high number of 10 UV fi lters 
displayed as much as three distinct hormonal activities each, having two of them in common, 
namely being hAR and hERα antagonists. Androgenic activity in combination with hAR and 
hERα antagonism was found for the alkylated salicylate derivates HMS and OS, as well as 
the cinnamate derivates IMC, OMC and OC, all being alkyl substituted, which might explain 
the lack of estrogenic activity (Blair et al., 2000). On the other hand, the salicylates BS and 
PS, the benzophenones BP3 and BP4, and the camphor derivate 3BC displayed estrogenic 
besides antiestrogenic and antiandrogenic activities. This combination of hormonal activities 
is also found for bisphenol A (Lee et al., 2003). BP2 carrying as much as four hydroxy groups 
displayed three distinct hormonal activities; full estrogenicity and androgenicity besides 
antiandrogenicity. Hence, BP2 is the only UV fi lter being a hERα- and hAR agonist, which has 
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been observed with other estrogenic compounds that also activate the androgen receptor (Gaido 
et al., 1997; Sohoni and Sumpter, 1998). 
Six UV fi lters exhibited two distinct hormonal activities each. Antiandrogenicity was either 
coupled with full antiestrogenicity (4MBC and OD-PABA) or with full estrogenicity (BP1, 
4DHB, 4HB, Et-PABA). As for 4MBC and OD-PABA, the combination of antiestrogenicity 
and antiandrogenicity was observed for the antiestrogen 4HT acting as a weak antiandrogen 
(Sohoni and Sumpter, 1998). Weak estrogenic compounds such as FT and bisphenol A were 
found to act as strong antiandrogens in addition (Lee et al., 2003), which is also the case for 
the UV fi lters BP1, 4DHB, 4HB and Et-PABA. Also a variety of pesticides (Andersen et al., 
2002; Kojima et al., 2004), p,p’-DDE (Kelce et al., 1995; Gaido et al., 1997),  methoxychlor 
and its metabolites (Gaido et al., 2000) exhibit both estrogenic and antiandrogenic activities. 
It is not yet known, what structural features are necessary for exhibiting these combinations of 
multiple hormonal activities. Our data indicate that presumably many compounds in the aquatic 
environment will have complex interactions with the endocrine system that cannot strictly be 
categorized into one single hormonal activity. 
Comparison of in vitro and in vivo estrogenicity of Et-PABA in fi sh. The estrogenic activity 
in vitro with hERα and rtERα was matched in vivo for Et-PABA (Fig. 6C). The in vitro activity 
of Et-PABA towards the rtERα (EC50 3.0 x 10-4 M) was slightly higher than to the hERα (8.7 x 
10-4 M), but the potency of Et-PABA differed considerably, because of the lower sensitivity of 
rtERα towards E2, making Et-PABA much more potent towards the fi sh ER. This is consistent 
with our previous fi ndings (Kunz et al. 2006), where for most of the 23 investigated UV 
fi lters, relative sensitivities of rtERα and hERα systems varied within one order of magnitude, 
indicating that the main difference between the two receptors is their sensitivity towards E2. In 
juvenile fathead minnows Et-PABA led to VTG induction at 2.7 x 10-5 M, which is lower than 
in vitro. Similar results were obtained for the UV fi lters benzophenone-1 and benzophenones-
2, which were also pure estrogens in vitro towards the hERα and rtERα, and led to VTG 
induction in juvenile fathead minnows (Kunz et al. 2006). The underestimation of effects in 
vitro assays determined in our study by receptor-based in vitro assays as compared to in vivo 
effects, was previously observed in similar studies, where estrogenicity of municipal wastewater 
were analysed by the hERα assay and VTG induction in male medaka (Huggett et al., 2003; 
Sapozhnikova et al., 2005). 
When looking at the potencies relative to E2 calculated for Et-PABA, we fi nd that the rtERα 
assay and in vivo data are in a similar range (38’500- and 43’900-times weaker than E2, 
respectively), whereas the hERα assay strongly underestimates the potency of Et-PABA (3 
million times weaker than E2). This data indicate that the rtERα in vitro data are more accurate 
for prediction of the in vivo activity than the hERα. Hence, hormonal activity of UV fi lters 
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should be assessed by a suite of species related in vitro and in vivo assays, confi rming the 
approach previously suggested by Kunz et al. (2006), where we showed that an adequate in 
vitro assay should be able to predict in vivo activity of the most potent compounds for further 
in vivo testing. However, ligand-receptor based systems, such as the yeast assays used in this 
study, have some limitations. For example these systems are not able to detect alterations in the 
biosynthesis or degradation of a specifi c hormone and likewise indirect effects on endocrine 
feedback loops or precursors are not deteted.
Conclusions
Our fi ndings demonstrate that many UV fi lters occurring in aquatic systems possess multiple 
hormonal activities in vitro, including estrogenicity, antiestrogenicity, androgenicity and 
antiandrogenicity through interaction with hERα and/or hAR. Although most of the UV 
fi lters exert hormonal effects at concentrations that are orders of magnitude higher than in the 
environment, wide distribution and exposure to UV fi lter mixtures may have environmental 
consequences due to additive effects. The UV fi lters 4MBC, BP3, BP4, OMC, OC and HMS 
that repeatedly were detected in the aquatic environment, may contribute with their multiple 
hormonal activities in a complex manner to the mixture of endocrine disrupting chemicals 
already present in surface water and fi sh. For most of the UV fi lters with multiple hormonal 
activities residues in the aquatic environment and in biota are not yet known, and therefore their 
environmental relevance remains elusive. The fact that all 18 UV fi lters and one metabolite 
showed receptor ligand binding via transactivation - surprisingly most of them multiple bindings 
- reveals a complex picture of the hormonal activities of UV fi lters. In vitro antiestrogenicity and 
antiandrogenicity seems even more important than estrogenicity. Moreover, six UV fi lters have 
been demonstrated to be androgenic for the fi rst time. Our results support the fact that many 
estrogenic compounds may have more than one mode of action, and that their diverse hormonal 
activities are more complex than previously expected. The antiestrogenic, antiandrogenic and 
androgenic activities of UV fi lters in vitro are of signifi cant scientifi c and practical interest. 
Despite the limitations of yeast systems such as a lower metabolic capacity as compared to many 
animal cell systems and their restriction to ligand-receptor based mechanisms compared to in 
vivo systems which also can detect indirect effects on endocrine feedback loops and precursors, 
they are an elegant and effi cient tool to identify endocrine disrupting compounds that may 
further be investigated in vivo, especially regarding adverse effects in fi sh. 
With Et-PABA, a pure hERα agonistic UV fi lter, we demonstrated that the hERα assay is a useful 
tool to predict the in vivo estrogenicity in fi sh, although it tends to underestimate potencies 
of the estrogenic compounds, whereas the rtERα assay predicts the in vivo estrogenicity of 
Et-PABA in juvenile fathead minnows more accurately. Possible implications of our fi ndings 
should be addressed by the analysis of UV fi lters in the aquatic environment. Ongoing studies in 
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fi sh in our laboratory will show how the diverse hormonal activities of UV fi lters will translate 
into the activity in vivo. These fi ndings may be of considerable practical importance due to 
the frequent use of UV fi lters in sunscreens, skin care products, cosmetics and in a variety of 
different materials prone to contaminate aquatic ecosystems.
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Abstract 
UV-absorbing chemicals (UV fi lters) are widely used for protection against UV radiation in 
sunscreens and in a variety of cosmetic products and materials. Depending on the breadth and 
factor of UV protection, they are added as single compounds or as a combination thereof. 
Some UV fi lters have estrogenic activity, but their activity and interactions in mixtures are 
largely unknown. In this work, we analysed 8 commonly used UV fi lters, which are pure or 
partial hERα agonists, for their estrogenic activity in mixtures in a recombinant yeast assay 
carrying the human estrogen receptor alpha (hERα). Equi-effective mixture combinations 
of two and four pure hERα agonists alone or in combination with 17-β estradiol (E2) were 
assessed. Concentration-response relationships for all UV fi lter combinations were recorded 
and used to calculate predictions of their joint effects by employing the concentration addition 
(CA) and independent action (IA) model. Furthermore, mixtures of eight pure and partial hERα 
agonistic UV fi lters were studied at concentrations giving an increase of 10% of basal activity, 
(BC10) and at the no-observed-effect-concentrations (NOEC) of each compound. Most binary 
mixtures comprising of pure hERα agonists behaved according to the CA concept and showed 
a synergistic activity at all mixture combinations. Only in combination with benzophenone-
1, antagonistic activity was observed at some effect levels. All mixtures of four pure hERα 
agonists alone or including E2 showed synergistic activity at low effect concentrations (BC10). 
This occurred even at equi-effective concentrations that were at the NOEC level of each single 
compound. Mixtures of 8 UV fi lters alone or with E2 at the BC10 and NOEC level showed 
synergistic activity. Hence, there were substantial mixture effects even though each UV fi lter 
was present at its NOEC level. These results show that signifi cant interactions occur in UV 
fi lter mixtures, which is important for the hazard and risk assessments of these personal care 
products.
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Introduction 
Sunscreens and cosmetics including lipsticks, skin lotions, hair sprays, hair dyes, shampoos, and 
numerous other products like moldings, jet ink, tyres and fabrics contain increasing amounts 
of UV fi lters, which scatter and refl ect UV light. Increasing numbers of materials contain UV 
fi lters in order to prevent degeneration by UV radiation. Increased sunlight protection factors 
are used for preventing negative effects on the human skin. Generally this requires higher 
percentages of UV fi lters in the products and a growing use of combinations of different UV 
fi lters for absorbing UVA, UVB and UVC light. 
UV fi lters may penetrate the human skin when applied in sunscreens or cosmetics and indeed 
in human urine, benzophenone-3 (BP3) and its metabolite benzophenone-1 (BP1) have been 
detected 4 hr after application of commercially available sunscreen products to the skin (Felix 
et al., 1998). Residues of BP3 and OMC were also detected in human breast milk samples 
up to 445 ng/g lipid (Hany and Nagel, 1995). Commonly, combinations of several different 
UV fi lters are added to sunscreens, cosmetics and other materials, depending on the desired 
protection factor and range. Thus, mixtures of UV fi lters with distinct estrogenic activities are 
applied on human skin and human exposure can occur via dermal absorption or through the 
food chain, namely fi sh consumption.
Because of their persistence, UV fi lters may ultimately reach aquatic systems directly via 
recreational activities (bathing), and indirectly via wastewater. 4-Methylbenzylidene camphor 
(4MBC), BP3, octyl methoxycinnamate (OMC), and octocrylen (OC) were detected in 
lakes and wastewater up to 2’400 ng/L (Balmer et al., 2005; Buser et al., 2006). In southern 
California, benzophenone and OMC were found in the range of 0.26 to 5.61 µg/L in raw and 
treated drinking water (Loraine and Pettigrove, 2006). UV fi lters were also found in fi sh of up 
to 2 mg/kg lipid (Balmer et al., 2005). Recently, bioconcentration factors of 230-980 have been 
determined in fi sh (Kunz et al., in press). Once UV fi lters enter the aquatic ecosystems, they 
join in a mixture of other potential xenoestrogens. 
In recent years, it has become evident that some UV fi lters are estrogenic in vitro as demonstrated 
in MCF-7 cells (Schlumpf et al., 2001), recombinant cell lines (Schreurs et al., 2002; Mueller 
et al., 2003) and recombinant yeast systems carrying the human ERα (Routledge and Sumpter, 
1997; Schultz et al., 2000; Kunz and Fent, submitted). Moreover, a high proportion of commonly 
used UV fi lters has been found to exhibit multiple hormonal activities in vitro (Kunz et al., in 
press). Estrogenic activity has also been observed in rats (Durrer et al. 2005; Schlumpf et al. 
2001; Seidlová-Wuttke et al. 2004) and fi sh (Holbech et al., 2002; Inui et al., 2003; Kunz et 
al., 2006).
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As UV fi lters are applied as compound mixtures, it is important to understand their activity in 
mixture combinations. Moreover, this is the situation in the environment. Currently, however, 
the interactions in UV fi lter mixtures are largely unknown. A previous study using mixtures 
of estrogenic compounds including 2,4-dihydroxybenzophenone combined at concentrations 
below the no-observed-effect-concentrations (NOEC) demonstrated signifi cant mixture effects 
in the yeast hERα assay (Rajapakse et al., 2002; Silva et al., 2002). The effect of mixtures 
of four estrogenic UV fi lters on pS2-gene transcription was studied recently in MCF-7 cells. 
Mixtures of two (BP1, BP3) and four compounds (BP1, BP3, OMC, 4MBC) showed additive 
activity (Heneweer et al., 2005). Currently, it remains unclear whether and how the estrogenic 
and/or antiestrogenic activity of single UV fi lters at low aqueous concentrations contributes 
to mixture effects. In our study, we focus on these questions as such knowledge is needed for 
evaluating the potential hazards and risks of estrogenic UV fi lters for humans and on aquatic 
life.
The question of mixture activity has gained increasing attention in the last few years (Kortenkamp 
and Altenburger, 1998). Mixture effects of estrogenic compounds can be calculated based on 
the activities of individual mixture components. The joint action of weak estrogenic compounds 
was recently shown to be based on the concept of concentration addition (CA) in vitro (Payne 
et al., 2000; Rajapakse et al., 2002; Silva et al., 2002) and in vivo in fi sh (Brian et al., 2005) 
In our study, we applied two competing pharmacological concepts for the calculation of 
expected additive mixture effects. The concept of CA (Loewe and Muischnek, 1926) assumes 
that components of a mixture act in a similar way, such that one can be replaced by an equal 
fraction of an equieffective concentration of another, without weakening the overall mixture 
effect. Synergistic or antagonistic additivity can then be determined by applying the method 
of isoboles (Loewe and Muischnek, 1926; Kortenkamp and Altenburger, 1998). The concept 
of independent action (IA) on the other hand assumes that mixture effects are the result of 
interactions of individual mixture components with different modes of action and mixture 
components that are present below zero effects are not expected to contribute to the total mixture 
effect (Bliss, 1939).
In the present work we investigate the activities of 2, 4 and 8 UV fi lters alone and combined with 
E2 at different effect levels and at the NOEC. We selected commonly used UV fi lters, which 
were demonstrated to be pure hERα agonists or partial hERα agonists in vitro (Kunz et al., in 
press). We addressed the infl uence of partial agonism for the mixture activity, as little attention 
is given to this property when estrogenic chemicals are assessed in mixtures. By investigating 
multi-component mixtures of commonly used pure and partial hERα agonistic UV fi lters we 
test the hypothesis that multi-component mixtures comprising of pure hERα agonists follow 
the model of CA, leading to additive or even synergistic estrogenic activity. In addition, we 
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hypothesize that multi-component mixtures of pure and partial hERα agonists also follow the 
CA model, but lead to an antagonistic overall mixture effect, due to the antiestrogenic properties 
of the partial hERα agonists.
Material and Methods 
Chemicals. 17β-Estradiol (E2) was purchased from Fluka AG (Buchs, Switzerland). UV fi lters 
(Tab. 1) were obtained as follows: Benzophenone-1 (BP1), benzophenone-2 (BP2), benzophenone-
3 (BP3), 4,4’-dihydroxybenzophenone (DHB), benzylsalicylate (BS), phenlysalicylate (PS) 
and ethyl-4-aminobenzoate (Et-PABA) were obtained from Fluka AG (Buchs, Switzerland). 
3-Benzylidene-camphor (3BC) was purchased from Induchem (Volketswil, Switzerland). All 
compounds used were >99% pure. Stock solutions were made in ethanol and stored in the dark 
at 4°C. Analytical grade ethanol (free of UV fi lter) was purchased from T.J. Baker (Stehelin 
AG, Basel, Switzerland). Bidestilled water was produced using a Jencons Autostill double D-
ionstill (Renggli AG, Rotkreuz, Switzerland).
Yeast estrogen assay expressing human estrogen receptor alpha (hERα assay). The estrogen-
inducible expression system used was kindly gifted by J. Sumpter (Brunel University, U.K.) 
and is described in detail by (Routledge and Sumpter, 1996). In brief, the yeast (Saccharomyces 
cerevisiae) genome carries a stably integrated DNA sequence of the human estrogen receptor 
(hERα). Yeast cells also contain expression plasmids carrying estrogen responsive elements 
(ERE), regulating the expression of the reporter gene lacZ (encoding the enzyme β-galactosidase). 
Thus, when an active ligand (i.e. 17β-estradiol or an estrogenic UV fi lter) binds to the receptor, 
β-galactosidase is synthesised and secreted into the medium, leading to a colour change of 
chromogenic substrate chlorophenol red ß-D-galactopyranoside (CPRG) from yellow to red.
Preparation of assay media. Preparation of medium compounds was done as previously 
described by (Routledge and Sumpter, 1996). All components except Fe2(SO4)3, inotisol, 
copper (II) sulphate (Fluka, Buchs, Switzerland) and CPRG (Roche, Basel, Switzerland), were 
purchased from Sigma (Glattbrugg, Switzerland). Ten-times concentrated stock cultures of both 
recombinant yeast strains, were stored at -20°C in 0.5 mL aliquots. Every four months (shelf 
life), both yeast strains were replaced with new -20°C stock cultures. Prior to the experiments the 
growth medium was inoculated with 125 µL ten times concentrated yeast stock, and incubated 
at 28°C for 24 h on an orbital shaker. The fi nal assay medium was prepared by seeding 50 mL 
fresh growth medium with 4x107 yeast cells. Then 0.5 mL CPRG was added. 
hERα assay procedure. The yeast assay was carried out within a type II laminar fl ow. Stock 
solutions of standards and chemical mixtures were serially diluted in ethanol. Aliquots of 10 
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Table 1. Chemical structures, molecular weight and CAS numbers of compounds
analysed.
Compound Chemical Molecular CAS
 structure Weight (g/L)
17?-Estradiol (E2) 272.39 50-28-2
OH
OH
3-Benzylidene camphor (3BC) 240.34 15087-24-8O
Benzophenone-1 (BP1) 214.22 131-56-6
O
OH
OH
Benzophenone-2 (BP2) 246.22 131-55-5
O
OHOH
OHOH
Benzophenone-3 (BP3) 228.25 131-57-7
OOH
O
4,4’-Dihydroxybenzophenone (4DHB) 214.22 611-99-4
O
OHOH
Ethyl-4-aminobenzoate (Et-PABA) 165.19 94-09-7
NH2
O
O
Benzyl salicylate (BS) 228.25 118-58-1
O
OH
O
Phenyl salicylate (PS) 214.22 118-55-8
O
OH
O
Abbrevations: CAS, Chemical Abstracts Service
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µL were then transferred 96-well optically fl at-bottomed microtitre plates (Greiner Bio-One, 
Huber AG, Basel, Switzerland) and ethanol was allowed to evaporate to dryness. In all assays 
experiments were repeated at least twice and each plate contained a positive control with E2 in 
triplicates. The tested compounds were analysed in quadruplicates. A blank row with ethanol 
was added in order to control for a possible CPRG conversion due to the medium components 
or materials alone. After adding aliquots of 200 µL of the fi nal assay medium to the plates, they 
were sealed with plate sealers (Micronic, Vitaris AG, Baar, Switzerland) and shaken vigorously 
for 2 min on a titre plate shaker before incubation at 32 °C. After the 72 hours of incubation, 
plates were shaken vigorously for 2 min and left for 1 h to allow yeasts to settle. The plates were 
than read at absorbances of 540 nm and 620 nm, using a Tecan GENios plate reader (Tecan AG, 
Männedorf, Switzerland). 
Calculations. The absorbance-measurement at 540 nm (CPRG) and 620 nm (turbidity) allowed 
for subsequent correction for turbidity (yeast growth), as follows:
 
 absorbanceblank  
 absorbance chemical
absorbance chemical  absorbance Corrected
nm 620
nm 620
nm 540 ⎥⎦
⎤⎢⎣
⎡ −−=
 absorbanceblank nm 540−
Statistical analysis. For curve fi tting and EC50 calculations, the corrected absorbance values 
versus the logarithm of concentration were plotted, whereby the best fi t from a number of non-
linear regression models was selected for fi nal data analysis. In this study, we used the four-
parameter logistic equation (Hill equation) to fi t full dose-response curves according to 
                                                               ,                      
where X is the logarithm of concentration and Y is the response showing a sigmoid shape. 
LogEC50 is the concentration of the mixture yielding half maximal effects and HillSlope is the 
slope parameter. Coeffi cient of determination (R2), residuals and 95% confi dence intervals were 
calculated so as to verify that the fi tted curve represents the data correctly. The runs test was 
carried out in order to ensure that the model chosen to fi t the curve does not signifi cantly deviate 
from the data. Submaximal dose-response curves were fi tted using the best fi t from a number 
of non-linear regression models. Curve fi tting was carried out using GraphPad Prism software 
(GraphPad Software Inc., San Diego, USA). 
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Effi cacies, i.e. cure heights of full and submaximal dose response curves were calculated as 
follows for single compounds and mixtures:
 
          ,
where the  curve height (Top UV fi lter - Bottom UV fi lter) of the compound was compared with the 
curve height of the corresponding standard (Top Standard - Bottom Standard, effi cacy set at 100 %).
Estrogenic activities were calculated for dose-response curves of single compounds and mixtures 
by normalizing the data (blank or basal absorbance=1) and using non-linear regression analysis 
to determine the concentration at which each compound caused elicits 50% of its maximal 
activity (EC50). Subsequently relative potencies (RP), i.e. estrogenic activities were derived 
for each compound and mixture by dividing the EC50 for E2 by the EC50 values of each single 
compound or mixture (Table 2).
Mixture design and testing. The compounds used for the mixture experiments were previously 
found to be either pure or partial hERα agonists in the hERα assay (Kunz et al., 2006; Kunz 
et al., in press). BP1, BP2, DHB and Et-PABA were full hERα agonists exhibiting full dose-
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Figure 1   Estrogenic and antiestrogenic activities of single compounds in the hERα assay. (A) Estrogenic 
activity of pure hERα agonists. (B) Antiestrogenic activity of pure hERα agonists. (C) Estrogenic activity of 
partial hERα agonist. (D) Antiestrogenic activity of partial hERα agonists. Data shown are means ± 95% CI 
band (3 experiments with 4 replicates each). Data from Kunz and Fent, in press.
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Table2.
Estrogeniceffectsof8UV
filtersandE2intheyeast hER?
assayandtheirconcentrations in isoeffectivemixtures of two, four andeight compounds.
 
Efficacy a
RP
b
Asym
m
etric hill function param
eters
Binary m
ixure ratios (M)
Multiple m
ixture ratios (M)
1/…
HillSlope
Max
c
EC50(M)
EC25 
EC50 
EC75 
BC10
NOEC*
E2
100%
1
1.632± 0.38
1.536± 0.16
2.59±
1.19E-10
1.08E-10 
2.11E-10 
4.14E-10
3.91E-11 
6.32E-12
BP1
96%
5'000
1.300 
1.604 
1.15E-06
4.96E-07 
1.15E-06 
2.69E-06
1.93E-07 
1.68E-08
BP2
91%
21'000
2.107 
1.336 
1.09E-05
6.47E-06 
1.09E-05 
1.85E-05
3.55E-06 
6.16E-07
4DHB
91%
170'000
1.902 
1.256 
7.34E-05
4.12E-05 
7.34E-05 
1.29E-04
2.39E-05 
3.28E-06
Et-PABA
87%
3’500'000
2.395 
1.490 
8.96E-04
5.49E-04
8.69E-04 
1.37E-03
2.82E-04 
6.39E-05
3BC
21%
1'300'000
1.000 
0.326 
3.10E-04
--
--
1.75E-03
1.56E-06
BP3
18%
45'000
2.322 
0.324 
1.86E-05
--
--
2.49E-05
1.28E-06
BS
12%
860'000
1.000 
0.157 
1.66E-04
--
--
5.05E-03
8.38E-07
PS
32%
480'000
1.699 
0.529 
1.10E-04
--
--
6.89E-05
3.69E-06
Abbreviations: For abbreviationsof listed compounds see Table 1; EC75, EC50 and EC25,concentration of the compound
exhibiting 75%
, 50%
 and 25%
, respectively, of its total effect; BC10, concentration
of the compound
exhibiting a 10%
increase of the
baseline
absorbance, used instead of EC10 because of too large differences in curve steepness and height; NOEC, calculated as a 0.3%
 increase of the
baseline absorbance. EC-, BC- and NOEC-values of compounds derived from 3 experiments with four replicates each.  --, not calculated. Values for E2-standard are given in mean S.E.M. (n= 9). Value of
compounds from
3 experiments with four replicates each.
a Efficacy, effect (curve height) of a compoundgivenas percentage of the effectof E2.
b RP, relative potency gives ratio of the EC50 of a compounddividedby the EC50 of E2. 
c Max, curve-height = top –bottom.
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response curves (Fig. 1A) with no antiestrogenic activity (Fig. 1B). BP3, BS, PS and 3BC 
are partial hERα agonists with submaximal dose-response curves (Fig. 1C). They show full 
antiestrogenic activity when co-exposed with E2 (Fig. 1D)(Kunz et al., in press). Table 2 gives 
data about their dose-response curves and relative potencies (RP), which served as a basis for 
our mixture experiments. 
In our experiments the compounds were mixed at iso-effective concentrations; this means that 
the single compounds would lead to the same effect when tested alone. Mixture experiments 
with combinations of two and four compounds with or without E2 were conducted with pure 
hERα agonistic UV fi lters only (Fig. 1 A-B). In order to investigate mixture activities of these 
UV fi lters, binary mixture experiments were conducted fi rst by mixing effect concentrations of 
the single UV fi lters for the effect levels of EC25, EC50 and EC75, respectively. Experiments 
with mixtures of four  pure hERα agonists and mixtures of 8 UV fi lters (+/- E2), comprising of 
pure and partial hERα agonists (Fig. 1 A and C), were then conducted at lower mixture levels 
in order to investigate activities at low concentrations (10% effect level, BC10) and below the 
NOEC (NOEC).
In order to get equipotent multi-component mixtures of 4 or 8 UV fi lters, with and without E2, 
we used non-linear regression analysis for the normalized dose-response curves of each mixture 
component to determine the concentration at which each compound caused a 10 % (BC10) 
increase of basal hERα activity. The NOEC was defi ned as an increase of 0.3 % of basal hERα 
activity. We used equi-effective concentrations based on absorbance and baseline instead of 
EC-mixture levels for the multi-compound mixtures, because thereby we bypassed differences 
in curve height and slope. We used this approach to calculate NOECs, because they generally 
denote the highest concentration at and below which the response of exposed organisms do not 
depart signifi cantly from untreated controls. They are calculated by the Dunnet’s statistical test. 
Hence, the NOEC may not represent a true “zero-effect”, but the effect may not be detected in 
the assay, because it is too weak. In order to prevent testing weak undetectable effects instead 
of NOEC we used the ECx point estimates, which are discussed to replace NOEC in risk 
assessment (Van der Hoeven, 1997). 
Calculations of predicted mixture effects. The joint effects of a mixture with known composition 
were calculated on the basis of the Hill regression models for each UV fi lter in the mixture by 
using the CA concept, the toxic unit approach, and independent action (IA).
In the CA model (Loewe and Muischnek, 1926), compounds act similarly, on the same receptor 
site and can replace each other. Each compound in the mixture contributes individually to 
the mixture-effect in proportion to its concentration. Therefore the mixture ratio (the relative 
abundance of the compound in the mixture) has to be known and dose-response data for each 
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individual compound has to be available that produces the same effect as the mixture on its 
own. Thus assuming that the combined effect of the mixture with n components is concentration 
additive, the following equation will hold for any effect level:
    
                                (1) 
where ci denotes the concentration of the compound i in a mixture yielding to an effect E and 
ECi the concentration of i needed to produce the same effect on its own. 
The concentration ci of the compound i in the mixture is related to the total mixture 
concentration by:                                                                                                                           
                                                                                                                                                  (2) 
where the ratio pi ,  is the concentration of i relative to the total mixture concentration  ECmix 
producing the total mixture effect E. Substitution of ci in equation (1) gives: 
                                  
(3)
 and rearranging yields
                                         
(4)
The concentrations ECi where calculated from the concentration-response curves of the single 
compounds by using the inverse expression of the asymmetric Hill function.
Mixtures that are found to follow the concept of CA were investigated for additivity, synergism 
or antagonism by using the method of isoboles (Loewe and Muischnek, 1926). For binary 
mixtures it is carried out by constructing graphs that show curves describing combinations of 
two compounds A and B, which produce the same specifi c effect (isobole). The axes of the 
graph are the doses of the two compounds on a linear scale. A line is drawn between the iso-
effective doses A and B, representing additivity of the mixture. For mixtures with more than 
three components the toxic unit approach (Berenbaum, 1985) can be used.  Additivity (zero 
interaction) of a mixture is expressed if equation (1) equals 1. Each fraction (ci/ECi) of equation 
(1) represents the concentration of a mixture component scaled for its relative toxicity and is 
generally referred to as the toxic unit of that component (Altenburger et al., 2000). If a given 
mixture deviates from 1, a synergistic mixture effect is indicated by values < 1, whereas an 
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antagonistic mixture effect result in values > 1. This method is suitable to analyze combinations 
of compounds, irrespective of the shape of their individual dose-response curves and can also 
be used in the case of partial agonism (Kortenkamp and Altenburger, 1998).
In the concept of IA (Bliss, 1939), it is assumed that compounds act on different subsystems and 
show different modes of action. This leads to effects in mixtures, which are based on individual 
compound-effects that are greater than zero. This model allows predicted effects of mixtures of 
known composition to be calculated using the expression:
            (5)
where E(ci) is the effect E produced by the compound i at concentration c. Inherent in this 
expression is the fact that E(ci) cannot exceed 1, i.e. E(ci) is a fraction of a maximal possible 
effect, making IA a probabilistic model. Therefore when applying this model to our assay 
effects AE(ci), a maximal effect Emax has to be defi ned. We used in our assays E2, which gave 
the highest absorbance value as a reference. The effect of the mixture is expressed relative to 
the maximal effect of E2. 
(6)
If the concentration-response relationships of all mixture compounds i are described by an 
appropriate regression model Fi (asymmetric Hill function), the assay effect AE(ci) can be 
estimated from the mean effect Fi (ci ), predicted by the regression model. Thus,
                                            and                                                                 (7)
substitution of E(ci) in this equations yields
.                                                     (8)
In order to assure comparability of the IA predictions with those of CA, the fractional effect in 
above equation were rescaled by multiplications with Emax. Thus
                                 and                                                       .               (9)
Chapter 3
- 63 -
Results
Binary mixtures of pure hERα agonists. In all mixture experiments, each UV fi lters was used 
at non-cytotoxic concentrations only. The hERα agonistic UV fi lters (BP1, BP2, DHB and 
Et-PABA) were fi rst assessed in binary mixtures at three different effect levels each (EC25, 
EC50 and EC75). The dose-response curves are shown in Figure 2. The estimates calculated 
for all binary mixtures produced almost identical curves for the concept of CA and IA (not 
shown in Fig. 2 for clarity reasons). An example of estimated CA and IA curves in binary 
mixtures is shown in Figure 3. The dose-response curves for the observed and expected mixture 
effects agreed well, when the mixture was close to additivity and displayed weak antagonism 
(Fig. 3A), whereas when the mixture was strongly synergistic, the observed curve was shifted 
considerably to lower concentrations (Fig. 3B). 
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Figure 2  Binary mixtures of pure hERα agonistic UV fi lters, dose-response curves for mixtures at effect levels 
EC25, EC50 and EC75. Dotted lines represent dose-response curve of single mixture compounds (data from Kunz 
and Fent, in press). Results are presented in panels A-F for clarity reasons. Equieffective mixtures of BP2 and DHB 
(A), BP2 and Et-PABA (B), BP1 and Et-PABA (C), BP1 and DHB (D), BP1 and BP2 (E) and DHB and Et-PABA (F).
with CA and IA, isoboles for effect levels.
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Figure 3   Two examples for estimated CA and IA curves for binary mixtures. (A)  Binary mixture of BP1 
and Et-PABA at EC75 with weakly antagonistic mixture activity. (B)  Binary mixture of BP1 and BP2 at 
EC50 with synergistic mixture activity. Dotted lines represent dose-response curve of single mixture 
compounds (data from Kunz and Fent, in press).
Figure 4   Equi-effective isobole graphs for binary mixtures of pure hERα agonistic UV fi lters, at ef-
fect levels EC25, EC50 and EC75. Dotted lines represent the additivity line with the 95% confi dence 
intervals (CI) band for the single compounds. Results are presented in panels A-F for clarity reasons. 
Equieffective mixtures of BP2 and DHB (A), BP2 and Et-PABA (B), BP1 and Et-PABA (C), BP1 and 
DHB (D), BP1 and BP2 (E) and DHB and Et-PABA (F).
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In order to evaluate binary mixtures for additivity, synergism or antagonism, we have plotted 
the results using the isobole method and the results are shown in Fig. 4. Moreover, toxic units 
were calculated for all mixtures and effect levels (Fig. 5). Binary mixtures with BP1 exhibited 
antagonism at EC25 (mixture with DHB, Fig. 4A, Fig. 5) or at EC75 (mixture with BP2, Fig. 
3B, Fig. 5), or at both mixture levels (Fig. 4C, Fig. 5). However, these were exceptions. For all 
other binary mixtures and effect levels, we observed synergistic interactions (Fig. 4 D-F, Fig. 
5). Generally, lower mixture levels elicited even stronger synergism. For example, the EC25 
level of BP2 with DHB and BP1, and DHB with Et-PABA (Fig. 2 A, E-F and Fig. 4 B,D-E) 
exhibited marked synergism. 
Mixtures of four UV fi lters and E2. All mixture of 4 pure hERα agonists (BP1, BP2, DHB 
and Et-PABA) followed the CA model (Fig. 6) and displayed synergistic activity (Figs. 6, 7). 
Comparison of their relative potencies with those of single UV fi lters revealed that mixtures 
of pure hERα agonists at BC10 and NOEC level led to enhanced relative potencies. Mixture 
activities reached values similar to the EC50 value of BP1, the most estrogenic UV fi lter (Fig. 
7A). 
To our surprise the mixture of four pure hERα agonists (BP1, BP2, DHB and Et-PABA) that 
were added at concentrations below their NOEC showed a full dose-response curve (Fig. 6C). 
It exhibited a stronger relative potency (Fig. 7) than the mixture of these 4 UV fi lters that were 
mixed at the effect level of BC10. This mixture produced a dose-response curve of lesser height 
(Fig. 6B) and displayed a lower relative potency than E2 (Fig. 7A). In the mixture of 
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Figure 5  Toxic unit calculations for binary mixtures of pure hERα agonistic UV 
fi lters, at effect levels EC25, EC50 and EC75. If the calculated toxic unit equals 
1, additivity is assumed; if it is > 1, antagonism is assumed and if it is < 1, syner-
gism.
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UV fi lteradded at their NOEC, the addition of E2 enhanced the relative potency. In case of the 
mixture at the BC10 level, addition of E2 led to a reduced relative potency (Fig. 7).
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Figure 6  Multi-component mixtures of four pure hEΡα agonistic UV fi lters (BP1, BP2, DHB, Et-
PABA), with/without E2, at effect levels BC10 and NOEC. Dotted lines represent estimates for CA 
and IA curves. Results are presented in panels A-C for clarity reasons. Data shown are means ± 
S.E.M. (3 experiments with 4 replicates each).
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Figure 7 Toxic unit calculations for mixtures of 4 agonistic (BP1, BP2, DHB, Et-PABA), or 
4 agonistic and 4 antagonistic (BP3, 3BC, BS, PS) UV fi lters, with/without E2, at effect 
levels BC10 and NOEC. If the calculated toxic unit equals 1, additivity is assumed; if it is 
> 1, antagonism is assumed and if it is < 1, synergism.
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Mixtures of eight UV fi lters and E2. The combination of eight UV fi lters (BP1, BP2, DHB, 
Et-PABA, BP3, BS, PS and 3BC) mixed at their NOEC, displayed submaximal dose-response 
curves that were higher than those of the same compounds mixed at their BC10 (Fig. 8A). 
The activities of mixtures consisting of 4 pure (BP1, BP2, DHB and Et-PABA) and 4 partial 
(BP3, BS, PS and 3BC) hERα agonists, alone or in combination with E2, differed from the 
CA and IA model because of their considerable synergistic activity (Fig. 9). This was the case 
for both the mixtures at the BC10 and NOEC level. As with binary mixtures, the calculated 
estimates of the mixtures of 8 UV fi lters produced very similar curves for the CA and IA model. 
Table 3 Parameters of UV filter mixtures in the yeast hER? assay.
Effect Efficacy RP Hill function parameters Highest mixture
 level 1/… Hill Max EC50 (M) concentration (M) 
BP1 + BP2 EC25 99% 4’389 7.448 1.624 4.456E-07 6.999E.06
 EC50 88% 1’629 1.369 1.044 4.552E-07 1.266E.05
 EC75 100% 2'256 1.000 1.862 1.046E-05 2.110E-05
BP1 + 4DHB EC25 86% 2'588'699 1.000 1.481 2.445E-04 4.154E-05
 EC50 120% 18’840 1.000 1.478 2.372E-05 1.137E-05
 EC75 90% 68’690 2.302 1.636 1.321E-05 1.320E-04
BP1 + Et-PABA EC25 52% 4'094'450 1.392 0.904 7.621E-04 5.505E-04
 EC50 66% 132'538 1.441 0.983 6.102E-05 8.713E-04
 EC75 104% 2'548'848 1.552 1.853 4.370E-04 1.378E-03
BP2 + Et-PABA EC25 76% 1'420'000 2.082 1.349 3.017E-04 5.565E-04
 EC50 115% 1'062'711 2.305 1.912 2.042E-04 8.816E-04
 EC75 107% 1'462'580 2.159 1.852 2.777E-04 1.394E-03
BP2 + DHB EC25 100% 93'595 1.585 1.800 1.758E-05 4.753E-05
 EC50 96% 97'862 2.727 1.667 1.456E-05 8.406E-05
 EC75 110% 128'339 1.627 1.937 2.624E-05 1.477E-04
DHB + Et-PABA EC25 94% 2'110'570 1.434 1.617 3.119E-04 5.910E-04
 EC50 96% 1'003'004 2.439 1.901 2.070E-04 9.427E-05
EC75 103% 2'035'410 1.830 1.961 2.990E-04 1.505E-03
4-Mixture BC10 72% 7’172 1.64 1.360 4.361E-06 3.093E-04
NOEC 88% 6’083 1.53 1.360 3.060E-06 6.769E-05
4-Mixture + E2 BC10 83% 7’161 1.82 1.217 5.438E-06 3.093E-04
NOEC 100% 5’106 2.01 1.828 2.287E-06 6.769E-05
8-Mixture BC10 41% 181'421 0.83 0.629 1.544E-04 7.199E-03
NOEC 69% 9’163 1.87 1.092 7.399E-06 7.507E-05
8-Mixture + E2 BC10 78% 244'241 0.48 1.343 1.459E-04 7.199E-03
NOEC 67% 8’373 1.38 1.178 5.086E-06 7.507E-05
For abbreviations  see Table 1 and 2;. value of compounds from 3 experiments with four replicates each.
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Figure 8 Mixtures of 4 agonistic (BP1, BP2, DHB, Et-PABA), or 4 agonistic and 4 antagonistic (BP3, 3BC, BS, 
PS) UV fi lters, with/without E2, at effect levels BC10 and NOEC. (A) Dose-response curves of multi-compo-
nent at BC10 (solid lines) and NOEC (dotted lines). (B) Calculated relative potencies (RP) compared to E2 for 
all single compounds, binary mixtures and multicomponent mixtures. Data derive from 3 experiments with 4 
replicates each).
Figure 9 Multi-component of 8 UV fi lters (BP1, BP2, DHB, Et-PABA, BP3, 3BC, BS PS), with/without E2, at 
effect levels BC10 and NOEC. Dotted lines represent estimates for CA and IA curves. Results are presented 
in panels A-C for clarity reasons. Data shown are means ± S.E.M. (3 experiments with 4 replicates each). 
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Surprisingly, the combined activity of these eight UV fi lters was synergistic (Figs. 7, 9). When 
they were mixed with E2 at their NOEC, they showed relative potencies that were two orders 
of magnitude higher compared to the mixture at the effect level BC10 (Tab. 3, Fig. 7). It is 
important to note that the relative potencies of the NOEC mixtures were again in the same range 
as the most estrogenic UV fi lter found in our study (Fig. 7).
Discussion
UV fi lters are commonly applied as mixtures in cosmetics and consequently, humans and the 
aquatic environment are exposed to mixtures of UV fi lters. In order to better understand the 
combined mixture activity, we analysed 8 commonly used UV fi lters with either pure or partial 
hERα agonistic activity for their estrogenicity. To our surprise the multi-component mixture 
experiments revealed pronounced synergistic activities of these UV fi lters when mixed at low 
effect concentrations. This marked effect was observed for mixtures with pure and partial hERα 
agonists, even when the individual UV fi lter concentrations alone were at their NOEC.
Concentration addition concept. The hypothesis that binary and multi-component mixtures of 
commonly used UV fi lters would follow the model of CA was supported by our data, although 
a distinction between the CA and IA model was diffi cult or even impossible. The estimates for 
all binary and multi-component mixtures calculated on the assumption of additive interaction 
produced almost identical curves for CA and IA. This was already observed for mixtures with 
the same mode of action (hERα agonists) using the same assay (Payne et al., 2000) and for 
mixtures of compounds with different modes of action in the E-screen (Payne et al., 2001). As 
the hERα assay is based on the compound’s interactions with hERα and does not recognize any 
other effects, the CA model should produce valid calculations of additive effects. Indeed mixtures 
of 4 and 8 environmental chemicals in the hERα assay corresponded well with the predictions 
of CA (Payne et al., 2000; Silva et al., 2002). For our fi ndings we assumed CA because of the 
reasons mentioned above, and used the isobole method and the toxic unit approach in order to 
analyse synergistic or antagonistic interactions. The results of these calculations indicate that 
the binary and multi-component mixtures incorporating pure as well as partial hERα agonists 
in fact follow the model of CA.
Binary mixtures with pure hERα agonists. In a fi rst series of experiments we mixed different 
combinations of two UV fi lters that are pure hERα agonists at three different effect levels. 
All these binary combinations displayed synergistic interactions. The only exceptions were 
combinations of UV fi lters with BP1 at some effect levels. A possible reason for this difference 
may be related to the large differences in relative potencies of the UV fi lters; BP1 possesses 
highest relative potency of all investigated UV fi lters. Its relative potency is also considerably 
Estrogenic activities of UV fi lter mixtures
- 70 -
higher than that of the other three pure antagonists. Other reasons are deviations from the equi-
effectivity of the mixture ratios, because the curve slopes at low and high effect levels differ.
When BP1 was combined with BP2 that shows a 4-times lower potency, antagonism was found 
at the effect level EC75, possibly due to system saturation. This may occur because of the 
high mixture effect level and/or because of differing slopes. Antagonism also occurred when 
BP1 was mixed with 4DHB (34-times lower potency) at EC25, or Et-PABA (700-times lower 
potency) at EC25 and EC75. As a consequence we calculated the equi-effective concentrations 
of single UV fi lters for mixtures of 4 and 8 compounds on the basis of equi-effective absorbance 
values, instead of EC values. Thereby, diffi culties arising from differences in curve slope and 
height were excluded.
Quaternary mixtures with pure hERα agonistic UV fi lters. Combinations of four compounds 
mixed at their BC10 and NOEC showed higher activities than predicted by the CA model. The 
toxic unit approach (Kortenkamp and Altenburger, 1998) demonstrates synergistic interactions 
for all mixtures at all effect concentrations. The mixture of BP1, BP2, 4DHB and Et-PABA at 
the NOEC level led to a full dose-response curve and to higher relative potency, as when mixed 
at BC10 level. This suggests that synergism increases with decreasing mixture levels. Similar to 
our fi ndings, Silva et al. (2002) found substantial mixture effects and high effi cacies when they 
mixed 8 xenoestrogens at low-dose levels.
The dose-response curves of BC10 mixtures displayed a lower effi cacy of 72 to 83%, which 
seems to be caused by cytotoxicity to the yeasts. Toxicity occurred in the BC10 mixture at 
concentrations greater than 2 x 10-3 M, whereas the concentrations at which the individual 
compounds were added to the mixture were far from being toxic on their own. The cytotoxic 
concentrations of UV fi lters BP-2 (>2.5 x 10-3 M) and Et-PABA (>2.5 x 10-3 M) were well above 
those having maximal estrogenicity. This indicates that the cytotoxicity of some UV fi lters 
might also be additive or even synergistic in multi-component mixtures, whereas in binary 
mixtures the interaction of these compounds apparently does not lead to toxicity. The addition 
of E2 enhanced the effi cacy of the mixture, but a stronger relative potency was only observed at 
the NOEC level. Similarly, a mixture of 11 xenoestrogens combined at their EC01 levels (zero 
effect level) with E2 led to a shift of the resulting dose-response curve to lower concentrations 
(Rajapakse et al., 2002). 
Multi-component mixtures of pure and partial hERα agonistic UV fi lters. The strong 
synergism in mixtures incorporating pure and partial hERα agonistic UV fi lters was surprising. 
Synergistic activity was observed, when 4 pure hERα agonists were co-exposed with 4 partial 
hERα agonists. Due to the antiestrogenic activity of partial hERα agonists an overall antagonistic 
mixture activity was expected, based on the fact that partial agonists elicit only submaximal 
Chapter 3
- 71 -
dose-response curves on their own and block the effect of full agonist, when co-exposed with this 
compound (Stephenson, 1956). Partial agonists may only induce a suboptimal conformational 
change of the hERα (Pike et al., 1999; Bowers et al., 2000; Gangloff et al., 2001), or bind to a 
secondary binding site (Dudley et al., 2000; Jensen and Khan, 2004), both of which can lead 
to steric or ionic interferences resulting in reduced effi cacy. The only indication of a weak 
inhibitory action mediated by the partial agonists was found when 8 UV fi lters were mixed at 
their BC10 level. In this case, a considerably lower relative potency was observed compared to 
a mixture of 4 UV fi lters (7’161 vs. 181’421). 
Surprisingly, the activity of mixtures of 8 UV fi lters (with or without E2) combined at their 
NOEC was much more potent than its counterpart at the BC10 level. It showed an enhanced 
activity, which is highly synergistic and only slightly less potent than the NOEC mixtures with 
4 pure hERα agonistic UV fi lters.  Nevertheless, the effi cacies were only submaximal, with a 
slightly decreasing effect at the highest concentration, indicating slight toxicity even at NOEC 
mixture level. The high estrogenicity and effi cacy of the NOEC mixture of 8 UV fi lters may be 
explained as follows. At very low doses components with higher affi nity to the hERα may bind 
fi rst compared to components having lower affi nity, whilst these may rather act as co-activators. 
Thereby, partial agonism of a compound seems to have only a minor effect at NOEC mixtures. 
It was shown that a partial agonist exposed alone or in the presence of low concentrations of a 
full agonist, the resulting effect is submaximal agonistic or additive, respectively (Stephenson, 
1956; Kenakin, 2004).
Possible explanations for the high incidence of synergism found in the yeast hERα assay. 
Why do low-dose mixtures or mixtures at NOEC result in such marked effects? Low-dose 
effects of endocrine disrupting chemicals are mediated by endocrine signaling pathways that 
evolved to act as powerful amplifi ers, with the result that large changes in cell function can occur 
in response to extremely low concentrations (Welshons et al., 2003). Thus, in a mixture some 
compounds may directly mimic E2, whereas others interfere with the production of metabolism 
or transport of E2 (Weltje et al. 2005), or with regard to our study, they may interfere with β-
galactosidase production in the yeast hERα assay. In multi-compound mixtures at very low 
doses, mixture components with higher affi nity to the ER may fi rst bind to it, whilst other 
compounds rather act as co-activators. Thereby the tiniest amount of a chemical added could 
have an effect, because its activity adds to a chemical, which is already there, resulting in no 
threshold effects (Sheehan et al. 1999). Similar to our fi ndings with UV fi lters, xenoestrogens at 
levels below individual non-signifi cant concentrations may indeed enhance estrogenic effects in 
yeasts and MCF-7 cells (Payne et al., 2000; Rajapakse et al., 2002; Silva et al., 2002), but also 
in transfection systems (Le Page et al., 2006). Also a binary mixture of E2 and ethinylestradiol 
was more potent than either of the individual compounds in vivo in fi sh (Thorpe et al., 2003).
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However, synergistic interactions of xenoestrogen mixtures have caused particular concern, 
originating in a study that reported strong synergism of a mixture of weak xenoestrogens (Arnold 
et al., 1996), which could not be reproduced by other laboratories (Ashby et al., 1997; Gaido et al., 
1997; Ramamoorthy et al., 1997). This led to the withdrawal of the original paper (McLachlan, 
1997). Recently, Kortenkamp and Altenburger (1998) reinvestigated mixture studies with the 
isobole method and found that at some effect levels (Gaido et al., 1997; Shekhar et al., 1997) 
and mixture ratios (Ashby et al., 1997) synergism was overlooked. We used the method of 
isoboles and the toxic unit calculations in order to evaluate mixtures for additivity, synergism or 
antagonism. The additional calculations of CA and IA, as well as of relative mixture potencies 
further support our fi ndings with the isobole method for synergistic interactions.
Thus we hypothesize that the observed synergism in most of the mixtures with UV fi lters - even 
when combined at individual NOEC’s, and even when partial agonists were added - is unlikely 
due to the characteristics of the yeast transactivation assay, but rather caused by properties of the 
UV fi lters, which may activate and co-activate the hERα and other co-activators and factors via 
diverse actions. In addition, other signal transduction pathways responsible for estrogen-related 
effects may also play a role. Hormone receptor agonists are not only determined by ligand-
receptor binding, but they may also interact with other factors such as co-regulators that are able 
to modulate the transcriptional activity of steroid hormone receptors (Katzenellenbogen et al., 
1996). In contrast to our observations with UV fi lters, additive interactions were observed in the 
same hERα assay for mixtures consisting of other xenoestrogens at their NOEC (Rajapakse et 
al., 2002; Silva et al., 2002). Signifi cant effects in multi-component mixtures were also found 
with estrogenic pharmaceuticals (Fent et al., in press), and the interaction was synergistic in 
some cases. UV fi lters actually seem to have synergistic activities in mixtures, at least in the 
hERα assay. However, synergism may also be related to and caused by interactions with co-
factors in the yeast system. Thus individual compounds in a mixture may have different activities 
that may infl uence transactivation, binding, co-activation and expression of β-galactosidase. In 
order to prove the synergistic interactions of UV fi lters in mixtures as observed in our study, 
further analysis in other systems such as cell-lines are necessary. 
Conclusions and possible environmental consequences
Recent studies demonstrate that UV fi lters possess endocrine disrupting properties at rather 
high concentrations (Schlumpf et al., 2001; Holbech et al., 2002; Inui et al., 2003; Kunz et al., 
2006). Our fi ndings on the pronounced synergistic effects of multi-component mixtures of UV 
fi lters combined at their individual NOEC indicate that low UV fi lter concentrations present 
on the human skin and in the environment may produce relevant estrogenic activity on their 
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own, or lead to enhanced estrogenic activities of other xenoestrogens or E2, depending on the 
mixture components. 
 
Indeed, concentrations of single UV fi lters in the NOEC mixtures were mostly in the μg/L 
range, when eliciting highest estrogenic activities. These effect concentrations are close to 
residual concentrations of UV fi lters found in the environment. In drinking water and reclaimed 
wastewater in southern California two UV fi lters were found in the range of 0.26 to 5.61 µg/L 
(Loraine and Pettigrove, 2006). Residues of BP3 and OMC were found in human breast milk 
samples up to 445 μg/kg lipid (Hany and Nagel, 1995) and in fi sh 4 to 6 different UV fi lters 
were identifi ed in the low mg/kg range . Our fi ndings suggest that partial agonistic UV fi lters do 
not reduce the overall mixture activity due to antagonism. This seem not to be the case at very 
low concentrations, were these compound also seem to add to the overall mixture effect. 
Our study reveals a novel and more detailed picture of the hormonal activity of UV fi lter 
mixtures in vitro and discloses unexpected synergistic properties of these compounds. In order 
to assess, whether our in vitro fi ndings will translate into other in vitro systems and in vivo, 
further studies are needed. The consequences of mixture activities of UV fi lters found in this 
study are of signifi cant scientifi c and practical interest. For an adequate risk assessment it seems 
unavoidable to consider compound mixtures, when investigating endocrine disrupting properties 
of UV fi lters towards humans and aquatic organisms. Ongoing in vivo studies in our laboratory 
will show, whether in vitro mixture activities of UV fi lters will translate into the activity in fi sh 
at environmentally relevant concentrations. 
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Determination of nine organic UV-absorbing compounds in water 
by gas chromatography-mass spectrometry and high-performance 
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Determination of 9 UV fi lters by SPE and GC/MS or HPLC
- 78 -
Abstract
Ultraviolet-absorbing organic chemicals (UV fi lters) used in sunscreens, cosmetics and 
a number of materials for light protection enter surface water directly or via wastewater. 
Residues of some UV fi lters have been detected in surface water, wastewater, sediment, and 
biological samples. Due to widespread use of different UV fi lters and possible environmental 
contamination, there is a need for appropriate analytical methods for water samples. Here the 
development of an analytical technique for determination of 9 UV-fi lters in water is described. It 
is based on solid phase extraction combined with either gas chromatography-mass spectrometry 
for 4-methylbenzylidene camphor and 3-benzylidene camphor, or high-performance liquid 
chromatography for benzophenone-1, benzophenone-2, benzophenone-3, benzophenone-4, 
4,4’-dihydroxy-benzophenone, octyl-methoxycinnamate, 4-methylbenzylidene camphor, 3-
benzylidene camphor, and ethyl 4-aminobenzoate. By using three different SPE cartridges 
and two solvents, recoveries were between 87 and 107% even though the analytes show large 
differences in polarity. Quantifi cation limits in the μg/L range were achieved with HPLC and/or 
GC/MS, respectively. By an additional concentration of the water sample during SPE separation 
by a factor of 250 to 2’500, the quantifi cation limits could be reduced to the low ng/L. The 
developed HPLC-method allows fast and reproducible determination of a series of UV fi lters 
in water samples.
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Introduction
Organic ultraviolet-absorbing chemicals (UV fi lters) are widely used in sunscreens, cosmetics, 
and for light protection of materials. Various combinations of different UV fi lters are applied to 
achieve the required degree of protection. While showering, bathing, and swimming, sunscreens 
and cosmetics like shampoos are easily washed off and thereby, UV fi lters may contaminate 
the aquatic environment directly or via household wastewater and sewage works. Since an 
increasing number of products contain UV fi lters, production volumes of these compounds 
are rising. Residues of some UV fi lters have been found in surface water, wastewater, sewage 
sludge and fi sh (Nagtegaal et al., 1997; Poiger et al., 2001; Balmer et al., 2005; Buser et al., 
2006; Loraine and Pettigrove, 2006). Critical chemical properties such as persistence, high 
lipophilicity and exhibition of estrogenic activity in fi sh and rats (Schlumpf et al., 2001; 
Holbech et al., 2002; Inui et al., 2003; Schlumpf et al., 2004; Kunz et al., 2006) make UV fi lters 
of potential environmental concern. 
Hitherto, UV fi lters have been analyzed mainly in products such as sunscreens and cosmetics, 
but also in water, and biological samples such as fi sh and human breast milk (Balmer et al., 
2005; Buser et al., 2006) by means of several methods. In commercial formulations UV fi lters 
are quantifi ed by reversed-phase liquid chromatography with UV detection, in order to ensure 
compliance with the proposed maximum permissible concentrations (Gagliardi et al., 1989; 
DiNunzio and Gadde, 1990; Felix et al., 1998; Rastogi and Jensen, 1998; Vanquerp et al., 
1999; Hauri et al., 2003; Salvador et al., 2005). Gas chromatography with mass spectrometry 
(GC/MS) was used to determine residues of 5 different UV fi lters in natural waters (Poiger et 
al., 2004; Loraine and Pettigrove, 2006), 3 different UV fi lters in sewage sludge (Plagellat et 
al., 2006), and 6 different UV fi lters in fi sh  ranging from 2-125 ng/L, 110-5510 μg/kg, and 26-
3’100 μg/kg, respectively. Benzophenone-3 (BP-3) and its metabolites have been measured in 
water and human urine by SPME and ion trap GC/MS (Felix et al., 1998), as well as by liquid 
chromatography (LC)  in sewage sludge (Plagellat et al., 2006), in rat biological fl uids and 
tissues (Abdel-Nabi et al., 1992; Soeberg et al., 2006). 
Generally, UV fi lters are analyzed either by GC/MS (Chisvert et al., 2001; Chisvert and 
Salvador, 2002; Balmer et al., 2004; Balmer et al., 2005) when being volatile, lipophilic and 
non-polar (e.g. 4-MBC, OMC, octocrylene and homosalate) or slightly polar (e.g. BP-3, 4-
isopropyldibenzoylmethane and 4-tert.-butyl-4’-methoxy-dibenzoylmethane). HPLC is applied 
for BP-4, BP-5, OD-PABA (Rastogi and Jensen, 1998; Chisvert et al., 2001; Chisvert and 
Salvador, 2002; Giokas et al., 2004; Salvador et al., 2005) for water soluble and polar comounds 
with rather low volatility and/or high molecular weight. This leads to a fairly high instrumental 
effort, when residues of several UV fi lters with different chemical characteristics should be 
detected in experimental waters and in natural waters in particular. 
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Accurate detection of UV fi lters in water is crucial for the determination of exposure 
concentrations in ecotoxicological experiments with aquatic organisms and environmental 
samples and ultimately, for environmental risk assessment. In particular, a fast and reliable 
method is needed for the analysis of actual concentrations of UV fi lters in exposure experiments 
with aquatic organisms (Kunz et al., 2004; Kunz et al., 2006). For this purpose, we have modifi ed 
an existing GC/MS method (Poiger et al., 2004; Balmer et al., 2005) for the analysis of two 
UV fi lters (4-MBC and 3-BC) in exposure experiments with frogs. We subsequently extended 
it for the analysis to 9 different UV fi lters currently in use having different polarity and water 
solubility by developing a method based on solid phase extraction followed by analysis with 
HPLC-DAD.
Material and Methods
Reagents and solutions
Benzophenone-1 (BP-1), benzophenone-3 (BP-3), benzophenone-4 (BP-4), ethyl 4-
aminobenzoate (Et-PABA), and 4,4’-dihydroxybenzophenone (4DHB) were purchased from 
Fluka AG (Buchs, Switzerland). Octyl-methoxycinnamate (OMC), 4-methylbenzylidene 
camphor (4-MBC) and 3-benzylidene camphor (3-BC) were purchased from Merck (Dietikon, 
Switzerland). Benzophenone-2 (BP-2) was purchased from Aldrich (Fluka AG, Buchs, 
Switzerland).  Benzyl cinnamate was obtained from Fluka AG (Buchs, Switzerland). Analytical 
grade ethanol (EtOH), methanol (MeOH), dichloromethane (MeCl2) and acetonitrile (ACN) 
were purchased from T.J. Baker (Stehelin AG, Basel, Switzerland). All compounds used had a 
purity grade ≥ 99 %.
2-Hexanol and formic acid (FA, puriss, p.a. ~98%) were purchased from Fluka AG (Buchs, 
Switzerland). Bi-distilled water was produced using a Jencons Autostill double D-ionstill 
distillator (Renggli AG, Rotkreuz, Switzerland) and additionally fi ltered through membrane 
fi lters (RC 55, 0.45μm, Ø 50 mm, Schleicher & Schuell, Geneva, Switzerland) when used as a 
HPLC solvent.
Stock standard solutions of the UV fi lters were freshly prepared in ethanol and stored in the dark 
at 4°C. Their structures and relevant properties are given in Table 1. Spiked sample solutions 
were freshly prepared and acidifi ed with HCl (Fluka AG, Buchs, Switzerland) to pH of 3 to 
avoid decomposition prior to SPE procedure.
Experimental water samples were repeatedly taken during exposure experiments with frog and 
fi sh, collected in dark glass bottles, acidifi ed with HCl to pH of 3 to avoid decomposition and 
stored at 4°C until immediate extraction. The animals were exposed via the aqueous route 
and were held in artifi cial tab water spiked with the test substances (subsequently referred to 
as experimental water, for details see (Kunz et al., 2004; Kunz et al., 2006). Precautions were 
taken to prevent contamination by personnel, equipment and glassware.
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Separation and determination of 4-MBC and 3-BC by means of SPE and GC/MS
Solid phase extraction (SPE). One goal of this study was to develop a method to separate 
and concentrate residues of the UV fi lters 4-MBC and 3-BC, respectively, from experimental 
waters by solid phase extraction (SPE). Therefore commercially available SPE cartridges were 
tested, in order to fi nd a cartridge which gives good separation and recoveries for 4-MBC and 
Table 1 
Physiochemical properties of the analysed UV filters 
Compound Chemical structure Molecular Melting ?max CAS
Weight (g/kg) Point (nm)
4-Methylbenzylidene 254.37 66-68°C 225, 300 36861-47-9
Ocamphor
3-Benzylidene camphor 240.34 77-81°C 223, 292 15087-24-8
O
Benzophenone-1 214.22 139-140°C 215, 290 131-56-6
O
OH
OH
Benzophenone-2 246.22 195°C 195, 285 131-55-5
O
OHOH
OHOH
Benzophenone-3 228.25 65°C 220, 287 131-57-7O
OOH
Benzophenone-4 308.31 171°C 220, 287 4065-45-6
O
HO3S
OHO
4,4’-Dihydroxybenzo- 214.22 211-212°C 195, 297 611-99-4
phenone
Octyl-methoxycinnamate 290.40 liquid 225, 300 5466-77-3
Ethyl-4-aminobenzoate 165.19 89-92°C 221, 287 94-09-7
O
OHOH
O
O
O
NH2
O
O
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3-BC. Different volumes of experimental water samples and different elution solvent were 
tested in order to develop an optimized SPE procedure. 
Gas chromatography-mass spectrometry (GC/MS). In order to determine the UV fi lters 4-MBC 
and 3-BC, the GC/MS method used by Poiger et al. (2004) was established in our laboratory. 
This was performed on a Saturn WS System (Varian Star 3400 CX GC, Saturn 3 MS). 
Extension of the SPE method for 9 UV fi lters and development of a HPLC method
 SPE optimisation for the extraction of 9 UV fi lters. In order to extract and concentrate residues 
of 9 UV fi lters from experimental waters, modifi cations of the SPE procedure were necessary, 
as the previously developed method for the extraction of 4-MBC and 3-BC failed to extract BP-
4, 4-DHB, BP-2 and displayed only poor recoveries for BP-1 (Tab. 2). Hence in order to extract 
9 chemically distinct compounds the SPE method was further improved. Twelve commercially 
available SPE cartridges were tested to fi nd the appropriate cartridges with the best recoveries 
for every compound analysed.
HPLC method development for the separation of 9 UV fi lters. GC/MS turned out to be an 
adequate method for the determination of 4-MBC and 3-BC. When 7 additional UV fi lters 
were tested with GC/MS, very poor sensitivity was achieved for some of the benzophenones 
(see results and discussion). Therefore a HPLC method was developed for the simultaneous 
determination of 9 UV fi lters, by choosing appropriate HPLC columns, wavelengths and 
gradient elution. The HPLC 1100 system (Agilent Technologies, Basel, Switzerland) used in 
this study comprised a solvent delivery pump, an autosampler, a photodiode array detector 
(DAD) and chromatography software (Agilent ChemStation) for LC and LC/MS. 
 
Calculations for Linearity, LOD and LOQ. For the GC/MS and HPLC methods regression 
analysis were used for linearity calculations for all 9 UV fi lters in the investigated concentration 
ranges-. The LOD for the developed GC/MS and HPLC methods was defi ned as the UV fi lter 
concentration that gives a signal equal to 3yb, where yb is the signal of the baseline noise. 
Similarly, the LOQ was defi ned as 10yb.
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Results
The aim of this study was to develop one analytical method that allows the determination 
of 9 commonly used UV fi lters with large differences in polarity and water solubility in 
experimental waters originating from exposure experiments with aquatic organisms. Therefore 
we fi rst modifi ed an existing method (Poiger et al., 2004; Balmer et al., 2005) based on a 
solid phase extraction procedure coupled with GC/MS in order to analyse 4-MBC and 3-BC in 
water samples from exposure experiments. Second we extended the SPE method to additional 
7 commonly used UV fi lters and developed a HPLC method for 9 UV fi lters. 
Table 2  Recoveries with different SPE cartridges and eluents. 
________________________________________________________________________
    Recovery (%) with different eluents
SPE     BP-4    4-DHB      BP-2    Et-PABA     BP-1     BP-3     3-BC   4-MBC     OMC
____________________________________________________________________________________________________________
         
Eluent: Dichloromethane
I 101 18.9 ± 0.1 92.8 ± 0.2 87.6 ± 0.5 47.7 ± 0.1 82.0 ± 0.3 81.6 ± 0.4 74.5 ± 0.3 71.2 ± 0.3 55.9 ± 1.4
SX US 62.3 ± 0.1 101.9 ± 0.1 94.6 ± 0.1 87.7 ± 0.1 82.9 ± 0.1 55.5 ± 0.1
SX P    3.7 ± 0.1 50.2 ± 0.1    100.5 ± 0.2 92.7 ± 0.1 78.3 ± 0.4 83.3 ± 0.4 70.8 ± 0.5
SX CM      83.0 ± 1.1 81.9 ± 1.2 86.4 ± 0.9 86.5 ± 1.3
SP C18 105.6 ± 0.5 67.9 ± 0.3 .7 ± 0.1 34.9 ± 0.1 97.4 ± 0.4 92.0 ± 0.3 69.5 ± 0.3
CE     5.4 ± 0.1  56.9 ± 0.5 59.4 ± 0.5 85.0 ± 0.8 81.9 ± 0.8 78.2 ± 0.8 62.7 ± 0.6
I C8E    56.8 ± 2.0 59.6 ± 2.2 53.8 ± 1.9 25.0 ± 0.9 38.4 ± 1.4 47.0 ± 2.9 
I C18    56.6 ± 0.4 22.4 ± 0.1 65.2 ± 0.4 74.8 ± 0.5 70.7 ± 0.6 56.1 ± 2.1 
S DPA    63.0 ± 0.9  91.2 ± 1.2 83.8 ± 1.2 82.8 ± 1.2 69.7 ± 1.0 
CE H    62.7 ± 2.1 58.0 ± 1.9 86.4 ± 2.7 82.5 ± 2.6 78.5 ± 2.5 62.3 ± 2.1 
S Env C      84.3 ± 3.6 79.3 ± 3.4 80.7 ± 3.5 67.8 ± 3.0
I C18E     30.5 ± 0.1 88.4 ± 0.1 89.2 ± 0.1 87.1 ± 0.1 83.8 ± 0.1
I PAH  24.8 ± 0.1   6.0 ± 0.1 15.5 ± 0.1   8.0 ± 0.1   8.6 ± 0.1   4.9 ± 0.3
          
          
Eluent: Methanol
I 101 74.2 ± 0.3 85.7 ± 0.5 78.1 ± 0.4 46.0 ± 0.2 84.8 ± 0.4 76.3 ± 0.2 34.3 ± 0.2 46.8 ± 0.1 24.7 ± 0.1 
I C18 74.2 ± 2.0 76.3 ± 1.5 74.7 ± 1.5 27.4 ± 0.5 75.0 ± 1.6 41.0 ± 0.8 18.7 ± 0.4 24.8 ± 0.5 19.4 ± 0.4
I E+ 29.7 ± 1.3 92.7 ± 1.6 88.2 ± 1.8  86.4 ± 1.7 23.4 ± 0.6 43.3 ± 0.8 35.7 ± 0.7   3.5 ± 0.1
S NH2    8.4 ± 0.1    1.1 ± 0.1    2.5 ± 0.1   6.0 ± 0.1 11.1 ± 0.1
CE  96.4 ± 0.5 90.7 ± 0.5 39.9 ± 0.2 93.2 ± 0.5 57.7 ± 0.4 29.9 ± 0.2 26.0 ± 0.1 18.2 ± 0.1 
SP  C18    104.3 ± 0.1    106.9 ± 0.4    102.4 ± 0.4 .9 ± 0.2     104.2 ± 0.4 64.2 ± 0.1 47.0 ± 0.2 36.2 ± 0.1 24.1 ± 0.1
?polar ----------------------------------------------------------------------------------------------------------------------------------------  non-polar ?
Tested SPE cartridges with corresponding mean recoveries and standard deviations for 9 UV filters, based on spiked 
water samples with compound concentrations of 10 µg/L. The elution solvents used were either dichloromethane 
(MeCl2) or methanol (MeOH). Cartridges used: Isolute SPE 101 (I 101), Strata-X 33u Universal Sorbent (SX US), 
Strata-X-C Polymeric  Sorbent (SX-C P), Strata-X-C 33um Cation Mixed-Mode Polymer (SX-CM), Sep-Pak Vac 3cc 
C18 (SP C18), Chromabond Easy (CE),  Isolute C8/ENV+ (I C8E), Isolute C18(EC) (I C18), Supelco Discovery DPA-
6S (S DPA), Chromabond Easy HRP (CE H), Supelco Supeclean ENVI-Carb (S ENV), Isolute C18/ENV+ (I C18E), 
Isolute ENV+ (I E+), Isolute PAH (I PAH), Supelco Discovery DSC-NH2 (S NH2). In bold are the cartridges used for 
optimised SPE procedures and subsequent recoveries. 
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Separation and determination of 4-MBC and 3-BC by means of SPE and GC/MS
Solid phase extraction (SPE). For the extraction of 4-MBC and 3-BC from experimental 
water we used commercially available SPE cartridges instead of glass columns containing 
polystyrene adsorbent. We evaluated three different SPE cartridges for this purpose, Isolute 
C8/ENV, C18/ENV and C18/PAH. In Table 2 the achieved recoveries are listed. For further 
analysis the Isolute C18/ENV+ cartridges were chosen, because of good recoveries from spiked 
water samples between 87% and 89% (Tab. 2) and their broad use and applicability.  
The extraction of 4-MBC and 3-BC, respectively, from experimental waters was performed as 
follows: Isolute C18/ENV+ cartridges (Separtis GmbH, Grellingen, Switzerland). C18/ENV+ 
cartridges were conditioned with 2 x 3 mL dichloromethane, followed by the same amount 
of methanol and H2O bi-distilled prior to the extraction. Then the experimental water samples 
(usually 250 mL) were fi ltered under vacuum through the cartridges at a fl ow rate of 1-2 
mL/min. The cartridges were then air-dried for 30 min and eluted into test tubes with 3 x 3 
mL dichloromethane.  The test tubes were transferred to a Syncore Reactor (Büchi, Flawil, 
Switzerland) and dichloromethane was reduced to dryness under vacuum (700 mbar, 50 °C). 
The glass walls were then rinsed with 1 mL of dichloromethane in order to increase the recovery 
and then dichloromethane was allowed to evaporate to dryness under the same conditions. The 
dry eluent was resuspended in 100 µL of 2-hexanol and was then transferred into a GC vial 
(brown glass) and analysed with GC/MS by on column injection.
With this SPE method we achieved a simplifi cation of the extraction procedure and a better 
signal/noise ratio (data not shown). The cleanup step used by Poiger et al. (2004) after SPE was 
abandoned, once we had demonstrated that it did not improve recoveries or determination by 
GC/MS. For a internal standard we fi rst used benzyl cinnamate, which gave good results when 
working with spiked water samples, but was no longer detectable by GC/MS when added to 
Figure. 1   Typical GC/MS-SIM chromato-
gram of 4-methylbenzylidene camphor (4-
MBC) and 3-benzylidene camphor (3-BC) 
extracted from experimental water samples 
of exposure experiments with fi sh. Nominal 
concentrations for both compounds were 500 
μg/L. Water samples were taken directly af-
ter water renewal (0 h) and before the next 
renewal after 24 hours of exposure (24 h). 
Actual concentrations were determined by 
means of an external standard with the same 
concentration as the experimental water 
sample (500 μg/L).
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our experimental water samples. Instead, we used the other analyte as external standard (e.g. 
for the analysis of 4-MBC, 3-BC served as external standard). Thereby the amount of UV fi lter 
was determined from peak area relative to the internal standard (Fig. 1).
Gas chromatography-mass spectrometry (GC/MS). The analysis of 4-MBC and 3-BC was 
performed on a Saturn WS System (Varian Star 3400 CX GC, Saturn 3 MS) by on column 
injection (SPI). The GC was fi tted with a SE 54 capillary column (J&W Scientifi c, MSP Friedli + 
Co., Koeniz, Switzerland), 30 m x 0.32 mm x 0,25 µm. Analyses were performed in the selected 
ion monitoring (SIM) mode using electron ionisation (EI). The following ions were selected 
from the spectrum of each compound in order to quantify the response under SIM mode: m/z 
239, 240 and 241 for 3-BC, m/z 239, 253, 254 and 255 for (Z-)-4-MBC, m/z 239, 253, 254 and 
255 for (E-)-4-MBC. The temperature program run was: 85°C, held for 2 min, ramped at 20 
°C/min to 180 °C for 4.75 min and then ramped at 5 °C/min to 280 °C for 20 min. The injector 
temperature program run was: 60 °C, held for 0.1 min, ramped at 180 °C/min to 280 °C, held 
for 20 min and 2.0 μL injections were made. Helium (Carbagas, Bern, Switzerland, purity grade 
> 99.99%) was used as carrier gas with an inlet pressure of 19 psi (1.34 bar).
SPE optimisation for the extraction of 9 UV fi lters. The cartride (C18/ENV+) used to extract 
4-MBC and 3-BC cartridge failed to extract BP-4, 4-DHB, BP-2 and displayed only poor 
recoveries for BP-1 (Tab. 2). Thus we tested twelve commercially available SPE cartridges in 
order to fi nd the appropriate cartridges with the best recoveries for every compound analysed 
(Tab. 2). The Sep Pak C18 cartridge (Waters AG, Rupperswil, Switzerland) was able to extract 
7 out of 9 compounds, with recoveries between 102 and 107% for BP-4, 4-DHB, BP-2 and 
BP-1 when eluted with methanol, and between 92 and 105% for 4-DHB, 3-BC and 4-MBC 
when eluted with dichloromethane. For Et-PABA, the recovery was only 68% with this solvent 
and could not be improved by applying other cartridges. Because of the insuffi cient recoveries 
with Sep Pak C18 cartridges, UV fi lters BP-3 and OMC were extracted with either Strata-X 
Universal Sorbent cartridges or Strata X Cation Mixed Mode cartridge (both Brechbuehler 
AG, Schlieren, Switzerland), respectively, and dichloromethane as elution solvent resulting in 
recoveries of 87 and 95% (Tab. 2). The dry eluent was resuspended in ethanol prior to HPLC 
analysis instead of 2-hexanol, leading to improved peak quality.
Upgrading of the GC/MS method for 9 UV fi lters. We expanded the GC/MS method in order 
to determine additional 6 UV fi lters (BP-1, BP-2, BP-3, BP-4, DHB, Et-PABA and OMC). This 
led to diffi culties for BP-1, which gave very broad peaks and for BP-2 and DHB, which were not 
detectable in GC/MS and led to artefacts (data not shown).  Modifi cations of temperature regime, 
injection temperatures and solvents did not improvement the detection. Thus experiments were 
conducted to analyse the compounds by HPLC instead of applying GC/MS.
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HPLC method development and optimisation for 9 UV fi lters. For the HPLC method 
development, data collection was fi rst performed for all 9 compounds across the 190-400 
wavelength range. The diode array detector was then set to 290 nm, which is a compromise 
giving good UV responses for all 9 analytes (Fig. 2). Bi-distilled water was processed 
Figure 2  Typical chromatogram of the 9 UV fi lters determined by HPLC-DAD (290 nm), showing peaks 
of the compounds solved in ethanol (25 mg/L). This concentration is based on a concentration factor of 
2500 when concentrating 250 mL of a spiked water sample (10 μg/L) by SPE to 100 μL of eluent.
BP-2
BP-1
Retention time (min)
Figure 3  Typical HPLC-DAD (290 nm) chromatogram of determination of benzophenone-2 (BP-2) 
extracted from experimental water samples of exposure experiments with fi sh. Nominal concen-
trations of benzophenone-1 (BP-1) and benzophenone-2 (BP-2) were 10 μg/L. Water samples 
were taken directly after water renewal (0 h) and before the next renewal after 24 hours of exposu-
re (24 h). Actual concentrations of BP-2 were determined by means of BP-1 as internal standard.
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as procedural blank and spiked with UV fi lters at concentrations of 10 and 100 µg/L for the 
determination of recoveries. As internal standards we used UV fi lters with structural or chemical 
similarities to the UV fi lter analysed (Tabs. 1 and 2). The amount of UV fi lter was determined 
from peak area ratios relative to the internal standard (Fig. 3). 
Linearity, LOD and LOQ for GC/MS and HPLC. Linearities for all 9 compounds in the 
investigated concentration ranges are presented in Table 3. For the developed GC/MS method 
the LOD and LOQ for 4-MBC and 3-BC were in the range 50–62.5 µg/L and 167.5–212.5 µg/
L, respectively. When including SPE in these calculations with a concentration factor of 2’500, 
LOQ of 67-85 ng/L were achieved for 4-MBC and 3-BC, respectively.  For the HPLC method 
for 9 UV fi lters the LOD and LOQ values ranged between 87.5-137.5 µg/L and 287.5–462.5 
µg/L, respectively, for all compounds except BP-4, which had higher LOD and LOQ. Again by 
including SPE with a concentration factor of 2’500 in these calculations, LOQ of 115-185 ng/L 
were achieved for all compounds except BP-4 (Tab. 3).
Table 3  Analytical parameters of calibration curves, LOD and LOQ. 
UV filter RT CR Regression Equationb LOD LOQ SPE LOQ Internal
 (Min) (µg/L) Interceptc Sloped r2 (n)e (?g/L) (?g/L)    (ng/L)
 standard
GC/MS
3-BC 10.700 0.564-56.4 -34.81 ± 22.18a   12.21 ± 0.64a 0.9918(5)  62.5 212.5  85 4-MBC
4-MBC 11.783 0.516-51.6 -30.38 ± 18.76a   15.27 ± 0.59a 0.9909(5)  50.0 167.5  67 3-BC
HPLC
4-MBC 26.932 0.05-100  57.42 ± 35.30 142.70 ± 0.93 0.9998(7) 100.0 325.0 130 3-BC
3-BC 25.522 0.10-100         102.40 ± 54.27   153.2 ± 1.32 0.9997(6) 100.0 312.5 125 4-MBC
BP-1 18.130 0.05-100  26.74 ± 16.63   107.8 ± 0.44 0.9999(7) 112.5 362.5 145 BP-2
BP-2 13.953 0.10-100  18.11 ± 10.20   83.34 ± 0.27 0.9999(7) 137.5 462.5 185 BP-1
BP-3 22.383 0.05-100  29.01 ± 15.69 113.40 ± 0.41 0.9999(7) 125.0 387.5 155 BP-1
BP-4 11.901 0.05-100    8.21 ± 6.21   75.19 ± 0.15 1.0000(6) 525.0   1’750.0 700 BP-1
4-DHB 12.663 0.05-100  66.79 ± 39.91 157.00 ± 1.05 0.9998(7)   87.5 287.5 115 3-BC
OMC 29.963 0.05-100  80.58 ± 46.75 153.00 ± 1.23 0.9997(7) 100.0 312.5 125 4-MBC
EAB 14.414 0.05-100  87.85 ± 55.06 173.10 ± 1.45 0.9997(7) 100.0 300.0 120 4-DHB
Retention times (RT), concentration range (CR), linearity, limits of detection (LOD) and limits of quantitation
(LOQ) of the GC/MS and HPLC method. SPE LOQ Limits of quantitation including the extraction and
concentration by SPE (SPE LOQ) with a concentration factor of 2’500 when concentrating 250 mL of a spiked
water sample (sample concentration: 100 µg/L) by SPE to 100 µL of eluent.
 a value = calculated value x 10-5
 b Linear unweighted regression analysis, with a regression equation y = a + bx, where x is concentration in
µg/L.
 c (a ± S.D.), where a is the intercept and S.D. is the standard deviation.
 d (b ± S.D.), where a is the slope and S.D. is the standard deviation.
e r2 is the correlation coefficient and n is the number of points in each calibration curve; each point is the mean
of 4 experimental measurements.
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Analysis of experimental waters
The methods described were applied for the GC/MS or HPLC determination, respectively, of 
actual concentrations of 2 UV fi lters in experimental waters with frogs (for details see (Kunz et 
al., 2004)) and of 9 UV fi lters in experimental waters with fi sh. The results are shown in Table 
4 and details are given in Kunz et al. (2006)(Fig. 3). 
Table 4. Example of Nominal and measured water concentrations of analyzed UV filters by 
HPLC and GC/MS (4MBC and 3BC) during a 14-day experiment with juvenile 
fathead minnows, exposed via the aqueous route toward 9 different UV filters (from 
Kunz et al. 2006). 
Exposure concentrations 
Nominal Measured 
(µg/L) 0 h (µg/L) 24 h (µg/L) Median (µg/L)* After 24 h (%)** 
3BC 10 9.5 ± 0.3 8.0 ± 1.2 9 84% 
500 516.7 ± 36.7 352.5 ± 130.8 435 68% 
1'000 1'070.0 ± 28.3 835.0 ± 49.5 953 78% 
BP1 10 9.8 ± 0.1 8.1 ± 0.2 9 82% 
1'000 1'032.4 ± 54.8 930.0 ± 14.1 981 90% 
5'000 5'191.7 ± 58.7 4'647.1 ± 221.4 4'919 90% 
BP2 10 10.7 ± 0.6 9.9 ± 0.9 10 93% 
1'000 1'102.5 ± 9.8 1'031.7 ± 17.0 1'067 94% 
10'000 9'747.3 ± 557.9 7'818.5 ± 104.5 8'782 80% 
4MBC 10 9.6 ± 1.8 7.4 ± 0.4 9 77% 
500 492.4 ± 102.7 337.5 ± 17.7 415 69% 
1'000 826.1 ± 189.4 680.0 ± 198.0 753 82% 
OMC 10 8.8 ± 0.1 6.5 ± 0.7 8 74% 
1'000 1'012.5 ± 165.6 765.0 ± 63.6 889 76% 
5'000 5'450.0 ± 282.8 4'600.0 ± 141.4 5'025 84% 
BP3 10 13.5 ± 1.1 9.7 ± 0.2 12 71% 
1'000 879.5 ± 115.0 652.2 ± 65.4 766 74% 
5'000 4'175.0 ± 247.5 3'625.0 ± 106.1 3'900 87% 
BP4 10 11.5 ± 0.9 10.8 ± 0.8 11 94% 
1'000 1'068.2 ± 64.4 1'027.7 ± 99.2 1'048 96% 
5'000 5'158.9 ± 425.2 4'634.3 ± 26.4 4'897 90% 
4DHB 10 11.8 ± 1.0 9.0 ± 0.1 10 76% 
1'000 901.9 ± 48.4 899.0 ± 42.9 900 100% 
5'000 5'388.5 ± 2.7 4'633.0 ± 232.4 5'011 86% 
*: Median of actual concentrations at 0 h and 24h
**: Percentage of actual concentration at 24 h relative to 0h
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Discussion
The aim of this study was to develop one analytical method that allows the determination of 9 
commonly used UV fi lters with large differences in polarity and water solubility in experimental 
waters originating from exposure experiments with aquatic organisms. Two methods for analysis 
of UV fi lters in water were developed. In order to analyse 4-MBC and 3-BC in water samples 
from exposure experiments we modifi ed an existig method (Poiger et al., 2004; Balmer et al., 
2005) based on a solid phase extraction procedure coupled with GC/MS. The extension of this 
method to additional 7 commonly used UV fi lters led to diffi culties, and therefore, resulted in 
the development of a SPE and HPLC-DAD method for 9 UV fi lters.
Modifi cation and optimisation of SPE and GC/MS method for 4-MBC and 3-BC. Because 
of slight differences in the requirements the existing method (Poiger et al., 2001; Poiger et al., 
2004) was simplifi ed as follows. Extraction of 4-MBC and 3-BC from experimental water was 
performed with commercially available SPE cartridges instead of glass columns containing 
polystyrene adsorbent. For this purpose we tested three different SPE cartridges (Isolute C8/ENV, 
C18/ENV and C18/PAH) and fi nally the Isolute C18/ENV+ cartridges was chosen for extraction 
of 4-MBC and 3-BC, because of its good recoveries and its broad use and applicability. This led 
to a simplifi cation of the extraction procedure. 
We abandoned the cleanup of the extracts on silica after SPE (Poiger et al., 2001; Poiger et al., 
2004), once we had demonstrated that the cleanup, besides removing some other compounds and 
leading to artefacts in the cleaned extract, was not advantageous for the GC/MS determination 
of 4-MBC and 3-BC in experimental water, although it might be still of use in natural waters. 
Furthermore the internal standard compound was changed. While benzyl cinnamate as internal 
standard gave good results in our hands when working with spiked water samples, it was no 
longer detectable by GC/MS when added to our experimental water samples. Instead, we used 
the other analyte as internal standard (e.g. for the analysis of 4-MBC, 3-BC served as internal 
standard, and vice versa). These modifi cations led to a more practicable and faster SPE procedure 
and adaptations of the GC/MS measurement regime.
Diffi culties with the upgrading of the GC/MS method for 9 UV fi lters. The expansion of the 
GC/MS method in order to determine additional 6 UV fi lters (BP-1, BP-2, BP-3, BP-4, DHB, 
Et-PABA and OMC) led to diffi culties. BP-1 gave very broad peaks, BP-2 and DHB were not 
detectable and led to artefacts.  Modifi cations of temperature regime, injection temperatures and 
solvents did not lead to improvements in detection. Possibly, high boiling points (DHB, 213-
215°C), reduced volatility and enhanced polarity made them diffi cult to determine by GC/MS. 
Thus experiments were conducted to analyse the compounds by HPLC instead of applying 
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GC/MS. As a consequence of the diffi culties in upgrading the SPE and GC/MS method for 4-
MBC and 3-BC, we developed a novel SPE and HPLC method in order to determine effective 
concentrations of 9 different UV fi lters in experimental exposure waters.  
SPE optimisation for the extraction of 9 UV fi lters. The previously used C18/ENV+ cartridge, 
which gave good recoveries for 4-MBC and 3-BC failed to extract BP-4, 4-DHB, BP-2 and 
displayed only poor recoveries for BP-1. Thus adaptation of the SPE method had to be undertaken 
to extract 9 chemically distinct compounds. From twelve commercially available SPE cartridges 
tested three were chosen for further SPE of UV fi lters. The Sep Pak C18 cartridge (Waters AG, 
Rupperswil, Switzerland) was used for the extraction of BP-4, 4-DHB, BP-2 and BP-1 with 
methanol as eluted and for 4-DHB, 3-BC and 4-MBC with dichloromethane as eluent. For Et-
PABA, the recovery was only 68% with this solvent and could not be improved by applying 
other cartridges. Because of the insuffi cient recoveries with Sep Pak C18 cartridges, UV fi lters 
BP-3 and OMC were extracted with either Strata-X Universal Sorbent cartridges or Strata X 
Cation Mixed Mode cartridge (both Brechbuehler AG, Schlieren, Switzerland), respectively 
and dichloromethane as elution solvent. The dry eluent was resuspended in ethanol prior to 
HPLC analysis instead of 2-hexanol, leading to improved peak quality.
 HPLC method development and optimisation for 9 UV fi lters. In order to measure the nine 
UV fi lters by HPLC, the diode array detector was set to 290 nm, which is a compromise giving 
good UV responses for all 9 analytes (Fig. 2). For analysis of experimental water samples a 
guard cartridge was not needed, but it might be necessary when analysing natural waters. 
As internal standards we used UV fi lters with structural or chemical similarities to the UV fi lter 
analysed (Tabs. 1 and 2). For example, when determining residues of 4-MBC in experimental 
waters, 3-BC was used as internal standard. The amount of UV fi lter was determined from peak 
area ratios relative to the internal standard (Fig. 3). This faster and more feasible procedure 
comprises of a SPE method using three different cartridges (Sep-Pak Vac C18, Strata-X Universal 
Sorbent and Strata-X-C Cation Mixed-Mode Polymer), two elution-solvents (methanol and 
dichloromethane) and a HPLC-DAD method for simultaneous analysis of these 9 compounds. 
Linearity, LOD and LOQ for GC/MS and HPLC. Regression analysis revealed linearity for 
all 9 compounds in the investigated concentration ranges (Tab. 3). For the developed GC/MS 
method the LOD and LOQ for 4-MBC and 3-BC were in the low µg/L range. When including 
SPE in these calculations with a concentration factor of 2’500, LOQ in the low ng/L range were 
achieved for 4-MBC and 3-BC, respectively
For the newly developed HPLC method for 9 UV fi lters the LOD and LOQ, were a little higher 
than for GC/MS, and were in the low to medium µg/L range for all compounds except BP-4, 
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which had higher LOD and LOQ. Again by including SPE with a concentration factor of 2’500 
in these calculations, LOQ of 115-185 ng/L were achieved for all compounds except BP-4 
(Tab. 3). Our method may be used for water samples with lower concentrations by increasing 
volumes for SPE to 500 or 1000 mL and reducing the fi nal eluent volume to 50 µL, thereby 
concentration factors of 5’000 to 10’000 may be achieved.
Application
In this study, an analytical method for the detection of the UV fi lters 4-MBC and 3-BC based 
on SPE and GC/MS was modifi ed and simplifi ed. In addition, a SPE-HPLC method for the 
quantitative determination of 9 commonly used UV fi lters in experimental waters was developed. 
Accordingly, these 9 chemically different compounds were extracted and concentrated from 
spiked water samples by the use of 3 different cartridges and two different sovents, giving 
recoveries higher than 87 % for all 8 UV fi lters. The resulting extracts were either analysed 
by GC/MS (4-MBC and 3-BC) or HPLC (all 9 compounds). Although HPLC-DAD does 
not achieve the sensitivity of GC/MS or HPLC/MS, it offers a fast and reliable analysis of 
experimental water samples in aquatic toxicological studies.
We applied the methods described for the determination of actual concentrations of 2 UV fi lters 
in experimental waters with frogs (for details see Kunz et al. (2004)) and of 9 UV fi lters in 
experimental waters with fi sh (Kunz et al., 2006) (Tab. 4 and Fig. 3) and achieved good results. 
However, it may well be used as a versatile tool to determine UV fi lter residues in natural 
waters. Especially when larger samples volumes are used for the SPE procedure, the detection 
limit will be reduced to the low ng/L range. This is particularly needed for monitoring purposes, 
as UV fi lters are of growing concern regarding their possible hormonal activity and adverse 
effects on the aquatic environment.
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Abstract
In this work, we evaluate whether in vitro systems are good predictors for in vivo estrogenic 
activity in fi sh. We focus on UV fi lters being largely used in sunscreens and in UV stabilization 
of materials. First, we determined the estrogenic activity of 23 UV fi lters and one UV 
fi lter metabolite employing a recombinant yeast carrying the estrogen receptor of rainbow 
trout (rtERα) and made comparisons with yeast carrying the human hERα for receptor 
specifi city. Benzophenone-1 (BP1), benzophenone-2 (BP2), 4,4-dihydroxybenzophenone, 
4-hydroxybenzophenone, 2,4,4-trihydroxy-benzophenone and phenylsalicylate showed full 
dose-response curves with maximal responses of 81-115%, whereas 3-benzylidene camphor 
(3BC), ocylsalicylate, benzylsalicylate, benzophenone-3 and benzophenone-4 displayed lower 
maximal responses of 15-74 %. Whereas the activity of 17β-estradiol was lower in the rtERα 
than the hERα, the activities of UV fi lters were similar or relatively higher in rtERα, indicating 
different relative binding activities of both ER. Subsequently, we analysed whether the in vitro 
estrogenicity of 8 UV fi lters is also displayed in vivo in fathead minnows by the induction 
potential of vitellogenin after 14 days of aqueous exposure. Of the three active compounds in 
vivo, 3BC induced vitellogenin at lower concentrations (435 µg/L) than BP1 (4919 µg/L) and 
BP2 (8783 µg/L). The study shows for the fi rst time estrogenic activities of UV fi lters in fi sh 
both in vitro and in vivo. Thus we propose that receptor-based assays should be used for in vitro 
screening prior to in vivo testing, leading to environmental risk assessments based on combined, 
complementing and appropriate species-related assays for hormonal activity.
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Introduction 
Numerous studies have focused on compounds that are agonists for estrogen receptors α and 
β (ERα, ERβ) (Routledge and Sumpter 1997; Schultz et al. 2000; Sohoni and Sumpter 1998; 
Soto et al. 1991). These include a wide range of different compounds having different molecular 
structures and binding affi nities that may induce effects in wildlife (Jobling et al. 1998; Vos et 
al. 2000). With regard to the considerable number of chemicals that are and will be assessed 
for possible estrogenic activity, in vitro systems play an important role for identifi cation and 
fi rst screening of estrogenic compounds that interact with the ER. Within the framework on the 
Endocrine Disrupters Testing and Assessment (EDTA) of the OECD, animal and non-animal 
tests are proposed (OECD 2002). For assessing possible ecotoxicological effects, a fi sh in 
vivo screening assay is planned, but no in vitro assays using fi sh-based systems (OECD 2004). 
Considering the vast number of compounds to be tested for aquatic systems, it is important to 
employ appropriate in vitro systems for fi sh (Ackermann et al. 2002; Le Guével and Pakdel 
2001; Pakdel et al. 2000). In this regard, the question arises as to what extend in vitro systems 
can mimic in vivo activity of estrogenic compounds. In vitro systems are cost effective tools 
and allow for rapid screening of a large number of compounds, but they have limitations, 
which may result in unreliable predictions. Therefore, the most appropriate way to determine 
the endocrine-disrupting activity of chemicals seems to include both in vitro and in vivo assays, 
as no single assay may be best suited to determine the hormonal activity of a compound. In 
our present work, we address this question focusing on important chemicals in personal care 
products found in the aquatic environment.  
Sunscreens and cosmetics including lipsticks, skin lotions, hair sprays, hair dyes, shampoos, and 
numerous other products contain increasing amounts of compounds protecting from ultraviolet 
(UV) radiation. Either organic UV fi lters, or inorganic micropigments (ZnO, TiO2) scattering 
and refl ecting UV light, or combination of both, are applied. Increased sunlight protection 
factors are being used for preventing negative effects on the human skin, which generally 
requires higher percentages of UV fi lters in the products. Combinations of different UV fi lters 
are increasingly employed for absorbing UVA, UVB and UVC light. 
Inputs of UV fi lters into the aquatic system occur directly via recreational activities (bathing) 
into surface water, and indirectly via wastewater. UV fi lters are photostable, many of them 
highly lipophilic (log Kow 3-7) and relatively stable in the aquatic environment (Balmer et al. 
2005; Poiger et al. 2004), which makes these compounds critical for bioaccumulation. Residues 
of several UV fi lters have yet been detected in human milk (Hany and Nagel 1995) and fi sh 
(Balmer et al. 2005; Nagtegaal et al. 1997), in the latter between 21-3100 ng/g lipid, but also 
in lakes and wastewater, with maximum concentrations up to 125 ng/L (Poiger et al. 2004) and 
19 µg/L (Balmer et al. 2005), respectively. 
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At present, the estrogenicity of UV fi lters in fi sh remains elusive and the ecotoxicological risk 
for aquatic life is not known. Estrogenic activity in vitro has been shown for some UV fi lters 
in MCF-7 cells (Schlumpf et al. 2001), recombinant cell lines (Mueller et al. 2003; Schreurs et 
al. 2002) and recombinant yeast systems carrying the human ERα (Kunz and Fent submitted; 
Routledge and Sumpter 1997; Schultz et al. 2000). Estrogenic activity has also been observed 
experimentally in vivo in rats (Durrer et al. 2005; Schlumpf et al. 2001; Seidlová-Wuttke et al. 
2004). In fi sh high concentrations of 3-benzylidene camphor, 4-methyl-benzylidene camphor 
and octyl-methoxycinnamate (Holbech et al. 2002; Inui et al. 2003) were found to be estrogenic 
after short-term exposure. Contrary to these studies, no estrogenicity was observed at 10 µM 
octyl-methoxycinnamate, benzophenone-3, homosalate, octyl dimethyl-p-aminobenzoic acid, 
butyl methoxydibenzoylmethane and 1 µM 4-methyl-benzylidene camphor after short-term 
exposure of transgenic zebrafi sh (Schreurs et al. 2002). Therefore the estrogenic activity of UV 
fi lters at low aqueous concentrations remains unclear.
The objectives of this study were to elucidate, whether commonly used UV fi lters are estrogenic 
in vitro and in vivo in fi sh, to compare the in vitro activities in two in vitro systems carrying 
either a fi sh or the human ERα, and to compare the in vitro with the in vivo activity. We test 
the hypothesis that the estrogenic activity of chemicals is best assessed by the use of a tiered 
approach using a combination of in vitro and in vivo assays of the same phyla. As the rtERα 
has a different activity towards known estrogenic compounds than the hER (Le Guével and 
Pakdel 2001; Pakdel et al. 2000; Petit et al. 1995), the question arises whether fi sh-based in 
vitro systems should be used for assessing estrogenicity in fi sh. Direct comparison of fi sh 
in vitro and in vivo activity demonstrates that the estrogenic activity in vivo may be in part 
predictable from the in vitro activity, although in vitro screening tends to overestimate the 
number of estrogenic compounds due to lack of or low metabolism. This indicates the need for 
a tiered approach combining in vitro and in vivo assessments of hormonal activity of UV fi lters 
for ecological risk assessment.
 
Material and Methods
Chemicals 
17β-Estradiol (E2) was purchased from Fluka AG (Buchs, Switzerland). UV fi lters (Tab. 1) 
were obtained as follows. Benzophenone-1 (BP1), benzophenone-2 (BP2), benzophenone-3 
(BP3), benzophenone-4 (BP4), 4’-hydroxybenzophenone (4HB), 4,4’-dihydroxybenzophenone 
(4DHB), 2,4,4’-trihydroxybenzophenone (THB), 4-aminobenzoic acid (PABA), benzylsalicylate 
(BS), phenlysalicylate (PS), octyl salicylate (OS), octocrylene (OC) and octyl dimethyl PABA 
(OD-PABA) were from Fluka AG; octyl-methoxycinnamate (OMC), 3-(4`-methylbenzylidene-
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camphor) (4MBC), 3-benzylidene-camphor (3BC) and homosalate (HMS) were from 
Merck (Glattbrugg, Switzerland). Ethoxylated ethyl-4-aminobenzoate (PEG-25 PABA), a 
polymer consisting of ethyl 4-aminobenzoate and oxirane, was purchased from Induchem 
(Volketswil, Switzerland), and isopentyl-4-methoxycinnamate (IMC) was from Haarmann 
& Reimer (Holzminden, Germany). Bisimidazylate (BIM) was purchased form T.H. Geyer 
(Friedrichsthal, Germany). 4-tert-Butyl-4’-methoxydibenzoylmethane (BM-DBM) and 2-
phenly-5-benzimidazole-sulfonic-acid (PBS) were purchased from Aldrich (Fluka AG, Buchs 
Switzerland). 2,2-Methylenbis-phenol (ECL) was purchased from Ciba Speciality Chemicals 
(Basel, Switzerland) and Uvinul A plus B (UAB), a mixture of 35% 2-(4-Diethylamino-
2-hydroxybenzoyl)-benzoic acid hexylester and 65% OMC, was a gift from BASF AG 
(Wädenswil, Switzerland). All compounds were >99% pure. Stock solutions were made in 
ethanol and stored in the dark at 4°C. Analytical grade ethanol (EtOH, free of UV fi lters) was 
purchased from T.J. Baker (Stehelin AG, Basel, Switzerland). Bidestilled water was produced 
using a Jencons Autostill double D-ionstill destillator (Renggli AG, Rotkreuz, Switzerland).
Experiments in vitro in yeast
Recombinant yeast assay expressing the rainbow trout estrogen receptor alpha (rtERα 
assay). We investigated estrogenic activity of UV fi lters in vitro by applying a quantitiative β-
galactosidase assay in liquid culture of recombinant yeast expressing the estrogen receptor of 
rainbow trout (rtERα) that was kindly provided by F. Pakdel, University of Rennes. We slightly 
modifi ed the previously described assay procedure (Le Guével and Pakdel 2001; Petit et al. 
1995). In general the assay is based on transactivation of rtERα and induction of β-galactosidase 
leading to a color change. The estrogen-inducible expression system used is described in detail 
in (Le Guével and Pakdel 2001). In brief, the yeast (Saccharomyces cerevisiae) genome carries 
a stably integrated DNA sequence of the rainbow trout estrogen receptor (rtERα). Yeast cells 
also contain expression plasmids carrying two estrogen responsive elements (ERE) upstream 
of the yeast proximal iso-1-cytochrome c gene promoter fused to the lacZ gene (encoding the 
enzyme β-galactosidase). Thus, the induction is strictly dependent on the presence of rtERα 
and estrogens (Petit et al. 1995). When an active ligand (i.e. 17β-estradiol or an estrogenic 
UV fi lter) binds to the receptor, β-galactosidase is synthesised and secreted into the medium, 
leading to a catalytic hydrolysis of o-nitrophenly-β-D-galactopyranosid (ONPG) and resulting 
in the development of a yellow color which was measured as absorbance at 405 nm.
Preparation of rtERα assay media and yeast growth. The assay media were prepared as 
previously published (Le Guével and Pakdel 2001; Petit et al. 1995) and described (F. Pakdel, 
personal communication) with the following amendments. Complete Minimal Dropout Medium 
(CM) was prepared by adding 2 % D-glucose instead of 1 %. In addition to the CM media we 
used YPD growth media (2 % peptone enzymatic digest from meat, 2 % D-glucose and 1% 
Comparison of in vitro and in vivo estrogenic activity of UV fi lters
- 100 -
Table 1. Chemical structures, molecular weight and CAS numbers of compounds analysed. 
Compound Chemical  Compound  Chemical   
MW, (CAS) structure  MW, (CAS) structure 
4MBC   3BC 
254.37 (36861-47-9) 240.34 (15087-24-8) 
O O
BP1   BP2 
O
OHOH
OHOH
H
214.22 (131-56-6)  246.22 (131-55-5)  
O
O
4HB   4DHB 
198.22 (1137-42-4) 214.22 (611-99-4) 
THB  BP3     
230.22 (1470-79-7) 228.25 (131-57-7)    
        
BP4    PBS 
308.31 (4065-45-6) 274.30 (27503-81-7) 
IMC   OMC 
248.32 (71671-10-2) 290.40 (5466-77-3) 
OC   BS 
361.48 (6197-30-4) 228.25 (118-58-1) 
PS   HMS 
214.22 (118-55-8)  262.35 (118-56-9) 
OS   PABA 
250.33 (118-60-5)  137.10 (150-13-0) 
PEG25-PABA (113010-52-9) OD-PABA
44.05 (75-21-8)  277.41 (21245-02-3) 
165.2 (94-09-7) 
BIM   BM-DBM 
275.40 (180898-37-7)   310.38 (70356-09-1) 
ECL    UAB    
658.87 (103597-45-1) 397.52 (302776-68-7) 
    
   290.40 (5466-77-3) 
        
Abbrevations: MW, molecular weight; CAS, Chemical Abstracts Service; 4MBC, 3-(4`-methylbenzylidene-
camphor); 3BC, 3-benzylidene-camphor; BP1, benzophenone-1; BP2, benzophenone-2; 4HB, 4-
hydroxybenzophenone; 4DHB, 4,4’-dihydroxybenzophenone; THB, 2,4,4’-trihydroxybenzophenone; BP3, 
benzophenone-3; BP4, benzophenone-4; PBS, 2-phenly-5-benzimidazole-sulfonic-acid; IMC, isopentyl-4-
methoxycinnamate; OMC, octyl-methoxycinnamate; OC, octocrylene; BS, benzylsalicylate; PS, phenlysalicylate; 
HMS, homosalate; OS, octyl salicylate; PABA, 4-aminobenzoic acid; PEG25-PABA, ethoxylated ethyl-4-
aminobenzoate; OD-PABA, octyl dimethyl PABA; BIM, bisimidazylate; BM-DBM, 4-tert-Butyl-4’-
methoxydibenzoylmethane; ECL, 2,2-methylenbis-phenol; UAB, Uvinul A plus B.  
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yeast extract). Thus prior to the assay yeast cell growth was conducted as described (Petit et 
al. 1995), but with the modifi cation that yeast colonies from CM medium were inoculated in 
Erlenmeyer fl asks containing 15 mL of YPD growth medium instead of CM medium, which 
lead to increasing growth rates and better assay performance.
rtERα assay procedure. The whole assay was performed as described in detail previously (Le 
Guével and Pakdel 2001; Petit et al. 1995) but instead of hemolysis tubes in clear polystyrene 
96-well microplates (Greiner Bio-One, Huber AG, Basel, Switzerland) were used leading to 
small modifi cations of the assay procedure according to (Schultis and Metzger 2004). Thereby 
the centrifugation step after cell lysis was excluded and the lysed suspension was transferred 
to the fl at bottom 96-well plate, instead of the supernatants only. The protein measure (Petit et 
al. 1995) was replaced by measuring yeast turbidity (A620), in order to assess and correct for 
yeast growth and as a control for cytotoxicity. Cytotoxicity was maniftested by signifi cantly 
reduced yeast growth or even cell lysis and was determined by absorbance at 620 nm. High 
concentrations of some UV fi lters that lead to cytotoxicity were omitted from curve fi tting and 
calculations.
For screening of the UV fi lters a 96-well V-bottomed microtitre plate was fi lled with 100 
µL/well S. cerevisiae cells in YPD culture. Three rows contained serially diluted positive 
control E2, one row the ethanol-blank, and four rows the analysed UV fi lter in quadruplicates 
with increasing concentrations resulting in dose response curves. After cell lyses the lysed 
suspension was transferred to a new fl at-bottom 96-well plate (Greiner Bio-One, Huber AG, 
Basel, Switzerland), ONPG was added and the estrogenic activity measured as previously 
described  (Le Guével and Pakdel 2001; Petit et al. 1995; Schultis and Metzger 2004). 
The hERα recombinant yeast was kindly provided by J. Sumpter, Brunel University and 
the assay was performed according to Routledge and Sumpter (1996) and Kunz and Fent 
(submitted). The yeast (S. cerevisiae) genome carries a stably integrated DNA sequence of 
the human estrogen receptor (hERα), and they also contain expression plasmids carrying 
estrogen responsive elements, regulating the expression of the reporter gene lacZ (encoding 
the enzyme β-galactosidase). Thus, when an active ligand (i.e. E2 or an estrogenic UV fi lter) 
binds to the receptor, β-galactosidase is synthesised and secreted into the medium, leading to a 
colour change of chromogenic substrate chlorophenol red ß-D-galactopyranoside (CPRG) from 
yellow to red. 
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Experiments in vivo in fi sh
Fish. The 14-days fi sh experiments were conducted using juvenile, sexually undifferentiated 
fathead minnows (Pimephales promelas), between 2-3 months of age and with a total body 
length between 19-27 mm. This fi sh species has been chosen because of its frequent used 
in the fi eld of endocrine disrupters and established techniques including vitellogenin (VTG) 
antibodies.  The experimental procedure and duration was similar to that of Panter et al. (2002), 
who showed that estrogens and antiestrogens are detectable after 14 days of exposure by virtue 
of the VTG response.
Mixed sex juvenile fathead minnows were received from the cultivator (Aquatic Research 
Organisms, Hampton NH, USA) and adapted for a minimum of 14 d in our laboratory in 
aquaria prior to the experiment. Fish were fed with Tetramin pellets (Tetra GmbH, Melle, 
Germany) twice a day with a quantity of 1% of body weight prior to the onset of experiments. 
During the experiments, fi sh were fed with brimeshrimp (Artemia salina, Argent Chemical 
Labs, Redmond WA, USA) at a feeding rate of 1% of body weight twice a day.
Exposure. Fish were held in well-aerated reconstituted tab water medium (total hardness 160 
mg/L as CaCO3, total alkalinity 30 mg/L as CaCO3, conductivity 500 µs/cm) and a 16 h/8 h 
light/dark cycle at 25±1°C.  The studies were conducted using a 24 h static-renewal procedure 
with daily renewal of total aquaria water. For exposure, 10 randomly selected fi sh each were 
placed in stainless steel tanks (10 L) and exposed to individual UV fi lters for 14 d. Not all UV 
fi lters evaluated in vitro could be analysed in vivo. In order to have an reasonable amount of in 
vivo experiments, UV fi lters were selected as follows: either because they exhibited maximal 
estrogenic activities in our in vitro assays (BP1, BP2, 4DHB), or because they possessed 
submaximal (BP3, BP4, 3BC) or no (4MBC, OMC) estrogenic activities in our in vitro assays, 
but were reported to be estrogenic by other studies and because of its frequent use. 
First, an experiment was performed with 4MBC, 3BC, BP1 and BP2, and second, an experiment 
with BP3, BP4, OMC and 4DHB. In both experiments a control, solvent control (SC, 1 mL 
ethanol in 10 L water) and positive control for estrogenic activity (100 ng/L E2) were included. 
Stock solutions of each chemical were prepared freshly in ethanol prior to the start of the 
experiment and added daily to the experimental water by mixing. The following nominal 
concentrations of UV fi lters were used: 10, 100, 500, 1’000 and 5’000 µg/L for BP1, BP3, BP4, 
OMC and 4DHB, respectively; 10, 100, 500 and 1’000 µg/L for 4MBC and 3BC, respectively; 
and 10, 100, 500, 1’000 and 10’000 µg/L for BP2.
The concentrations were selected on the basis of environmental residues and including higher 
levels in order to span a large concentration range. Toxic side effects (i.e. lethargy, uncoordinated 
swimming, loss of equilibrium, hyperventilation) were observed for fi sh exposed to 5’000 µg/L 
BP3 and 1’000 µg/L 4MBC, and these experiments were stopped at day 8 of exposure.
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Physico-chemical measurements and biological observations. Physico-chemical para-meters 
were determined daily. pH and oxygen saturation ranged between 7.2–7.9 and 6.5–8.3 mg/
L, respectively, throughout the whole exposure period. Mortalities and abnormal behavior 
were recorded daily and dead fi sh were removed from the tanks. On day 14 all fi sh were 
anaesthesized with buffered tricaine methan sulfonate (MS-222, 100 mg/L with 200 mg 
NaHCO3/L). Subsequently individual fi sh were measured, weighted, transferred into labelled 
Eppendorf® tubes, frozen and stored at -20 °C for homogenisation and VTG analysis.
Vitellogenin analysis. Fish were defrosted at 4°C and individually homogenized in ice-cold 
assay buffer (Biosense, Bergen, Norway) in a 1:2 ratio wet weight:buffer volume, using a Ultra 
Turax homogenizer (IKA, Huber + Co. AG, Reinach, Switzerland). The homogenates were 
centrifuged at 10’000 g for 3 min at room temperature using a microcentrifuge (Eppendorf 
centrifuge 5415 D, Vaudaux-Eppendorf AG, Schönenbuch, Switzerland). The supernatant 
was withdrawn and immediately used for vitellogenin (VTG) analysis or frozen at –80 °C 
until required for VTG analysis. Whole-body homogenates were assayed for VTG using a 
quantitative heterologous carp enzyme-linked immunosorbent assay, which has been shown to 
be highly reliable for VTG determination in fathead minnow (Panter et al. 2002; Tyler et al. 
1999). The commercially available quantitative carp vitellogenin ELISA kit, which is based on 
a sandwich ELISA format (Biosense, Bergen, Norway), was used for determination of VTG 
in whole body homogenates of individual fi sh and was conducted as described by Biosense. 
Purifi ed carp VTG from blood plasma (Biosense, Bergen Norway) was used as a standard for 
quantitation according to the provider’s description. 
Analytical chemistry. For the duration of the experiment four aliquots of 250 mL exposure 
waters were taken from the two highest and the two lowest concentrations of each UV fi lter 
and controls at the beginning (0 h) and prior to water renewal (24 h). The aliquots of the same 
concentration of UV fi lter were pooled for each UV fi lter at each concentration and time point 
in brown glass fl asks, preserved by acidifi cation using HCl to pH 2-3 and stored at 4°C until 
analysis. Chemical analyses of UV fi lter concentrations were carried out by high performance 
liquid chromatography and UV detection. Briefl y, 25 or 250 mL of water samples, depending 
on sample concentration, were extracted and concentrated by solid phase extraction (SPE). The 
2’500-times concentrated eluent was then analyzed by HPLC-DAD.
Data processing and statistical analysis
Recombinant yeast assay. The absorbance measurement at 405 nm (ONPG) and 620 nm 
(turbidity) for the rtERα assay allowed for subsequent correction for turbidity (yeast growth) 
as follows:
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[ ]nm 405nm 620
nm 620nm 405
 absorbanceblank  -  absorbanceblank  -
 absorbance chemical-  absorbance chemical  absorbance Corrected =
For all UV fi lters the maximal response relative to the standard (=100%) were calculated. 
Thereby the height of the UV fi lter dose-response curve was expressed as percentage of the 
maximal effect produced by the dose response curve of E2.
High concentrations of some UV fi lters that inhibited growth of the yeast, or even lysed cells were 
omitted from curve fi tting and calculations. For curve fi tting and EC50 calculations (GraphPad 
Software Inc., San Diego, USA), the corrected absorbance values versus the logarithm of 
concentration were plotted, whereby the best fi t from a number of non-linear regression models 
was selected for fi nal data analysis. In this study, we used the Hill equation (or sigmoidal dose-
response with variable slope) to fi t full dose-response curves, which reached the same height 
(≥ 80% maximal response) as the corresponding standard E2. Moderate (30-80% maximal 
response) and submaximal (< 30% maximal response) dose-response curves were fi tted using 
the best fi t from a number of non-linear regression models. Coeffi cient of determination (R2), 
residuals and 95% confi dence intervals were calculated and the runs test was carried out to 
verify that the fi tted curve represents data correctly.  Estrogenic potencies were calculated 
for all active UV fi lters. Thereby the EC50 of UV fi lters with full dose-response curves was 
divided by the EC50 of the E2 standard. For UV fi lters with submaximal dose-response curves, 
estrogenic potencies were estimated based on their EC50 values, despite differences in curve-
steepness and –height when compared to the standards. Thereby a good approximation of the 
estrogenic potencies of submaximal UV fi lters was achieved.
Fish experiment. After testing the data distribution for normality by using the Kolmogorov-
Smirnov test, means of wet weight and total length of individual fi sh were calculated and data 
analysed by analysis of variance (ANOVA) followed by a Dunnett’s Multiple Comparison test 
to compare the treatment means with respective controls.  Means of VTG concentrations of 
individual fi sh were calculated and data analysed with the non-parametric Kruskal-Wallis test 
followed by a Dunn’s Multiple Comparison test to compare the treatment means with respective 
controls. Statistical comparisons with the control were made using the SC as the overall control. 
The results are given as mean ± standard error of mean (SEM). Differences were considered 
signifi cant at p ≤ 0.05. All computations were performed with PRISM 4.0 (GraphPad Software 
Inc., San Diego, USA).
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Results
Estrogenic activity of UV fi lters in vitro
Ten of 23 analyzed UV fi lters and the UV fi lter metabolite 4HB were found to possess estrogenic 
activity in the recombinant yeast assay expressing the rainbow trout ERα. BP1, BP2, 4DHB, 
THB, 4HB and PS were full rtERα agonists exhibiting full dose response curves. They had 
maximal responses of 81 to 123% as compared to E2 (Fig. 1). Moderate, but clear dose-response 
curves were found for BS, BP3 and BP4, characterized by lower maximal responses of 43-74% 
(Fig. 1). Submaximal dose response curves were observed with 3BC and OS with maximal 
responses of 27% and 15%, respectively (Fig 1). Table 2 shows the relative potencies of the 
UV fi lters compared to E2, as determined by their half-maximal induction activities (EC50). 
The most potent UV fi lter was BP1, which was only 87-times less potent then E2. Estrogenicity 
decreased in the following order 4HB > 3BC > BS > BP2 > BP3 > THB > PS > 4DHB > BP4 
> OS. The estrogenic potencies were in the range of 390 to 24’750 times lower than E2. The 
remaining 12 UV fi lters, namely 4MBC, BIM, BM-DBM, ECL, HMS, IMC, OC, PABA, OD-
PABA, PEG25-PABA, OMC, PBS and UAB were inactive up to 2.5x10-2 M. In every assay we 
checked for potential cytotoxicity caused by the UV fi lter, by routinely measuring yeast growth 
(620 nm) besides β-galactosidase activity (405 nm). Hence UV fi lter concentrations, which lead 
to reduced yeast cell growth or complete growth inhibition, were omitted from data analysis for 
hormonal activities. At high concentrations slight cytotoxicity occurred for BS (≥ 5.04 x 10-5 
M), BP4 (≥ 10.0 x 10-4 M), 4DHB (≥ 1.00 x 10-3 M) and PS (≥ 1.00 x 10-4 M). Hormonal activity 
was therefore assessed at non-cytotoxic concentrations only.
Comparison with hERα. The same UV fi lters found active in our present study with recombinant 
yeast expressing the rainbow trout ERα were previously found active in a recombinant yeast 
system expressing the human estrogen receptor alpha (hERα). By using this system we 
investigated 17 UV fi lters and one metabolite for their multiple hormonal activities such as 
estrogenicity, antiestrogenicity, androgenicity and antiandrogenicity in vitro (Kunz and Fent, 
submitted). The only exception was OS that exhibited minimal estrogenic activity in the 
rtERα only. The activities of BP1, 3BC and the salicylates were relatively higher with rtERα 
than hERα, but lower for the remaining benzophenones displaying lower EC50 values with 
hERα. BP1 and 4HB showed strongest activities in both receptor systems. The rankings of 
the other UV fi lters differed between the receptor systems, however. Whereas in the hERα 
assay benzophenone derivates were the most potent compounds benzophenone-, camphor-, and 
salizylate-derivates were most potent in the rtERα assay. The maximal responses of estrogenic 
compounds in the rtERα assay were in most cases higher than in the hERα, with only BP2 and 
4DHB as exceptions (Table 2). A direct comparison of both assays is shown in Figure 2. BP1 
as most potent UV fi lter in both assays displayed an estrogenic activity of only 87-times less 
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than that of E2 with rtERα and 5’000-times less with hERα. In particular, the relative activity 
of 3BC was higher in the rtERα assay. In contrast to the relatively higher activity of UV fi lters 
in the rtERα assay, the hERα assay was 62-times more sensitive towards E2
Estrogenic activity of UV fi lters in fi sh in vivo 
Measured exposure concentrations. Concentrations of UV fi lters in aquaria waters were 
measured at the beginning of exposures (0 h) and 24 h later prior to water renewal at the 
lowest and the two highest exposure concentrations in order to determine actual effect 
concentrations and to get an estimate of concentration decrease. Concentrations decreased 
during the exposure, but to a variable extent for different compounds. Table 3 shows that actual 
concentrations determined by HPLC analysis were close to nominal. After 24 h before water 
renewal, concentrations decreased to various degrees (0-32%) depending on compound and 
concentration. The different concentration decreases are a result of different physico-chemical 
properties of UV fi lters (lipophilicity) and uptake by fi sh. 
Effects of UV fi lters on fi sh survival, weight and length. No mortality was observed in controls, 
solvent controls (SC) and positive controls (E2) exposed fi sh in both experiments. The UV 
Table 4. Body weight and length of exposed fish after 0 and 14 days of exposure. 
Exposure    Body weight    Body length Exposure Body weight Body length 
(?g/L)         (mg)        (mm) (?g/L) (mg)  (mm) 
Controls Day 0 62.0 ± 24.4 18.9 ± 2.2 Controls Day 0 161.3 ± 45.7 27.4 ± 2.1
Water 211.3 ± 91.1 29.4 ± 2.8 Water 313.1 ± 80.0 33.8 ± 3.1
Solvent 238.0 ± 88.8 30.8 ± 3.5 Solvent 277.0 ± 62.2 32.0 ± 2.2
E2 249.0 ± 111.8 29.6 ± 4.1 E2 282.9 ± 70.7 32.4 ± 2.6
4MBC 9 272.4 ± 82.9 31.1 ± 2.9 BP3 12 313.9 ± 59.9 34.6 ± 2.0
100 237.3 ± 60.6 30.4 ± 2.4 100 317.5 ± 05.4 33.3 ± 3.7
415 103.9 ± 40.8 ** 23.6 ± 2.6 ** 500 281.6 ± 23.7 32.7 ± 3.5
753 43.1 ± 25.2 ** 17.1 ± 3.6 ** 766 257.3 ± 51.1 32.0 ± 1.7
3'900 134.6 ± 36.6 ** 27.9 ± 2.2 *
3BC 9 335.9 ± 128.9 * 32.8 ± 3.1
100 258.9 ± 95.9 30.9 ± 3.4 BP4 11 330.5 ± 14.6 34.2 ± 4.4
435 115.1 ± 37.4 ** 24.7 ± 2.4 ** 100 326.4 ± 02.2 33.4 ± 3.0
953 95.8 ± 25.8 ** 23.7 ± 1.8 ** 500 309.2 ± 69.3 34.1 ± 1.9
1'048 299.9 ± 57.8 33.5 ± 1.7
BP1 9 246.5 ± 77.0 30.0 ± 2.6 4'897 375.4 ± 97.5 * 35.5 ± 2.8 *
100 273.1 ± 141.2 31.7 ± 4.6
500 240.4 ± 67.8 30.5 ± 2.1 OMC 8 303.3 ± 14.5 33.4 ± 3.6
981 245.0 ± 90.0 29.4 ± 3.8 100 266.7 ± 54.5 32.4 ± 2.5
4’919 121.9 ± 46.9 * 24.6 ± 3.2 ** 500 283.3 ± 62.6 32.8 ± 1.8
889 303.2 ± 65.8 33.2 ± 2.2
BP2 10 272.9 ± 125.7 30.9 ± 4.9 5'025 267.4 ± 60.5 32.4 ± 2.1
100 264.5 ± 116.9 30.6 ± 4.1
500 247.6 ± 73.7 30.5 ± 2.2 4DHB 10 321.8 ± 70.2 34.7 ± 1.1
1'067 293.4 ± 113.4 32.1 ± 3.6 100 316.9 ± 11.4 34.0 ± 3.4
8'783 171.4 ± 35.0 25.9 ± 1.8 ** 500 340.9 ± 02.2 34.4 ± 3.0
900 351.4 ± 93.7 34.5 ± 2.6
5'011 371.5 ± 97.0 35.5 ± 3.0 *
E2: 17?-Estradiol; **, Significantly different from solvent control at p < 0.01; *, Significantly different from solvent control at 
p < 0.05. 
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fi lters did not affect survival during exposure, except at the highest concentrations of 4MBC, 
3BC and BP1. After 8 d of exposure, two fi sh died at 753 µg/L 4MBC (survival 80%) and the 
experiment was stopped. At 953 µg/L 3BC and 4919 µg/L BP1, one fi sh each was found dead 
at day 12 and 11, respectively. Fish at 8783 µg/L BP2 showed some signs of edema at the end 
of exposure.
During the 14 d exposures, all control, SC and E2 fi sh grew as determined by increase in 
wet weight and total body length (Table 4). At low concentrations of UV fi lters no signifi cant 
differences to controls was observed. Length gain was signifi cantly decreased for 500 and 
1000 µg/L 3BC and 4MBC (Table 4), however. No difference occurred in wet weight and 
mean length in the SC and E2. 3BC and 4MBC led to a dose related decrease in the weight 
gain and body length at 435 and 953 µg/L, and 415 and 753 µg/L, respectively. No decreases 
in body weight gain and body length were observed with all other UV fi lters at all exposure 
concentrations, except for 4919 µg/L BP1 after 14 d of exposure.
Estrogenicity of UV fi lters. 
Signifi cant VTG induction occurred 
in fi sh exposed to the 100 ng/L E2. 
Mean whole-body VTG content was 
2’600 µg/mL and highly induced, 
compared to the water and solvent 
control having a residual level of 0.3 
µg/mL. Dose-dependent increases in 
VTG were observed in fi sh exposed 
to 3BC, BP1 and BP2 (Figure 3). 
3BC showed higher VTG induction 
and at lower concentration compared 
to BP1 and BP2. Dose-related 
signifi cant 
VTG induction occurred at 3BC 
concentrations of 435 µg/L (407 µg 
VTG/mL) and 953 µg/L (1753 µg 
VTG/mL). Concentration related 
VTG induction was also found after 
exposures to higher concentrations 
of BP1 and BP2. Although increased 
at medium concentrations, VTG 
induction was signifi cant only at 
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Figure 3 Vitellogenin concentration in juvenile fathead minnows ex-
posed to eight UV fi lters. Values are means ± SEM (n=10). Asteric 
denotes a signifi cant difference from control (solvent) at p ≤ 0.05. 
Concentrations given as actual median measured, except 100 and 
500 µg/L.
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the highest concentrations of BP1 and BP2, namely at 4919 µg/L BP-1 (907 µg VTG/mL), 
and 8783 µg/L BP2 (1504 µg VTG/mL). The UV fi lters BP3, BP4 and 4DHB did not result 
in a signifi cant VTG induction at all exposure concentrations in fi sh, although they showed 
submaximal estrogenic activity in vitro. 4MBC and OMC, which showed no estrogenicity in 
vitro, were not estrogenic in vivo. Therefore, two of fi ve UV fi lters which exhibited estrogenic 
activity in vitro were also estrogenic in vivo. 
Discussion 
In our present study we show that it is most appropriate to determine the endocrine-disrupting 
activity of chemicals both in vitro and in vivo, preferably in a tiered approach, as no single assay 
may be best suited to determine the hormonal activity of a compound and because of species 
differences. Thereby we demonstrate for the fi rst time that as many as ten of 23 commonly used 
UV fi lters are estrogenic in an in vitro yeast assay carrying a fi sh ER (rtER). Compared to our 
results in the recombinant yeast carrying the hERα, where we investigated 17 UV fi lters and 
one metabolite for estrogenicity, antiestrogenicity, androgenicity and antiandrogenicity in vitro 
(Kunz and Fent submitted), we found that all compounds, except OS, were equally estrogenic 
in both assays despite lower activity of E2 in the rtERα assay. In fi sh we demonstrated that 
three of nine UV fi lers were estrogenic in vivo. Comparing in vitro activities in two systems 
with fi sh in vivo activity, we found the rtERα in vitro data more accurate than the hERα data for 
prediction of the in vivo activity. Hence estrogenic activity of chemicals is best assessed by the 
use of a tiered approach with a combination of in vitro and in vivo assays of the same species. 
In vitro activity in the rtERα assay. We found ten of 23 compound exhibiting estrogenic 
activities in the rtERα assay with different maximal responses and dose response curves.  The 
range of moderate to full dose-response curves can be explained by the molecular structures. 
UV fi lters displaying full dose-response curves are characterized by at least one ring substituted 
hydroxyl group. They display lower maximal responses with increasing molecular symmetry. 
Additional substituents on the phenolic ring have a diminishing effect on the maximal estrogenic 
responses in both ERα systems (Kunz and Fent submitted; Routledge and Sumpter 1997). This 
is the case for BP3, BP4, BS, OS and 3BC, which are substituted with methoxy-, sulfonic acid-, 
benzyl, octyl or camphor groups, possibly indicating only partial agonism. Inactive UV fi lters 
had with very few exceptions, like those compounds with very large molecular structures that 
prevent uptake into cells, only one non-hydroxylated ring that was connected and/or attached to 
other substituents such as ethoxy, alkyl-, amino-, cyano- or methoxy-groups, which were shown 
to signifi cantly decrease the chemical’s affi nity for the rtERα, as previously shown for hERα 
(Blair et al. 2000). The structural basis of the estrogenic UV fi lters found in our study goes in 
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line with recent fi ndings on structure activity relationships of structurally similar chemicals in 
hER-systems (Miller et al. 2001; Routledge and Sumpter 1997; Schultz et al. 2000). 
Comparison between rainbow trout and human ERα. We were interested in elucidating 
whether the structural differences between human and rainbow trout ERα (Petit et al. 1995; Petit 
et al. 2000) were responsible for functional differences.  Homologies in amino acid sequences 
between hERα and rtERα are variable, depending to the domains (Pakdel et al. 1990). The 
most highly conserved region is the C domain (92% homology), which is responsible for DNA-
binding and dimerization (Petit et al. 2000). Whereas rtERα and hERα have similar binding 
affi nities to an estrogen response element, the rtERα C domain is responsible for a weaker 
DNA binding stability. The E domain shares 60% similarity between rtERα and hERα and 
contains the hormone binding domain. Petit et al. (1995) found that the rtERα has a lower 
affi nity to E2 than the hERα. This was further demonstrated for 17α-estradiol, estrone and 
17α-ethinylestradiol (Le Guével and Pakdel 2001) and is confi rmed by our present study; the 
E2 concentration necessary to induce 50% activity was 62-times higher in the rtERα assay. 
The weaker magnitude of E2 stimulation mediated by rtERα is attributed to the lower DNA-
binding stability, rather than structural differences of the two ER (Petit et al. 2000). 
As for most of the UV fi lters, relative sensitivities of rtERα and hERα systems varied only little 
(one order of magnitude), indicating that the main difference between the two receptors is their 
sensitivity towards E2 (Table 2).  Differences between the two ER occurred for the salicylate 
derivatives (PS, BS, OS), which showed several times higher activity in rtERα, and 3BC that 
showed even 1’300-times higher activity than in the hERα. Maximal responses were generally 
higher in the rtERα assay, except for BP2 and 4DHB. This indicates a higher relative sensitivity 
and weaker partial agonism in the rtERα of compounds showing submaximal activity.
Thus in contrast to the lower activity of E2, the activity of some UV fi lters is relatively higher 
in the rtERα assay. This cannot be fully explained by a lower DNA-binding stability found by 
Petit et al. (2000) for estradiol, but is rather attributed to structural differences of the two ER and 
the molecular structure of the UV fi lters interacting with the ER. This points toward a slightly 
different substrate binding specifi city of the fi sh and human ERα based on differences in the 
binding domain of the two receptors. In addition, differences in the transactivation process such 
as dimerization and DNA-binding capacity may also account in part for the different relative 
sensitivities. Forthcoming studies focusing on UV fi lter receptor binding and infl uence on the 
transactivation process will elucidate the reasons for the differing sensitivities of the fi sh and 
hERα.
Comparison with other in vitro studies. The estrogenicity of UV fi lters found in our study 
with rtERα is consistent with results obtained in vitro in human ER-systems, although relative 
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sensitivities may differ. Estrogenicity of some salicylate and camphor derivatives have been 
reported in mammalian systems such as recombinant yeast (Kunz and Fent submitted; Miller 
et al. 2001; Mueller et al. 2003), receptor binding assays (Blair et al. 2000; Mueller et al. 2003; 
Schlumpf et al. 2004), proliferation of MCF-7 cells (Schlumpf et al. 2001; Schlumpf et al. 
2004) and reporter gene induction in transfected cell lines (Schreurs et al. 2002; Suzuki et al. 
2005; Yamasaki et al. 2003).  The estrogenicity of BP1, BP2, BP3, 3BC, found in our rtERα 
assay is consistent with fi ndings in MCF-7 cells (Schlumpf et al. 2001; Schlumpf et al. 2004), 
reporter hERα/HeLa cells (Yamasaki et al. 2003), MCF7 reporter cells (Suzuki et al. 2005) and 
HEK293 cells (Schreurs et al. 2005). Our results are also consistent with the hERα cell assay 
for BP3, but not for 4MBC in the HEK 293 reporter gene assay. In addition, 3BC, HMS and 
4MBC showed activity in the hERα assay (Schreurs et al. 2002).
In fi sh at least two ER subtypes, ERα and ERβ, occur, and in zebrafi sh, a third form has been 
reported (Menuet et al. 2002). Currently it is not known to what extent UV fi lters interact with 
these receptors. Reasons for differences between results obtained in our study with the rtERα 
assay and other in vitro assays are fi rst, that UV fi lters may be active towards the ERβ, but 
not the ERα. In the MCF-7 and other human cells, active UV fi lters may interfere with both 
hERs. 4MBC was estrogenic in the MCF-7 cells (Schlumpf et al. 2001), but did not exhibit 
estrogenic activity towards the rtERα in our present study, similarly as previously reported 
from our experiments with the hERα (Kunz and Fent submitted), which is based on the fact 
that 4MBC binds preferably to the ERβ (Schlumpf et al. 2004). This is also the case for HMS 
(Schreurs et al. 2002). In addition yeast has only a low capability for metabolism, therefore 
metabolites of UV fi lters binding to the ER are not identifi ed by the rtERα assay. The differences 
may also partly depend on different binding activities of the ERs of different species, and 
between in vitro assays and their different capabilities to metabolically activate a chemical. 
This leads to the conclusion that species differences in the estrogenic activity occur and that 
one in vitro assay alone is not suffi cient enough for assessing the estrogenicity of chemicals for 
fully characterizing its estrogenic potential. Moreover homologuous in vitro systems are more 
reliable for predicting in vivo activity. 
Comparison of in vivo activities. Our in vivo experiments demonstrate that of eight analysed 
UV fi lters, 3BC, BP1 and BP2 showed estrogenic activity in fathead minnows. 3BC led to 
dose dependent induction of VTG at lower concentrations (435, 953 µg/L) than BP1 (4919 
µg/L) and BP2 (8783 µg/L). 4MBC, OMC, BP3, BP4 and 4DHB did not induce VTG up to 
the highest concentrations in the range between 753 µg/L (4MBC) and 5010 µg/L (4DHB).  
Schreurs et al. (2002) observed no estrogenicity in transgenic zebrafi sh exposed for 96 h at 10 
µM of OMC (2.90 mg/L), OD-PABA (2.77 mg/L), HMS (2.62 mg/L), BP3 (2.28 mg/L), and 
1 µM of 4MBC (0.25 mg/L), which is consistent with our data with these UV fi lters analysed 
at similar concentrations, but for a longer period of time. Injection of high concentrations of 
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3BC (27, 68, 137 mg/kg and higher) induced VTG in rainbow trout (Holbech et al. 2002). In 
medaka, estrogenic activity of 4MBC and OMC was observed only at about 200-times higher 
concentrations (Inui et al. 2003), but was not found at 20-times higher concentrations than in 
our study. This may be related to species-specifi c differences in VTG induction. The relative 
degree of VTG induction is species-specifi c as shown for rainbow trout that reacted with higher 
VTG induction to endocrine disrupters than roach (Routledge et al. 1998). 
The UV fi lters 4MBC, BP3, 4DHB and OMC exhibited estrogenicity in vivo in rats (Mueller 
et al. 2003; Schlumpf et al. 2001; Schlumpf et al. 2004; Yamasaki et al. 2003), but this was 
not observed in our fi sh study. The differences can be explained by species differences in 
metabolism and different affi nities to the ERs, as 4MBC and HMS preferably bind to the ERβ 
(Schlumpf et al. 2004; Schreurs et al. 2002). Whether this is the case in fi sh is currently not 
known. Most likely, the differences are based on the different metabolic capabilities of fi sh 
compared to rats, but also on lower exposure concentrations. In our fi sh experiments, UV fi lter 
levels in water were lower than in rats, exposed to UV fi lters via feed.
Comparison of in vitro and in vivo activity. The estrogenic activity in vitro was matched 
in vivo for most UV fi lters. 4MBC and OMC exhibited neither estrogenic activity in vitro 
transactivation assays carrying either the hERα or rtERα, nor in fi sh in vivo. 3BC, BP1, BP2 
showing activity in vitro were also active in vivo. Both in vitro and in vivo they possessed the 
highest potencies of the tested UV fi lters. The in vitro activity of BP1 (EC50 7.9 x 10-7 M) 
was higher than that of 3BC (1.2 x 10-5 M), whereas BP2 was the least active of these three 
compounds, both in vitro and in vivo (Figures 1-3). The in vivo activity of 3BC was higher 
than expected from its in vitro potency in the rtERα assay, where it was the second potent UV 
fi lter after BP1. Being only 87-times less active than E2 in the rtERα assay, BP1 showed only 
weak in vivo activity in fathead minnows. This might be explained by the higher metabolism 
and lower lipophilicity (and lower bioaccumulation potential) compared to the more lipophilic 
3BC. Furthermore, the relatively higher estrogenicity of 3BC in vivo might be based on the 
higher binding activity of 3BC to the ERβ than to ERα of fathead minnows, as 3BC binds 
preferentially to human recombinant ERβ, and only barely to ERα (Schlumpf et al. 2004). 
There are no indications that metabolites of 3BC are more active than the parent compound. 
On the basis of the rtERα assay the relative low in vivo activity of BP2 is in consistence with 
our in vitro data. This might also be the case for 4DHB, BP3 and BP4 possessing lower rtERα 
potencies. The estrogenic activity of most benzophenones and salicylates seems to be abolished 
in vivo because of metabolism. 
When comparing the potency rankings of UV fi lters for the rtERα and the hERα assay, the 
data clearly demonstrates that the rtERα in vitro data are more accurate than the hERα data 
for prediction of the in vivo activity. This indicates that hormonal activity of UV fi lters should 
Comparison of in vitro and in vivo estrogenic activity of UV fi lters
- 114 -
be assessed by a suite of species related in vitro and in vivo assays, in which the in vitro assay 
should be able to predict to most potent compounds for further in vivo testing. Differences 
in vitro and in vivo activities, which we nevertheless observed in our fi sh-based assays, are 
attributed to metabolism, but also to different activities to different ERs in fi sh. Our approach 
using rtERα in vitro and fathead minnow in vivo may cover species differences in fi sh. Possibly, 
using the same fi sh species (rainbow trout) in the in vivo assay as in the in vitro assay may have 
resulted in more comparable results between the in vitro and in vivo assays. 
Environmental consequences. In the environment only a few UV-fi lters such as OC, 4MBC, 
BP3 and BM-DBM have been analysed so far. In lake water, BP3, 4MBC and OC occurred at 
concentrations of 80-125, 60-80 and 22-27 ng/L, respectively, in the upper layer of a bathing 
lake (Poiger et al. 2004), but were lower in other lakes (Balmer et al. 2005).  Concentrations 
in treated wastewater were 0.06-2.7 (4MBC), 0.01-0.7 (BP3), 0.01-0.1 (OMC) and 0.01-0.27 
µg/L (OC) (Balmer et al. 2005). Residues of 4MBC, OMC, BP3, and HMS were also found 
in muscle tissue of fi sh from a German lake being between 21-3100 ng/g lipid (sum of all UV 
fi lters 2 µg/g in perch and 0.5 µg/g in roach), and between 25-166 ng/g lipid in 10 white fi sh 
from Swiss lakes (Balmer et al. 2005). However, 3BC, BP1 and BP2 which were found in our 
study to be estrogenic, have not yet been analysed in aquatic systems. If they were in the same 
range, VTG induction after short-term exposure to a single UV fi lter may probably not pose 
a hazard to fi sh. However, different UV fi lters may act additively (Heneweer et al. 2005) as 
indicated for other endocrine disrupters (Routledge et al. 1998). Moreover, long-term exposure 
to UV fi lters may affect fi sh reproduction at much lower concentrations.
As it is not known to what extend these UV fi lters occur in the environment and in fi sh, 
comprehensive hazard and risk assessment is premature. Forthcoming studies should 
determine environmental concentrations of estrogenic UV fi lters and to relate them to effect 
concentrations. For hazard and risk assessment, potential effects on reproduction, fecundity 
and fertility in fi sh are necessary, as well as bioaccumulation studies. Moreover, UV fi lters may 
have multiple hormonal activities such as antiestrogenicity, androgenicity and antiandrogenicity 
besides estrogenicity (Kunz and Fent submitted). Whether these multiple hormonal activities 
are refl ected in vivo in fi sh and whether reproduction effects occur is currently investigated in 
our laboratory.
Conclusions 
Considering the vast number of compounds to be tested for possible endocrine activity, it is 
important to employ appropriate in vitro systems. They are cost effective and allow for rapid 
screening of a large number of compounds, but have limitations, which may result in unreliable 
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predictions. In our present study we show that it is most appropriate to determine the endocrine-
disrupting activity of chemicals both in vitro and in vivo, as no single assay may be best suited 
to determine the hormonal activity of a compound and because of species differences. We 
propose that receptor-based assays with related or even the same species should be used for in 
vitro screening prior to in vivo testing. In this tiered approach, the predictive power of in vitro 
systems is enhanced and cost intensive in vivo studies can be reduced by employing species-
specifi c in vitro assays. This leads to the conclusion that an environmental risk assessment 
should be based on combined, complementing and appropriate species-related in vitro and in 
vivo assays for hormonal activity. 
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Abstract
The UV fi lter 3-benzylidene camphor (3BC) is largely used in personal care products and in a 
number of materials for UV protection. 3BC has been shown in vitro and in vivo in fi sh to be 
estrogenic, but possible effects on fertility and reproduction are unknown. In this study we evaluate 
whether 3BC affects reproduction of fi sh Pimephales promelas. After a pre-exposure period of 
21 days, reproductively mature fathead minnows were exposed to increasing concentrations of 
3BC for 21 days in a static-renewal procedure. Actual 3BC concentrations measured by HPLC 
decreased to about 20% of initial levels and median concentrations were 0.5, 3, 33, 74 and 
285 μg/L. 3BC affected reproduction in a dose-dependent manner with an indication of weak 
effects on fecundity at 3 μg/L, a signifi cant decrease at 74 µg/L and a cessation of reproduction 
at 285 µg/L. 3BC was accumulated in fi sh with an average bioconcentration factor of 313±151. 
Dose-dependent demasculinisation in secondary sex characteristics of male fi sh and dose-
dependent induction of plasma vitellogenin occurred, which was signifi cant at 74 µg/L. 3BC 
had a profound and dose-dependent effect on the histology of gonads of males and female fi sh. 
At 74 and 285 µg/L oocyte and spermatocyte development was inhibited in male and female 
gonads. Testes of exposed males had much fewer spermatogenic cysts, and ovaries of exposed 
females had much fewer mature, and more artretic follicles. This study shows signifi cant effects 
of the common UV fi lter 3BC on fertility, gonadal development and reproduction of fi sh after 
short-term exposure that may have negative consequences on the population level.
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Introduction 
UV fi lters are increasingly used in cosmetics, skin and hair care products like sunscreens, 
shampoos, creams and fragrances. They are also applied in textiles, optical material and optics 
components, household products, fabrics, transdermal drug delivery systems and for UV 
stabilization of a variety of materials. By absorbing, scattering and refl ecting UV light they 
protect the human skin and materials from the negative effects of UV radiation. The amount of 
UV fi lters added are increasing, because higher sunlight protection factors are used, and thus 
generally higher percentages of different UV fi lters are required in the products.
Consequently it is not surprising that residues of UV fi lters have been detected in the environment. 
They enter the aquatic system either directly into surface water via recreational activities (bathing) 
or indirectly via wastewater.  In lakes and wastewater they were detected at concentrations up 
to 125 ng/L (Poiger et al., 2004) and 19 µg/L (Balmer et al., 2005), respectively. Because they 
are photostable, often lipophilic (log Kow 3-7), UV fi lters are relatively stable in the aquatic 
environment (Poiger et al., 2004; Balmer et al., 2005) and thus critical for bioaccumulation. 
Indeed, residues of several UV fi lters have been detected at concentrations of 21-3100 ng/g 
lipid in fi sh (Nagtegaal et al., 1997; Balmer et al., 2005; Buser et al., 2006) and even in human 
milk (Hany and Nagel, 1995). 
Besides being present in the environment, UV fi lters recently gained increasing environmental 
relevance because of their reported estrogenic activity in vitro (Routledge and Sumpter, 1997; 
Schultz et al., 2000; Schlumpf et al., 2001; Schreurs et al., 2002; Mueller et al., 2003; Kunz et 
al., 2006; Kunz and Fent, in press; Kunz and Fent, submitted)  and in vivo in rats (Schlumpf 
et al., 2004a; Schlumpf et al., 2004b). In particular the fact that estrogenic activity has been 
observed in fi sh in vitro (Kunz and Fent, in press) and in vivo (Kunz et al., 2006) makes UV 
fi lters of potential environmental concern for aquatic organisms. 3-Benzylidene camphor 
(3BC), benzophenone-1 and benzophenone-2 led to vitellogenin induction in juvenile fathead 
minnows (Kunz et al., 2006), and this was also found for 3BC in rainbow trout (Holbech et al., 
2002), 4-methyl benzylidene camphor (4MBC) and octyl-methoxycinnamate (OMC) in male 
medaka (Inui et al., 2003). Among the UV fi lters 3BC showed highest estrogenic activity in vivo 
in fi sh (Kunz et al., 2006), but also in rats (Schlumpf et al., 2004a; Schlumpf et al., 2004b). 
Currently, it is not known whether UV fi lters affect fecundity of fi sh. This question is of 
ecotoxicological and ecological importance because UV fi lters are present in the aquatic 
environment and may possess enough potency to adversely affect reproduction and development 
in fi sh. Estrogenic effects in several fi sh species was shown for many chemicals, and for 
sewage effl uents (Harries et al., 1997; Tyler et al., 1998; Rodgers-Gray et al., 2001; Tilton et 
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al., 2002; Sumpter and Johnson, 2005). In the United Kindom widespread sexual disruption 
was observed in wild roach (Jobling et al., 2002), likely due to chemicals in sewage.  Several 
different groups of chemicals were found to be estrogenic in short-term exposures by inducing 
VTG in juvenile and male fi sh. Subsequently they were demonstrated to negatively affect 
reproduction, sometimes at environmentally relevant concentrations such as ethinylestradiol 
(Nash et al., 2004), 4-tert-octylphenol (Gronen et al., 1999),  and bisphenol A (Haubruge et al., 
2000), to name a few.
In this work, we evaluate whether a common UV fi lter, 3BC, adversely affects reproduction in 
fathead minnows. This UV fi lters has practical importance as it is added to skin and hair care 
products (allowed up to 2% per weight in Switzerland and EU), but also to household products, 
fabrics, and other products. We investigated important parameters for endocrine disruption, 
such as fecundity, vitellogenin induction, secondary sex characteristics and gonad histology. 
The fi ndings of this study show for the fi rst time that a commonly used UV fi lter adversely 
affects reproduction in fi sh in a dose-dependent manner after short-term exposure.
Material and Methods
Chemicals. 3-Benzylidene-camphor (3BC, MG 240.34, CAS15087-24-8) was from 
Induchem (Volketswil, Switzerland) and 17β-Estradiol (E2) was purchased from Fluka AG 
(Buchs, Switzerland). All compounds were >99% pure. Stock solutions were made in N,N-
dimethylformamide  (DMF) and stored in the dark at 4°C. Analytical grade DMF was purchased 
from Arcos Organics (Geel, Belgium).
Fish. Fathead minnows are found as wildfi sh throughout much of North America and have been 
chosen because of short reproductive cycles, frequent use in endocrine disrupter research and 
established techniques including vitellogenin (VTG) antibodies (Parks et al., 1999).   We used 
reproductively, mature fathead minnows (Pimephales promelas) between 8-9 months of age. 
Fish have not been held in a culture situation conductive to routine spawning before the onset 
of the experiment.
Newly mature fathead minnows were received from the cultivator (Aquatic Research Organisms, 
Hampton NH, USA) and adapted for a minimum of 14 d in our laboratory in a tank prior to the 
experiment. Fish were fed with Tetramin pellets (Tetra GmbH, Melle, Germany) twice a day 
with a quantity of 1% of body weight prior to the onset of experiments. During the experiments, 
fi sh were fed with brimeshrimp (Artemia salina, Argent Chemical Labs, Redmond WA, USA) 
at a feeding rate of 1% of body weight twice a day.
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Exposure. The experimental procedure was similar to that described recently (Harries et al., 
2000; Ankley et al., 2001; Panter et al., 2002). During the pre-exposure and exposure period 
fi sh were held 10 L stainless steel aquaria in well-aerated reconstituted tab water medium (total 
hardness 160 mg/L as CaCO3, total alkalinity 30 mg/L as CaCO3, conductivity 500 µs/cm) and 
a 16 h/8 h light/dark cycle at 25±1°C.  A 48 h static-renewal procedure was used, renewing 
the total of aquaria water (10 L). After 24 hours, food remnants and faeces were removed by 
siphoning a third of the water volume and replacing it by new water containing the appropriate 
concentrations of 3BC. This administration regime was chosen because of the high lipophility 
of 3BC (Log-Kow = 5.37), which made it not possible to deliver it by a fl ow-through system. 
In order to ensure normal reproductive performance of the fi sh, unnecessary disturbances were 
minimized by a static-renewal regime of 48 h instead of 24 h. Thus water quality was monitored 
continuously in order to enable conformance with performance-based criteria (OECD, 2001). 
Aliquots of 250 mL water were taken for chemical analysis.
At the beginning of the experiment, four females and two males were randomly assigned to the 
replicate stainless steel tanks (10 L).  Prior to the exposure period, a pre-exposure phase was 
initiated in order to establish the reproductive capacity of females and to provide a tank-specifi c 
baseline data for potential statistical comparison after initiation of chemical exposure. During 
pre-exposure and exposure period survival, appearance and behavior of fi sh, reproductive 
behavior, secondary sex characteristics and fecundity (cumulative number of spawned eggs) 
were determined. Once successful spawning has been established, generally after 14 to 21 
days, 3BC exposure was started. Fish were exposed for 21 days to nominal concentrations of 1, 
10, 100, 250 and 500 µg/L 3BC. A control and a solvent control (SC, 1 mL DMF in 10 L water) 
were also included. Stock solutions of 3BC was prepared freshly in DMF prior to the start of 
the experiment and added to the experimental water by mixing. The 3BC concentrations were 
selected according to concentrations which were found to induce vitellogenin in juvenile fathead 
minnows (Kunz et al., 2006). For the selected concentrations of 3BC no toxic side effects (i.e. 
lethargy, uncoordinated swimming, loss of equilibrium, hyperventilation) were observed. 
Physico-chemical measurements and biological observations. Physico-chemical parameters 
were determined daily. pH and oxygen saturation ranged between 7.2–7.9 and 6.5–8.3 mg/
L, respectively, throughout the exposure period. Mortalities and abnormal behaviour were 
recorded daily and dead fi sh were removed from the tanks. At the end of the experiment (day 
21 of the exposure period) all fi sh were anaesthetized with buffered tricaine methan sulfonate 
(MS-222, 100 mg/L with 200 mg NaHCO3/L). Subsequently the length of individual fi sh was 
measured, they were weighted and measures of a number of endpoints were made. In order to 
determine plasma concentrations of vitellogenin, blood was collected from the caudal vein using 
a heparinised capillary tube (KABE Labortechnik GmbH, Nümbrecht-Elsenroth, Germany) 
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and transferred into a labelled Eppendorf® tube. Plasma was then separated from the blood by 
centrifugation (10 min. at 3’000 rpm at 4°C) and stored until analysis with protease inhibitors 
(Aprotinin, Fluka AG, Buchs, Switzerland) at -80 °C. After sampling of the blood gonads were 
removed and weighted for determination of the gonad-somatic index (GSI = 100 x gonad weight 
/ body weight). Gonads were then placed in Buoin’s solution (Fluka AG, Buchs, Switzerland) 
for subsequent histological analysis. Photographs of the head (number of nuptial tubercles) of 
male fathead minnows were taken for further analysis of the secondary sexual characteristics. 
The remainder of the carcass of the fi sh was frozen at -80°C for chemical residue analysis.
Vitellogenin analysis. Plasma samples were thawed on ice and ice-cold assay buffer (Biosense, 
Bergen, Norway) was added to the individual samples in order to achieve a 1:2 ratio of plasma:
buffer. The samples were vortexed and immediately used for vitellogenin (VTG) analysis. For 
quantifi cation of VTG a commercially available, homologous enzyme-linked immunosorbent 
assay (ELISA) for fathead minnow VTG was used as described by Biosense Laboratories AG 
(Bergen, Norway). Purifi ed fathead minnow VTG from blood plasma (Biosense AG) was used 
as a standard for quantitation according to the provider’s description. 
Histology. Routine histological procedures were used to analyse testes and ovaries of the fi sh. 
The gonads from the Buoin’s solution were embedded in paraffi n. Sections were taken along 
the long axis of the gonad at 6 µm intervals, in a serial step fashion. Two serial sections were 
collected from 3 steps equally spaced between the leading edge of the tissue and the midline 
of the gonad, for a total of 6 tissue sections/sample. The sections were stained with Haemalaun 
(Mayer’s Haemalaun; Merck, Darmstadt, Germany) and Eosin (Fluka AG, Buchs, Switzerland). 
Evaluation of the histological effect of 3BC on gonads was based on staging of ovarian and 
testicular development (similar to e (Leino et al., 2005).  The ovary was evaluated based 
upon relative frequencies of oogonia, early vitellognic, late vitellogenic and artretic follicles. 
Frequencies were evaluated by counting the different stages in three randomly selected fi elds 
of vision/female (90x magnifi cation). Testis staging was based on the relative frequency of 
spermatogonia, spermatocytes and spermatides present. Thereby for each male pictures of four 
randomly selected fi elds of vision (19’276 µm2) were taken and the areas occupied by the 
different stages were measured. 
 
Analytical chemistry. During the experiment 250 mL of exposure water were taken three times 
from all treatment groups at the beginning (0 h), after siphoning and renewal of the siphoned 
water (24 h) and prior to water renewal (48 h). The water samples were stored in brown glass 
fl asks at 4°C until analysis by HPLC-DAD. Briefl y, 25 or 250 mL of water samples, depending 
on sample concentration, were extracted and concentrated by solid phase extraction (SPE), 
using Sep-Pak Vac 3cc C18 cartridges (Waters AG, Rupperswil, Switzerland). Cartridges 
were conditioned wit dichloromethane, methanol and H2O bi-destilled prior to the extraction 
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of the water samples. The cartridge was then air-dried and eluted with dichlorotmethane. 
Dichloromethane was allowed to evaporate to dryness and the dry eluent was resuspended in 
100 µL of ethanol and analysed by HPLC-DAD (Agilent 1100 Series). Thereby a concentration 
of 250 to 2’500-times of the water sample was achieved.
The remainders of the fi sh carcasses were analysed for 3BC residues after the 21-day exposure 
period by means of a liquid-liquid extraction. Briefl y, single fi sh were homogenized together 
with bidestilled water and ethylacetat in a ratio of 1:2:2 (fi sh:water:solvent). The homogenate 
was vortexed until it was mixed thoroughly and then centrifuged (15 min, 4°C, 4’500 rpm). 
The supernatant (3BC solved in ethylacetat) was transferred to another vial and then the solvent 
was evaporated to dryness. The dry residue was resuspended in 1 mL of ethanol followed by 
another centrifugation step (30 min, 16’000 rpm). The supernatant was then transferred to a 
brown GC vial and analysed by HPLC-MS.
Data processing and statistical analysis. The data distribution was tested for normality by 
using the Kolmogorov-Smirnov test. Differences between treatments were assessed using 
either analysis of variance (ANOVA) followed by a Dunnett’s Multiple Comparison test 
to compare the treatment means with respective controls, or a non-parametric test, when a 
normality distribution of the data was not given.  In this case differences between treatments 
were assessed by a Kruskal-Wallis test followed by a Dunn’s Multiple Comparison test to 
compare the treatment means with respective controls. Statistical comparisons were made with 
the sovent control as the overall control, given that the results for comparisons with the water 
control lead to the identical fi ndings. The results are given as mean ± standard error of mean 
(SEM). Differences were considered signifi cant at p ≤ 0.05. All computations were performed 
with PRISM 4.0 (GraphPad Software Inc., San Diego, USA).
Results
Actual 3BC concentrations in aquaria waters and concentration in exposed fi sh. Water 
concentrations of 3BC were determined by HPLC-DAD measured at three time points (0, 24, 
and 48 h) at all exposure concentrations in order to determine actual effect concentrations. Table 
1 shows that actual concentrations at the beginning of the exposure (0 h) were close to nominal 
values (mean = 112.0±6.9%, n=5). During exposure 3BC concentrations decreased to a similar 
extent for all concentrations. After 24 h at partial water renewal 3BC concentrations decreased 
to 30-57 %, and after 48 h before water renewal, to 20-32% of nominal concentrations. The 
decrease is due to several factors including absorption on aquaria walls, spawning substrates, 
food, fi sh and eggs, as well as bioaccumulation of 3BC by fi sh and spawned eggs. To determine 
the bioaccumulation potential of 3BC whole body residues of 3BC in fi sh were measured at 
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the end of the experiment after 21 days. Table 1 shows that whole body residues of 3BC in adult 
fathead minnows were between 0.16 and 100.7 μg/g depending on the exposure concentration. 
Based on mean actual water concentrations, this gives an average bioconcentration factor of 
313±151.
Fish survival, weight and length. 
We observed identical survival rates 
(94.4±9.6 %, n=3 replicates) for the control 
fi sh and all exposed fi sh, except for the 
fi sh exposed to 33 µg/L 3BC (100 %, n=3 
replicates) and 285 µg/L 3BC (88.9±9.6 
%, n=3 replicates). However, survival did 
not differ signifi cantly from the control 
tanks (p = 0.9306). No differences were 
observed in length of males and females 
or in weights of males and females at the 
end of the experiment (Table 2).
Effects on reproduction. The cumulative fecundity, i.e. the cumulative number of eggs/
treatment, differed slightly for all treatments and replicates before exposure (Fig. 1). At the 
start of 3BC exposure, none of the fi sh of the water and solvent control replicates stopped 
spawning (Fig. 2A). At the lowest exposure concentration of 0.5 µg/L 3BC, fi sh in one of 
the three aquaria stopped spawning after 8 days of exposure, whereas fi sh in the other two 
replicates continued with slightly reduced spawning activity (Fig. 2B). At 3 µg/L 3BC, fi sh of 
one aquarium stopped spawning after 8 days, whereas fi sh of the other aquaria continued with 
reduced spawning activity compared to pre-exposure and controls (Fig. 2C). At 33 µg/L 3BC,
Exposure    Body weight    Body length 
(?g/L)         (mg)        (mm) 
Controls Water 211.3 ± 91.1 29.4 ± 2.8
Solvent 238.0 ± 88.8 30.8 ± 3.5
3BC 0.5 335.9 ± 128.9 32.8 ± 3.1
3 258.9 ± 95.9 30.9 ± 3.4
33 115.1 ± 37.4 24.7 ± 2.4
74 95.8 ± 25.8 23.7 ± 1.8
285 171.4 ± 35.0 25.9 ± 1.8
Table 2. Body weight and length of exposed fi sh after 21 
days of exposure.
Table 1. Nominal and measured concentrations of 3BC in exposure waters and fish after 21 days
of exposure.
EXPOSURE WATERS FISH
Nominal Measured Whole Body BCF*
0 h 24 h (µg/L) 48 h (µg/L) Median Concentration
(µg/L) (µg/L) (%) (µg/L) (%) (µg/L) (%) (µg/L) (?g/g)
1  1.1 ± 0.1 101%  0.5 ± 0.1 45%  0.3 ± 0.1 27% 0.5    0.16 ± 0.18 399
10  9.9 ± 0.3  99%  3.1 ± 1.1 31%  2.0 ± 0.4 20% 3 0.36 ± 0.27 102
100 118 ± 5 118%   44 ± 3 37%   22 ± 0.2 18% 33     7.22 ± 3.17 230
250 293 ± 34 117%   74 ± 3 25%   56 ± 1 19% 74   36.49 ± 21.91 493
500 547 ± 19 109% 285 ± 14 52% 160 ± 7 29% 285 100.73 ± 47.87 344
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the fi sh in two of the three aquaria stopped spawning after 4 and 7 days, respectively, whereas 
the third aquarium showed reduced spawning with less spawns and eggs/spawn (Fig. 2D). Fish 
in one aquarium exposed to 74 µg/L 3BC stopped spawning activity immediately, whereas the 
fi sh of the second and third aquarium spawned only once after the onset of exposure (Fig, 2E). 
All fi sh exposed to 285 µg/L 3BC ceased spawning activity immediately (Fig 2F). Overall, 3BC 
lead to a dose-dependent inhibitory effect on fertility and reproduction in fathead minnows. 
This was already observable at 0.5 µg/L 3BC, but was not signifi cant. Figure 3 A-C shows 
that the number of spawns, number of eggs/spawn and the number of eggs/female/day were 
signifi cantly decreased at 74 and 285 µg/L (ANOVA p > 0.05).
In male fathead minnows exposure to 3BC lead to a dose-dependent VTG induction, which was 
signifi cant at 74 and 285 µg/L 3BC (Fig. 4). In these fi sh mean plasma VTG content was between 
5’272 and 18’020 µg/mL compared to the water and solvent control having a mean residual 
level of 15 µg/mL VTG. In female fi sh no signifi cant VTG induction was observed. Mean levels 
ranged between 1’300 and 5’400 µg/mL for all treatment groups (Fig. 4).  Moreover, exposure 
to 3BC caused alterations in male secondary sexual characteristics (Fig. 5). The number of 
tubercles signifi cantly decreased at 74 and 285 µg/L, whereas the remaining tubercles appeared 
to be less pronounced (Fig. 5). The decrease in the number of tubercles was dose-dependent (Fig. 
6). At 33 µg/L 3BC and higher tubercles were less in numbers and seemed less pronounced. 
Neither in males, nor in females GSI was altered (data not shown). However, gonadal histology 
was profoundly affected by 3BC. This UV fi lter induced a dose-dependent inhibition of 
spermatogenesis in the testis of male fi sh. Even at concentrations of 3 µg/L 3BC, testes of
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Figure 1 Cumulative number of eggs spawned per treatment group during pre-exposure (days -21 to 0) and ex-
posure period (days 0 to 21). Treatments are given in measured median concentrations.
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Figure 2  Cumulative number of eggs spawned in each of the three replicates during pre-exposure (days -21 to 0) 
and exposure period (days 0 to 21), shown for controls  and each treatment group (A-G). Measured median 3BC 
concentrations are given.
Chapter 6
- 129 -
exposed males clearly differed from control testes, possessing reduced tubules with fewer 
spermatocytic stages. This effect increased with increasing concentrations, and at 74 and 285 
µg/L spermatocytic stages decreased by 30 to 40 % compared to the control. Spermatogenesis 
appears to be inhibited and testes were characterized by enlarged semiferuous tubules fi lled 
with sperms. Moreover, there is a relative lack of germinal epithelium and primary and 
secondary spermatocytes. Spermatognia apparently did not undergo a further differentiation to 
spermatogenic cysts at 3 µg/L 3BC and higher concentrations (p < 0.001). Spermatocytes were 
less present, whereas the area occupied by spermatides increased in a dose-dependent manner 
(Fig. 7A and 8). 
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Figure 3 Fecundity shown as percentage of eggs 
and spawns during exposure (black bars) rela-
tive to pre-exposure (100%)(white bars). Numb-
er of spawns (A). Number of eggs/female/day 
(B). Number of eggs/spawn (C). Data shown are 
means and SEM (3 replicates/treatmet). Asterics 
denote signifi cant difference from control at p ≤ 
0.05. Measured median 3BC concentrations are 
given.
Figure 4  Vitellogenin concentration in female and male 
fathead minnows exposed to 3BC. Values are means ± SEM 
(females: n=12, males: n=6). Asterics denote signifi cant dif-
ference from control at p ≤ 0.05. Measured median 3BC con-
centrations are given.
Figure 5  Number of nuptial tubercles in male 
fathead minnows exposed to 3BC. Values are 
means ± SEM (n=6). Asterics denote signifi cant 
difference from control at p ≤ 0.05. Measured 
median 3BC concentrations are given.
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In ovaries of treated females exposed to the lowest concentration of 0.5 µg/L 3BC no discernible 
differences between treated and control females could be seen.  Ovaries of exposed females 
to 3 µg/L 3BC and higher concentrations led to an increase in the number of artretic follicles 
up to 24%, accompanied by a decrease in early and late vitellogenic stages (Fig. 7B and 9). 
Late vitellogenic follicles decrease by 8% at 3 and 33 µg/L 3BC, but then remained stable in 
number at 74 and 285 µg/L. At 33 μg/L and higher, the numbers of oogonia increased (Fig. 7B). 
These histological alterations in gonads of male and females fi sh demonstrate a dose-dependent 
profound estrogenic effect of 3BC.
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Figure 7 Relative percentage of the different stages of spermatids in testis of male (A) and oocytes in ovaries 
of female (B) fathead minnows after 21 days of exposure to 3BC. For males, n = 4 to 5, for females, n = 4 to 6.
A B
Figure 8  (A) Section 
of testis from a con-
trol male, typical of 
active spawning. (B) 
Section of testis from 
a male exposed to 
285 µg/L 3BC. Note 
the enlarged semini-
ferous tubules fi lled 
with sperms and re-
lative lack of germinal 
epithelium in the tu-
bules.
A B C
Figure 6 Nuptial tubercles of male fathead minnows. A) Control male. B) Male exposed to 74 
µg/L 3BC. C) Male exposed to 285 µg/L 3BC.
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Discussion 
The UV fi lter 3BC is used in many products such as sunscreens, skin and hair care products, 
household products, textiles, fabrics, optical materials and components and transdermal 
drug delivery systems. Although 3BC enters the aquatic system either directly into surface 
or indirectly via wastewater, environmental concentrations are not yet known. However, its 
lipophilic nature makes 3BC prone for bioaccumulation in aquatic organisms. 3BC was shown 
to have estrogenic activity in vitro (Holbech et al., 2002; Kunz et al., 2006) and in vivo leading 
to signifi cant vitellogenin induction in fi sh (Holbech et al., 2002; Kunz et al., 2006). So far, it 
was unknown whether 3BC affects reproduction in fi sh in addition. 
In the present study, we show for the fi rst time that a commonly used UV fi lter adversely affects 
reproduction in fi sh in a dose-dependent manner. Immediately after the onset of exposure to 285 
µg/L 3BC spawning ceased completely, and it was signifi cantly reduced at 74 µg/L. Fish that 
were successful spawners during the pre-exposure period had no or signifi cantly less spawns 
with signifi cantly fewer eggs per spawn when exposed to 3BC. The immediate and strong 
impact of 3BC on spawning activity at the highest exposure concentration was surprising. This 
also holds for the clear effect at 74 and 285 µg/L.  At the lowest exposure concentration of 0.5 
µg/L fi sh showed slightly reduced spawning activity and one replicate even stopped spawning 
after eight days of exposure, which indicates adverse effects of 3BC on reproduction, although 
not being signifi cant.
. 
These dose-dependent effects down to the lowest exposure concentration were also observed 
in gonadal histology. Even at 3 µg/L testes of exposed males were clearly distinguishable 
from control testes, and possessed reduced tubules with fewer spermatocytic stages. This 
effect increased with increasing concentrations, and at 74 and 285 µg/L, spermatocytic stages 
A B C
Figure 9 (A) Section of control ovary, showing mature follicles typical of an actively spawning female. (B-C) Section 
of ovaries from females exposed to 285 µg/L, showing increased number of artretic follicles (B) and degenerated 
ovary with only early stages of oogonia (C).
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decreased by 30 to 40% compared to the control. Spermatogenesis appears to be inhibited 
and testes were characterized by enlarged semiferuous tubules fi lled with sperm and the 
relative lack of germinal epithelium and primary and secondary spermatocytes. Spermatognia 
apparently did not undergo a further differentiation to spermatogenic cysts. The fact that also 
egg production ceased so quickly suggests a standstill of milt production indicated by the 
accumulation of sperms in the lumen of enlarged semiferous tubules and the lack intermediate 
stages (spermatogenic cysts). 
The histological response of testes to 3BC is much like those observed in previous studies 
with E2 and EE2. Whereas these estrogens lead to a full inhibition of testicular development, 
depending on the dose from a degeneration of spermatozoa to total atrophy (Gimeno et al., 
1998; Miles-Richardson et al., 1999a; Palace et al., 2002; Pawlowski et al., 2004). The 21-
days exposure to 3BC also inhibited testicular development, but showed less degeneration. 
Similar inhibition of testicular development was recently reported for fi sh exposed to the weak 
estrogen receptor agonist 4-nonylphenol, which lead to a signifi cant reduction of fecundity 
(Miles-Richardson et al., 1999b; Harries et al., 2000) and a signifi cant necrosis of sperm cells 
and spermatozoa (Miles-Richardson et al., 1999b). Although we did not investigate the state 
of sertoli cells, the presence of phagocytic cells in the semiferous tubules and of macrophages 
in their lumina indicates an extension of the phagocytic role of these cells in males exposed 
to high concentrations of 3BC (Smith, 1974; Russell et al., 1990; Miles-Richardson et al., 
1999a). 
In ovaries the histological effects of 3BC were just as pronounced. Whereas at 0.5 µg/L 3BC 
no discernible differences between treated and control females could be seen, 3 µg/L 3BC 
and higher concentrations led to an increase in the number of artretic follicles up to 24%, 
accompanied by a decrease in early and late vitellogenic stages. Interestingly, from 3 to 33 
µg/L 3BC late vitellogenic follicles decrease by 8% but then remained stable in number at 74 
and 285 µg/L. This may be an indication that the strong inhibition of reproduction at the two 
highest exposure concentrations might be affected by the testicular status of the males, where 
spermatogenesis was increasingly inhibited with increasing exposure concentrations of 3BC. 
Strong estrogen receptor agonists such as E2 and EE2 have similar effects on ovaries (Kramer 
et al., 1997; Miles-Richardson et al., 1999a; Länge et al., 2001).  Similar to these estrogens, 
3BC seems to interfere with egg production and lead to fewer mature, and more artretic follicles 
in treated ovaries of female fathead minnows. Possibly sustained abnormally high vitellogenin 
levels induced by estrogen receptor agonists interfere with fi nal maturation and release of 
oocytes from the ovary, hypothetically by inhibiting gonadotropin II release by the pituitary 
(Kramer et al., 1997; Miles-Richardson et al., 1999a).  High concentrations of weak estrogen 
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receptor agonists such as methoxychlor also resulted in increased follicular artresia in some 
females (Ankley et al., 2001), whereas nonylphenol did not induce any histological changes in 
ovaries (Miles-Richardson et al., 1999b).
The estrogenicity of 3BC was manifested not only in a dose-dependent reduction of spawning 
activity caused by gonadal degeneration, but also by VTG induction and feminization of 
male secondary sex characteristics. Signifi cant VTG induction in male fathead minnows was 
observed at 74 μg/L 3BC. This was observed after 14 days of exposure to 435 μg/L (Kunz et 
al. 2006), but also for other estrogenic chemicals acting via the estrogen receptor, such as the 
pesticide methoxychlor (Ankley et al., 2001). VTG induction in 3BC exposed fi sh goes in line 
with a signifi cant decrease in fecundity. The cumulative number of eggs spawned and gonadal 
histology are considerably more sensitive to the effect of 3BC, contrary to methoxychlor, 
where VTG induction turned out as the most sensitive endpoint. No signifi cant VTG induction 
occurred in females, similar to methoxychlor (Ankley et al. 2001). However, when female 
fathead minnows are exposed to strong synthetic estrogens, a sustained increase in plasma 
vitellogenin occurred (Kramer et al., 1997; Miles-Richardson et al., 1999a). The lack of 
siginifi cant VTG increase above the already high VTG level in reproductive females is an 
indication of the weaker estrogenicity of 3BC compared to EE2.
Besides the reduced fecundity and the clear VTG induction, in males the signifi cant decrease of 
the number of tubercles in male fi sh was a clear indication for the estrogenic activity of 3BC. 
Males at the highest exposure concentration were visually not discernible from females and all 
but one have lost all tubercles. Nuptial tubercles in the male fathead minnow can decrease when 
exposed to both, the weak ER agonists 4-nonylphenol (Miles-Richardson et al., 1999a; Miles-
Richardson et al., 1999b; Harries et al., 2000) , and the strong ER agonists E2 and EE2 (Miles-
Richardson et al., 1999a; Pawlowski et al., 2004). The development of nuptial tubercles and 
the fatpad in male fathead minnows is stimulated by testosterone produced by the Leydig cells 
of the testes (Smith, 1978).  Testosterone production is under the control of FSH and LH, both 
of which are regulated by E2 in a feedback mechanism (Junqueira et al., 1986). Thus athropy 
of the nuptial tubercles may have resulted from an inhibition of LH because xenostrogens 
like 3BC may suppress androgen levels by altering neuroendocrine feedback loops (Trudeau 
et al., 1993; Jobling et al., 1996; Ankley et al., 1998). The number of tubercles, as well as the 
production of sperms are androgen-dependent processes, they are negatively correlated with 
exposure to estrogenic chemicals (Smith, 1974; Miles-Richardson et al., 1999a; Jensen et al., 
2001). Thus, demasculinisation refl ected by these endpoints is an indication for the estrogenic 
activity of 3BC.
Different effects on nuptial tubercles are observed with other compounds. The anti-androgen 
fl utamide, which has a limited binding capacity to fi sh androgen receptors (Wells and Van Der 
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Kraak, 1998; Sperry and Thomas, 2000) causes a signifi cant decrease in number of tubercles in 
male fathead minnows at high concentrations, but does not induce VTG production in males. On 
the other hand the aromatase inhibitor fadrozole leads to a signifi cant VTG induction in males 
and females, and to a signifi cant tubercles induction in female fi sh (Ankley et al., 2002). 
Reduced reproduction and even its cessation caused by 3BC may be related to alterations in 
both males and females. In males we observed a dose-dependent demasculinisation, indicated 
by the loss of secondary sexual characteristics, and the inhibition of spermatogenesis. This 
already started at 3 μg/L, and possibly resulted in a loss of gender specifi c mating behavior and 
in a stop of milt reproduction at 74 and 285 μg/L. In females, the inhibition of oogenesis started 
at 3 μg/L 3BC and was indicated histologically by an increase of artretic and a decrease of early 
and late vitellogenic follicles in ovaries. At 74 and 285 μg/L females stopped egg production 
and the release of mature oocytes. Possibliy this may be a reaction on the missing mating 
behaviour of demasculisized males present in the aquaria.
So far UV fi lters have been evaluated for estrogenic activity in fi sh by investigating VTG 
induction only. This was observed in juvenile fathead minnows for 3BC, BP1 and BP2 (Kunz 
et al., 2006), and also found after injection of 3BC (68 mg/kg) in rainbow trout (Holbech et al., 
2002), and after aqueous exposure to 100 mg/L 4MBC and 10 mg/L octyl-methoxycinnamate 
in male medaka (Inui et al., 2003). The benefi t of measuring VTG induction as a biomarker 
for estrogenicity is obvious in our study. It is easier to measure and provides information of 
the estrogencity of a certain compound with possible adverse effects on reproduction (Tyler 
et al., 1999; Sumpter and Johnson, 2005). The lowest observed effect concentrations after 
exposure to 3BC vary according to the endpoint. For VTG induction and secondary sex 
characteristics it was 74 µg/L, for effects on fecundity 33 µg/L, and histological alterations 
occurred already at 3 µg/L. VTG determinations in short-term experiments are rather fast, 
and less manpower- and time-consuming than a short-term reproduction test, but our results 
with 3BC suggest, that it posses lower sensitivity than other parameters. Nevertheless VTG 
induction is clearly associated with other direct markers of reproduction effects and thus well 
suited for screening estrogenic compounds (Tyler et al., 1999; Sumpter and Johnson, 2005). 
However, for hazard and risk assessments, short-term reproduction assays provide much more 
important toxicological and ecological information. They give a more detailed picture of the 
endocrine activities of a compound and give sensitive information on fecundity, histology and 
secondary sex characteristics, and thereby facilitate and refi ne risk assessment. 
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Conclusions and environmental consequences
Our study demonstrates signifi cant effects of 3BC on the reproduction of fathead minnows. The 
lowest observed effect concentrations for the most sensitive parameter, gonadal histology, was 
3 µg/L. Environmental concentrations of 3BC in water and fi sh have not yet been reported, but 
may reach the same level than other UV fi lters such as 4MBC.  If environmental concentrations 
of 3BC are also in the low ng to µg range, effects of 3BC on fi sh reproduction can not be rouled 
out.  Especially, as 3BC is lipophilic and bioaccumulated during 21 day of exposure with 
an average bioconcentration factor of 313±151. Furthermore the presence of other UV fi lters 
and hormonally active compounds, which may interact additively may adversely affect fi sh 
reproduction in contaminated aquatic systems. The pronounced effect of 3BC on reproduction, 
fecundity and fertility in fi sh after a 21 days exposure sheds new light on the potential hazard 
and risks of widely used UV fi lters.
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Assessment of hormonal activity of UV fi lters in tadpoles of frog 
Xenopus laevis at environmental relevant concentrations 
 Petra Y. Kunz, Héctor F. Galicia and Karl Fent
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Abstract
Residues of UV fi lters used as ultraviolet absorbers in sunscreens, cosmetics and in light 
protection have been found in surface water and fi sh. Recently some of them were shown bearing 
estrogenic activity, however, very little is known about possible adverse effects to aquatic life. 
Here we investigate whether two UV fi lters, 4-methylbenzylidene camphor (4-MBC) and 3-
benzylidene camphor (3-BC), interfere with the thyroid and sex hormone system during frog 
metamorphosis. Xenopus laevis tadpoles were exposed to 1, 5 and 50 μg/L of 4-MBC and 3-
BC, respectively, for 35 days (stage 52-66). The rate of metamorphosis was not affected, and 
no obvious differences in body and tail length compared to controls were observed. Neither 4-
MBC, nor 3-BC lead to effects on the sex ratio or gross gonad morphology of X. laevis at stage 
66. Our results indicate that these UV fi lters do not negatively affect the thyroid system and sex 
ratio of frogs at environmental concentrations. 
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Introduction
UV fi lters used in sunscreens, cosmetics and light protection of materials may contaminate the 
aquatic environment in relevant concentrations, since these compounds are used in rather high 
volumes, and display critical properties such as high lipophilicity.  Recently, residues of UV 
fi lters have been found in water (Poiger, Buser & Müller, 2001) and fi sh (Nagtegaal, Ternes, 
Baumann & Nagel, 1997) ranging from 2-125 ng/L and 26-3’100 μg/kg , respectively. Some 
of them displayed estrogenic activity in vitro (Miller et al., 2001; Schreurs et al., 2002) and in 
vivo in rats (Schlumpf et al., 2001) and fi sh (Holbech et al., 2002). Still bioaccumulation of UV 
fi lters and possible sex hormone disrupting effects to aquatic life are largely unknown, along 
with the uncertainty whether other hormone systems like the thyroid system are also concerned. 
This hampers the environmental hazard and risk assessment of these chemicals.
This study is aimed at elucidating possible activities of the two UV fi lters, 4-methylbenzylidene 
camphor (4-MBC) and 3-benzylidene camphor (3-BC), towards the thyroid and sex hormone 
system of frogs Xenopus laevis, especially as some endocrine disrupting chemicals have 
been demonstrated to interfere with both, the thyroid and sex hormone system of amphibians 
(Goleman, Carr & Anderson, 2002; Moriyama et al., 2002). 
Material and Methods
Tadpoles of X. laevis were held in well-aerated artifi cial tab water (Kloas, Lutz & Einspanier, 
1999) and a 12 h/12 h light/dark cycle at 22±1°C. For exposure using a 48 h (weekdays) and 72 h 
(weekends) aqueous static-renewal procedure, 30 randomly selected tadpoles each were placed 
in 2 replicate stainless steel tanks (10 L) and exposed to 4-MBC and 3-BC, respectively, for 35 
days from stage 52 to 66). A control, solvent control and positive control for thyroid activity (1 
μg/L thyroxin, T4) were included. Nominal concentrations of both 4-MBC and 3-BC were 1, 
5 and 50 μg/L. Actual concentrations of repeatedly taken water aliquots were determined after 
solid phase extraction and GC/MS analysis (Poiger, Buser & Müller, 2001). 
Developmental stage, whole body and tail length of the tadpoles were determined in our 
experiments for possible effects of UV fi lters on metamorphic development, growth rate and 
tail resorption. All measurements were performed on day 0, 7, 14, 21, 28 and 35 of exposure. 
At the end of the experiment possible effects of the UV screens on the sex hormone system 
were investigated  by visual inspection of  gonads, thereby assessing sex ratio and  gross  gonad 
morphology. 
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Statistical comparisons were performed using Kruskal-Wallis one-way ANOVA (on ranks, 
Dunn’s test) for development stages, body and tail length on day 0 to 28 and the Chi-square test 
for sex ratio.
Results
Actual concentrations were close to nominal values at 0 h for all exposure groups, ranging 
between 93-115% and 84-100% for 4-MBC and 3-BC, respectively. Actual concentrations of 
the of 1 μg/L group decreased during the 72 h exposure to 39 % and 87% for 4-MBC and 3-
BC, respectively, and it is assumed that this also holds for the 5 and 50 μg/L exposure groups. 
Mortality was less than 3% in all treatment groups and no apparent behavioural differences 
were observed between treatments.
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Figure 1  Effects on developmental stages of X. laevis tadpoles after 35 days of exposure with 4-methylben-
zylidene camphor (a) and 3-benzylidene camphor (b) on day 28. Effects on the body length of tadpoles after 
exposure with 4-methylbenzylidene camphor (c) and 3-benzylidene camphor (d) on day 21. Effects on tail 
length of tadpoles after exposure with 4-methylbenzylidene camphor (e) and 3-benzylidene camphor (f) on 
day 21. Values are shown as mean ± SD (standard deviation). * denotes signifi cant difference from controls 
(p<0.001).
Chapter 7
-145-
Neither 4-MBC nor 3-BC affected the rate of metamorphosis. Recorded developmental stages, 
body and tail lengths of X. laevis tadpoles exposed to 1, 5 and 50 μg/L of 4-MBC and 3-BC, 
respectively, did not differ from the tadpoles of the water and solvent controls (Figs. 1a, 1b). 
At all concentrations growth, tail development and tail resorption were not affected by the UV 
fi lters (Figs. 1c-1f). In contrast, the positive control (1 μg/L T4) accelerated metamorphosis and 
differed signifi cantly (p<0.001) from all other treatment groups in the developmental stage, as 
well as body and tail length. The exposure of tadpoles to 1, 5 and 50 μg/L of 4-MBC and 3-BC, 
respectively, had no signifi cant effect on sex ratio, nor gross gonad morphology when compared 
with controls (Figs. 2a, 2b).
Discussion
The goal of this study was to elucidate whether the two UV fi lters 4-MBC and 3-BC adversely 
affect the thyroid and sex hormone system of frogs Xenopus laevis. Recently some endocrine 
disrupting chemicals have been demonstrated to interfere with both, the thyroid and sex 
hormone system of amphibians (Goleman, Carr & Anderson, 2002; Moriyama et al., 2002). Tail 
resorption and developmental stage are important parameters for the assessment of thyroidogenic 
activity (DeVito et al., 1999). Anti-thyroid and thyroid-mimicking substances can be detected 
through delayed or enhanced metamorphosis resulting in lower or higher developmental stages, 
respectively (Fioramonti et al., 1997; Goleman et al., 2002). Therefore developmental stage, 
whole body and tail length of the tadpoles were determined in our experiments for possible 
effects of UV fi lters on metamorphic development, growth rate and tail resorption.
Neither of the tested UV fi lters did affect the rate of metamorphosis and thus, they do not 
exhibit thyroid-mimicking or anti-thyroid activity. Recorded developmental stages, body and 
tail lengths of X. laevis tadpoles exposed to 1, 5 and 50 μg/L of 4-MBC and 3-BC, respectively, 
did not differ from the tadpoles of the water and solvent controls, indicating that neither growth, 
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Figure 2  Effects of 4-methylbenzylidene camphor (a) and 3-benzylidene camphor (b) on the sex ratio 
(number of females/number of males)(n= 2 x 30 per treatment group) of X. laevis after 35 days of expo-
sure. Values are shown as mean ± SD (standard deviation). * denotes signifi cant difference from controls 
(p<0.001).
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nor tail development and tail resorption were affected by the UV fi lters at these concentrations. 
In contrast, the positive control (T4) accelerated metamorphosis and differed signifi cantly 
from all other treatment. The exposure of tadpoles to 1, 5 and 50 μg/L of 4-MBC and 3-BC, 
respectively, had no signifi cant effect on sex ratio, nor gross gonad morphology when compared 
with controls.
Our results show that the exposure of X. laevis tadpoles to the two UV fi lters at environmentally 
relevant concentrations did neither affect metamorphosis, nor sex ratio. Whereas tadpoles of the 
positive control (T4) showed smaller body and tail lengths and reached metamorphosis earlier, 
thus confi rming the reliability of this assay at least for compounds with strong thyroid activity. 
Our preliminarily results showing no impact of 4-MBC and 3-BC on sex ratio and gonad 
morphology do not rule out other effects on the sex hormone system. Gonadal development in 
X. laevis takes place prior to stage 56, at which the differentiation in female and male gonads 
can be determined. At stage 51-53 an undifferentiated gonad is established  and after exposure 
to estradiol at stages 51–54 around 50 % of the tadpole gonads showed normal ovaries, whereas 
the other 50 % had abnormal gonads, corresponding to ovotestes, in which normal development 
of genetic males was disrupted (Villalpando & Merchant-Larios, 1990). Based on these fi ndings 
that partial effects of estradiol treatment occurred at stages 51-54, it cannot be ruled out, that in 
our studies, lasting from stage 52-66, ovotestes or vitellogenin may have been induced, despite 
the lack of effects on the sex ratio.   
4-MBC and 3-BC showing weak estrogenicity (Holbech et al., 2002; Schlumpf et al., 2001) 
may only display effects on the thyroid and sex hormone system at much higher concentrations 
or at prolonged exposure of the tadpoles. The former is supported by the fact that estrogenic 
activity was lacking after short-term exposure of fi sh to 254 μg/L 4-MBC, but occurred at higher 
concentrations in vitro (Schreurs et al., 2002). Differences in exposure route, bioavailability and 
the capability of UV fi lters for binding to the different hormone receptors in different species 
may account for the differences in the studies. Ongoing studies in our laboratory will further 
test the hypothesis whether the UV fi lters possess hormonal activity.
Acknowledgements
This work was supported by the Swiss National Science Foundation (NFP 50, contract 4050-
66554 to K. Fent). We thank Prof. D. Rungger, Institute of Zoology, University of Geneva, for 
generously providing X. laevis tadpoles, Dr. C. Schanné and Dr. T. Gries, Springborn Smithers 
Laboratories (Europe) AG, R. Opitz, Leibniz-Institute of Freshwater Ecology and Inland 
Fisheries, Berlin and Dr. H. Schmutz, FHBB, for advice and Prof. F. Jüttner, University of 
Zürich, for reading the manuscript.
Chapter 7
-147-
References
DeVito, M., Biegel, L., Brouwer, A. & Brown, S. (1999). Environmental Health Perspectives, 107, 407-415.
Fioramonti, E., Semlitsch, R.D., Reyer, H.U. & Fent, K. (1997). Environmental Toxicology and Chemistry, 16, 
1940-1947.
Goleman, W.L., Carr, J.A. & Anderson, T.A. (2002). Environmental Toxicology and Chemistry, 21, 590-597.
Holbech, H., Norum, U., Korsgaard, B. & Bjerregaard, P. (2002). Pharmacology and Toxicology, 91, 204-208.
Kloas, W., Lutz, I. & Einspanier, R. (1999). Science of the Total Environment, 225, 59-68.
Miller, D., Wheals, B.B., Beresford, N. & Sumpter, J.P. (2001). Environmental Health Perspectives, 109, 133-
138.
Moriyama, K., Tagami, T., Akamizu, T., Usui, T., Saijo, M., Kanamoto, N. et al. (2002). Journal of Clinical 
Endocrinology & Metabolism, 87, 5185-5190.
Nagtegaal, M., Ternes, T.A., Baumann, W. & Nagel, R. (1997). UWSF-Z Umweltchemie und Ökotoxikologie, 9, 
79-86.
Poiger, T., Buser, H.R. & Müller, M.D. (2001). Verbrauch, Vorkommen in Oberfl ächengewässern und Verhalten 
in der Umwelt von Substanzen, die als UV-fi lter in Sonnenschutzmitteln eingesetzt werden. Wädenswil. 
Eidgenössische Forschungsanstalt für Obst-, Wein- und Gartenbau, CH-8820 Wädenswil. 1-45.
Schlumpf, M., Cotton, B., Conscience, M., Haller, V., Steinmann, B. & Lichtensteiger, W. (2001). Environmental 
Health Perspectives, 109, 239-244.
Schreurs, R., Lanser, P., Seinen, W. & Van der Burg, B. (2002). Archives of Toxicology, 76, 257-261.
Villalpando, I. & Merchant-Larios, H. (1990). International Journal of Developmental Biology, 34, 281-285.
Hormonal activity of 4MBC and 3BC in frogs
-148-
Chapter 8
- 149 -
Chapter 8
General Conclusions and Outlook
General conclusions and outlook
- 150 -
This dissertation focused on the hormonal activity of UV fi lters towards the aquatic organisms. 
Recently, organic UV fi lters gained environmental relevance, because of their demonstrated 
estrogenicity, antiestrogenic and antiandrogenic activity and their detection in lake and 
wastewater, but also in fi sh. However, due to the lack of data on the ecotoxicological and 
hormonal activity of UV fi lters, it remains unclear, whether environmental concentrations of UV 
fi lters negatively affect the hormone system of aquatic organisms. Currently an ecotoxicological 
risk assessment for aquatic organisms is premature, because the data base is not suffi cient. 
This dissertation was aimed at fi lling some of these signifi cant gaps by the use of a series of 
ecotoxicological in vitro and in vivo assays. The overall goal was to evaluate the estrogenic, 
antiestrogenic, androgenic and antiandrogenic activity in vitro of a series of single UV fi lters 
and estrogenic mixtures activities thereof. In addition the estrogenic and thyroid activity in vivo 
was evaluated in order to understand the hormonal activity and ecokinetics in important aquatic 
organisms.
Hormonal activity of UV fi lters in vitro
Hormonal activity of single UV fi lters. Our fi ndings demonstrate that many UV fi lters occurring 
in aquatic systems possess multiple hormonal activities in vitro, including estrogenicity, 
antiestrogenicity, androgenicity and antiandrogenicity through interactions with hERα and/
or hAR. For most of the UV fi lters with multiple hormonal activities residues in the aquatic 
environment and in biota are not yet known, and therefore their environmental relevance 
remains elusive. The fact that all 18 UV fi lters and one metabolite showed hormonal activities 
- surprisingly most of them multiple activities - reveals a complex picture of their activities. 
Antiestrogenicity and antiandrogenicity in vitro seems even more important than estrogenicity. 
Moreover, androgenic activity of six UV fi lters is demonstrated for the fi rst time. 
Our results support the fact that many estrogenic compounds may have more than one mode of 
action, and that their diverse hormonal activities are more complex than previously thought. The 
antiestrogenic, antiandrogenic and androgenic activities of UV fi lters in vitro are of signifi cant 
scientifi c and practical interest. Despite the limitations of yeast systems such as lower metabolic 
capacity as compared to many animal cell systems, they are an elegant and effi cient tool to 
identify endocrine disrupting compounds that may further be investigated in vivo, especially 
regarding adverse effects in fi sh. 
Hormonal activity of UV fi lter mixtures. Recent studies on hormonal activities of UV fi lters 
suggest that these compounds possess only endocrine disrupting properties at rather high, 
environmentally not relevant concentrations. Although we found in the yeast hERα assay 
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that most of the UV fi lters exert multiple hormonal activities at concentrations that are orders 
of magnitude higher than in the environment, wide distribution of and exposure to UV fi lter 
mixtures may have environmental consequences due to additive effects. Thus the UV fi lters 
4MBC, BP3, BP4, OMC, OC and HMS that were repeatedly detected in the aquatic environment, 
may contribute with their multiple hormonal activities in a complex manner to the mixture of 
endocrine disrupting chemicals already present in surface water and fi sh. Our in vitro fi ndings on 
estrogenic mixture activities of pure and parital hERα agonistic UV fi lters seem to support this 
hypothesis. Especially the pronounced synergistic effects of multi-component mixtures of UV 
fi lters below the NOEC indicate that low UV fi lter concentrations present in the environment 
may produce relevant estrogenic activity on their own or lead to enhanced estrogenic activities 
of other more potent xenoestrogens or E2, depending on the mixture components. 
 
Indeed, concentrations of single UV fi lters in the NOEC mixtures were mostly in the μg/L 
range when eliciting highest estrogenic activities in vitro. These are effect concentrations that 
are close to residual concentrations of UV fi lters found in the environment. Our fi ndings on 
UV fi lter mixtures furthermore suggest that partial agonistic UV fi lters not necessarily lead to 
a reduced overall mixture activity and antagonism. In order to fi nd out if our in vitro fi ndings 
for mixtures will translate into animal cell-lines and to effects in vivo in fi sh, further studies are 
needed to support our results. 
Hormonal activity of UV fi lters in vivo
Estrogenic activity of UV fi lters in fi sh. In order to investigate whether our in vitro results on 
estrogenicity translate to in vivo activity we exposed juvenile fathead minnows for 14 days to 9 
different UV fi lters. Seven UV fi lters were found to be estrogenic in vitro (BP1, BP2, BP3, BP4, 
DHB, Et-PABA and 3BC), whereas the others possessed no estrogenicity (4MBC, OMC). Of 
these UV fi lters, 3BC, BP1 and BP2 showed estrogenic activity in fathead minnows. 3BC was 
the most estrogenic UV fi lter in juvenile fathead minnows and led to dose dependent induction 
of VTG at 435 and 953 µg/L. The estrogenicity detected for BP1 at 4919 µg/L and BP2 at 8783 
µg/L was considerably weaker. The other UV fi lters (4MBC, OMC, BP3, BP4, 4DHB) did not 
induce VTG up to the highest concentrations.
In the environment only a few UV-fi lters such as OC, 4MBC, BP3 and BM-DBM have been 
analysed so far and 3BC, BP1 and BP2 which were found in our study to be estrogenic are not 
among them. However, concentrations of UV fi lters were detected up to 125 ng/L in lake water, 
up to 2.7 μg/L in treated wastewater, and up to 3.1 µg/g in fi sh, and thus considerably lower 
than the UV fi lter concentrations to induce VTG. Our data on VTG induction suggest that one 
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single UV fi lter may probably not pose a hazard to fi sh. However, different UV fi lters may 
act additively (chapter 3) (Heneweer et al. 2005) as indicated for other endocrine disrupters 
(Routledge et al. 1998). Moreover, long-term exposure to UV fi lters may affect fi sh reproduction 
at much lower concentrations.
Predictive value for in vivo activity of the yeast hER and rtER in vitro assays. Considering the 
vast number of compounds to be tested for possible endocrine activity, it is important to employ 
appropriate in vitro systems. Thus in order to evaluate if the used in vitro assays, carrying either 
the hERa or rtERa, have any predictive value to estimate in vivo activity in fi sh, we compared 
our in vitro and in vivo fi ndings for the 9 UV fi lters investigated in juvenile fathead minnows. 
The advantage of in vitro assays is that they are cost effective and allow for rapid screening 
of a large number of compounds, but they have limitations, which may result in unreliable 
predictions. 
We found that all compounds, except OS, were equally estrogenic in vitro in both assays despite 
the lower activity of E2 in the rtERα assay. When comparing in vitro activities of the two 
systems with fi sh in vivo activity, we found that the rtERα in vitro data were more accurate for 
estimating in vivo activity. Hence estrogenic activity of chemicals is best assessed by the use 
of a tiered approach with a combination of in vitro and in vivo assays of the same phyla, and if 
possible, of the same species. In this tiered approach, the predictive power of in vitro systems is 
enhanced and cost intensive in vivo studies can be reduced by employing species-specifi c in vitro 
assays. Hence, environmental risk assessment should be based on combined, complementing 
and appropriate species-related in vitro and in vivo assays for hormonal activity. 
Effects of 3BC on fi sh reproduction. We investigated the most potent UV fi lter detected in 
the short-term experiment with juvenile fathead minnows, 3BC, for possible adverse effects 
on reproduction. 3BC signifi cantly affected the reproduction of this fi sh. Females stopped 
reproducing immediately after the onset of exposure at a concentration of 74 µg/L 3BC and 
higher. To our surprise, the lowest observed effect concentration for the most sensitive parameter, 
gonadal histology, was 3 µg/L. This parameter is an order of magnitude more sensitive than 
VTG induction. Hence the question arises whether the hormonal activity of a compound is 
underestimated by determining VTG induction alone, and that also BP1 and BP2, that were 
found active in fi sh, nevertheless pose a potential risk towards fi sh (chapter 4).
Environmental concentrations of 3BC in water and fi sh have not yet been reported, but may 
reach the same level than other UV fi lters such as 4MBC. If they are in the low n/L to µg/L range 
as other UV fi lters, effects of 3BC on fi sh reproduction can not be ruled out, especially as 3BC 
is lipophilic and bioaccumulated during the 21 days of exposure with a bioconcentration factor 
of 207 to 648. Furthermore the presence of other UV fi lters and hormonally active compounds, 
Chapter 8
- 153 -
which may interact additively may adversely affect fi sh reproduction in contaminated aquatic 
systems. The pronounced effect of 3BC on reproduction, fecundity and fertility in fi sh after a 
21 days exposure has signifi cant consequences for potential hazard and risks of widely used 
UV fi lters.
Effects of 3BC and 4MBC on frog metamorphosis. As another important representative of 
aquatic organisms, tadpoles of frogs Xenopus laevis were also studied for their susceptibility 
towards two UV fi lters. Because metamorphosis is a critical period for endocrine disruption, 
we investigated, whether 4MBC and 3BC interfere with the thyroid and sex hormone system 
during frog metamorphosis. Neither 4MBC nor 3BC did affect the rate of metamorphosis, and 
no obvious differences in body length and tail length compared to controls were observed. 
Also the UV fi lters did not lead to alterations of the sex ratio of X. laevis tadpoles. Our fi ndings 
indicate that neither 4MBC nor 3BC negatively affect the thyroid system and sex development 
of frogs at concentrations expected to be found in the environment. 
A tentative hazard assessment for UV fi lters
There are still more data needed such as the bioaccumulation potential and mixture activity 
of UV fi lter in fi sh, before an accurate ecotoxicological risk assessment for aquatic organisms 
can be performed. However, in order to evaluate whether a further risk assessment has to be 
performed, we calculated PEC/PNEC values based on our results and data on environmental 
concentrations from the literature.  
Environmental concentrations of 3BC, BP1, BP2 and Et-PABA are not existent, therefore 
we assume similar environmental concentrations of structurally similar compounds such as 
4MBC, BP3 and PABA as an approximation for the predicted exposure concentration (PEC). 
When lipid based weights in fi sh were used instead of concentrations in water, we divided the 
concentrations found in fi sh by a factor of 20, based on the assumption that the lipids content 
in fi sh are approximately 5%. 
The predicted no effect concentration (PNEC) was calculated as follows: 
PNEC = lowest exposure concentration / safety factor
For estimating the PNEC, we used the median value of the most signifi cant reproduction 
parameter, which was the alteration of the gonadal histology for 3BC and VTG induction for 
BP1, BP2 and Et-PABA. We used a safety factor of 100, which is used when acute LC 50 
values for fi sh, crustaceans or algae are known, or when chronic values for one of this group 
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exist. Values for acute and chronic toxicity parameters and environmental concentrations and 
calculations for our tentative hazard assessment are found in Table 1:
Toxicity 
acute
(mg/L)
chronic
(mg/L)
LOEC
(μg/L)
Safety
factor PNEC
(μg/L)
PEC
(µg/L)
PEC/
PNEC
Risk
3BC
BP1
BP2
Et-PABA
0.1411)
3.8822)
3.8822)
62.003)
>1
>5
>10
>10
3
4’919
8’783
4’393
100
100
100
100
0.03
49.2
87.8
43.9
0.1 4)
0.5 5)
0.5 5)
0.5 5)
3.3
0.010
0.005
0.011
YES
NO
NO
NO
1) 3BC, LC50 in fi sh 96 h, rainbow trout
2) BP3, LC50 in fi sh 96 h, rainbow trout
3) Et-PABA, LC50 in fi sh 24 h, rainbow trout, Invest Fish Control Rep. No. 87, Fish Wildl. Serv., Bur. Sport Fish. Wildl., 
U.S.D.I., Washington, D.C.; 50, 1979
4)Balmer et al., 2005: mean concentration of 4MBC in wastewater effl uent.
5)Lorraine and Pettigrove, 2006: mean concentration of benzophenone in raw drinking water.
The tentative risk assessment indicates that a hazard and risk of 3BC exists for fi sh, but not for 
BP1, BP2 and Et-PABA. However, the LOEC concentrations we used for BP1, BP2, and Et-
PABA are based on VTG induction, which may be two orders of magnitude less sensitive than 
histology towards endocrine disruption, which we clearly demonstrated for 3BC. Therefore, a 
potential risk of these UV fi lters cannot be ruled out.
Final remarks and outlook
Our study reveals a novel and more detailed picture of the hormonal activity of UV fi lters, 
as single compounds and in mixtures, in vitro and in vivo. It discloses unexpected multiple 
hormonal activities and synergistic properties of these compounds in vitro and an unexpected 
negative effect on fi sh reproduction by the UV fi lter 3BC at nearly environmentally relevant 
concentrations in vivo. Hence, diverse hormonal activities of UV fi lters found in this study are 
of signifi cant scientifi c and practical interest.
Generally we think that in order to perform an adequate risk assessment for UV fi lters it seems 
unavoidable to consider several levels of investigation. First, screening of UV fi lters for multiple 
hormonal activities and mixture activities in vitro reveals UV fi lters that may also have activity 
in vivo. Second, reproduction experiments in fi sh provide more sensitive and informative data 
on the endocrine disrupting properties of an UV fi lter and third, compound mixtures have to 
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be taken into account when investigating endocrine disrupting properties of UV fi lters towards 
aquatic organisms. 
As it is not known to what extend the estrogenic UV fi lters occur in the environment and in 
fi sh, a comprehensive hazard and risk assessment is premature. Forthcoming studies should 
determine environmental concentrations of UV fi lters with hormonal activity and should relate 
them to effect concentrations. For hazard and risk assessment, potential effects on reproduction, 
fecundity and fertility in fi sh are necessary, as well as bioaccumulation studies. Moreover, 
UV fi lters may have multiple hormonal activities such as antiestrogenicity, androgenicity and 
antiandrogenicity besides estrogenicity and their activity in mixtures has to be considered in 
addition. Whether these multiple hormonal activities and mixture activities are refl ected in 
vivo in fi sh and whether reproduction effects occur will be investigated in our laboratory in 
forthcoming studies.
General conclusions and outlook
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